Processing 00000000.tx.1: Rockefeller University Press, 0022-1007/2002/2/295/ $5.00 The Journal of Experimental Medicine, Volume 195, Number 3, February 4, 2002 295-308 Original Article Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMPdependent and independent Processes Kevin B. 

Phrase: "Rockefeller University Press,"

Phrase: "0022-1007/2002/2/295/ $5.00"

Phrase: "The Journal of Experimental Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "Volume 195,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "Number 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "February 4,"

Phrase: "2002 295-308 Original Article Matrix Metalloproteinases (MMPs)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1704640:Matrix [Spatial Concept]
   795   C1706515:Matrix [Body Substance]

Phrase: "Regulate"

Phrase: "Fibrin-invasive Activity via MT1-MMPdependent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "independent Processes Kevin B."
Processing 00000000.tx.2: Hotary1, Ikuo Yana1, Farideh Sabeh1, Xiao-Yan Li1, Kenn Holmbeck2, Henning Birkedal-Hansen2, Edward D. 

Phrase: "Hotary1,"

Phrase: "Ikuo Yana1,"

Phrase: "Farideh Sabeh1,"

Phrase: "Xiao-Yan Li1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450477:LI1 [Body Location or Region]
   827   C1420713:LI1 [Gene or Genome]

Phrase: "Kenn Holmbeck2,"

Phrase: "Henning Birkedal-Hansen2,"

Phrase: "Edward D."
Processing 00000000.tx.3: Allen1, Nobuaki Hiraoka1 and Stephen J. 

Phrase: "Allen1,"

Phrase: "Nobuaki Hiraoka1"

Phrase: "and"

Phrase: "Stephen J."
Processing 00000000.tx.4: Weiss1 1 University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109 2 National Institutes of Health/National Institute of Dental and Craniofacial Research, Bethesda, MD 20892 Address correspondence to Stephen J. 

Phrase: "Weiss1 1 University of Michigan Comprehensive Cancer Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1519799:University of Michigan Comprehensive Cancer Center [Health Care Related Organization]
   835   C1516764:Comprehensive Cancer Center [Health Care Related Organization]
   812   C1513817:Cancer Center [Health Care Related Organization]
   793   C0205099:Center [Spatial Concept]

Phrase: "Ann Arbor,"

Phrase: "MI 48109 2 National Institutes of Health/National Institute of Dental"

Phrase: "and"

Phrase: "Craniofacial Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "Bethesda,"

Phrase: "MD 20892 Address correspondence to Stephen J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0282413:Correspondence [Intellectual Product]
Processing 00000000.tx.5: Weiss, 5220 MSRB III, 1150 W. 

Phrase: "Weiss,"

Phrase: "5220 MSRB III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "1150 W."
Processing 00000000.tx.6: Medical Center Dr., Ann Arbor, MI 48109-0640. 

Phrase: "Medical Center Dr., Ann Arbor,"

Phrase: "MI 48109-0640."
Processing 00000000.tx.7: Phone: 734-764-0030; 

Phrase: "Phone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C1515258:Phone [Conceptual Entity]
  1000   C1705541:Phone [Manufactured Object]
   907 E C0042939:Voice [Organism Function]
   907 E C3244282:voice [Qualitative Concept]
   893 E C0205382:Vocal [Functional Concept]
   893 E C0871074:phonic [Intellectual Product]

Phrase: ":"

Phrase: "734-764-0030"

Phrase: ";"
Processing 00000000.tx.8: Fax: 734-764-0101; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "734-764-0101"

Phrase: ";"
Processing 00000000.tx.9: E-mail: SJWEISS{at}umich.edu  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  Cross-linked fibrin is deposited in tissues surrounding wounds, inflammatory sites, or tumors and serves not only as a supporting substratum for trafficking cells, but also as a structural barrier to invasion. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "SJWEISS{at}umich.edu  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cross-linked fibrin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0178576:Cross Linked [Natural Phenomenon or Process]
   901   C0332220:cross linked [Functional Concept]
   827   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C2828360:Cross [Conceptual Entity]
   793   C1517892:Link [Intellectual Product]
   793   C1704666:Link [Intellectual Product]
   755 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "is"

Phrase: "deposited in tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0040300:Tissues [Tissue]
   790   C0333562:deposited [Functional Concept]
   756 E C1547928:Tissue [Intellectual Product]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "wounds,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021501:wounds [Qualitative Concept]
  1000   C0043250:Wounds [Injury or Poisoning]

Phrase: "inflammatory sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "or"

Phrase: "tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "serves"

Phrase: "not only as a supporting substratum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205171:Only [Quantitative Concept]
   753   C1518422:Not [Functional Concept]
   753   C1720467:Only [Intellectual Product]
   719   C0183683:Support [Medical Device]
   719   C1521721:Support [Conceptual Entity]

Phrase: "for"

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "also as a structural barrier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0678594:Structural [Spatial Concept]
   760   C1706912:BARRIER [Medical Device]

Phrase: "to invasion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]
Processing 00000000.tx.10: While the plasminogen activator-plasminogen axis provides cells with a powerful fibrinolytic system, plasminogen-deleted animals use alternate proteolytic processes that allow fibrin invasion to proceed normally. 

Phrase: "While"

Phrase: "the plasminogen activator-plasminogen axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0004457:Axis [Body Part, Organ, or Organ Component]
   812   C0999597:Axis [Mammal]
   812   C1522496:Axis [Spatial Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "cells with a powerful fibrinolytic system,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "plasminogen-deleted animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "alternate proteolytic processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "fibrin invasion to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1269955:Invasion [Finding]
   827   C2699153:Invasion [Pathologic Function]

Phrase: "proceed"

Phrase: "normally."
Processing 00000000.tx.11: Using fibroblasts recovered from wild-type or gene-deleted mice, invasion of three-dimensional fibrin gels proceeded in a matrix metalloproteinase (MMP)-dependent fashion. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "recovered from wild-type"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C0521108:recovered [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]
   737 E C2004454:recover [Organism Function]

Phrase: "or"

Phrase: "gene-deleted mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "invasion of three-dimensional fibrin gels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1269955:Invasion [Finding]
   753   C2699153:Invasion [Pathologic Function]

Phrase: "proceeded in a matrix metalloproteinase (MMP)-dependent fashion."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C1704640:Matrix [Spatial Concept]
   748   C1706515:Matrix [Body Substance]
   748   C3244310:dependent [Functional Concept]
Processing 00000000.tx.12: Consistent with earlier studies supporting a singular role for the membrane-anchored MMP, MT1-MMP, in fibrin-invasive events, fibroblasts from MT1-MMPnull mice displayed an early defect in invasion. 

Phrase: "Consistent with earlier studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "a singular role for the membrane-anchored MMP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "MT1-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "in fibrin-invasive events,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "fibroblasts from MT1-MMPnull mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1522260:Mouse Fibroblast [Cell]
   760   C0016030:Fibroblasts [Cell]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "an early defect in invasion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.13: However, MT1-MMPdeleted fibroblasts circumvented this early deficiency and exhibited compensatory fibrin-invasive activity. 

Phrase: "However,"

Phrase: "MT1-MMPdeleted fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]

Phrase: "circumvented"

Phrase: "this early deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "and"

Phrase: "exhibited compensatory fibrin-invasive activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.14: The MT1-MMPindependent process was sensitive to MMP inhibitors that target membrane-anchored MMPs, and further studies identified MT2-MMP and MT3-MMP, but not MT4-MMP, as alternate pro-invasive factors. 

Phrase: "The MT1-MMPindependent process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "sensitive to MMP inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "that"

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "membrane-anchored MMPs,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "identified MT2-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT3-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "but"

Phrase: "not MT4-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "as"

Phrase: "alternate pro-invasive factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.15: Given the widespread distribution of MT1-, 2-, and 3-MMP in normal and neoplastic cells, these data identify a subset of membrane-anchored MMPs that operate in an autonomous fashion to drive fibrin-invasive activity. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the widespread distribution of MT1-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "2-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3-MMP in normal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C0164371:Matrix Metalloproteinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   844   C1366358:MATRIX METALLOPROTEINASE 3 [Gene or Genome]
   806   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "neoplastic cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0597032:Neoplastic cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1709160:Neoplastic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C0027651:Neoplasia [Neoplastic Process]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "identify"

Phrase: "a subset of membrane-anchored MMPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515021:Subset [Classification]

Phrase: "that"

Phrase: "operate in an autonomous fashion to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3242339:operate [Functional Concept]

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "fibrin-invasive activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.16: Key Words: matrix metalloproteinases  MT-MMP  fibrin  proteolysis  invasion  Introduction Top Abstract Introduction Materials and Methods Results Discussion References  In response to tissue damage, inflammation, or neoplastic growth, a provisional matrix largely composed of cross-linked fibrin and fibronectin is deposited at the affected site (1, 2). 

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "matrix metalloproteinases  MT-MMP  fibrin  proteolysis  invasion  Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   786   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  In response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0871261:Response [Organism Attribute]
   790   C1514811:Reference [Idea or Concept]
   790   C1704632:Response [Finding]
   790   C1706462:Reference [Conceptual Entity]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to tissue damage,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010957:Tissue damage [Injury or Poisoning]
           Damage
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   861   C1883709:Damage [Functional Concept]

Phrase: "inflammation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "or"

Phrase: "neoplastic growth,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0027651:Neoplastic growth [Neoplastic Process]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "a provisional matrix largely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "composed of cross-linked fibrin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0178576:Cross Linked [Natural Phenomenon or Process]
   806   C0332220:cross linked [Functional Concept]
   760   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C2828360:Cross [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "deposited at the affected site"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0449642:Affected site [Spatial Concept]
   760   C0205145:Site [Spatial Concept]
   760   C0333562:deposited [Functional Concept]
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: While the fibrin scaffolding functions initially as a structural support for infiltrating fibroblasts, endothelial cells, leukocytes, or tumor cells, the cross-linked network also acts as a physical barrier to cell traffic (214). 

Phrase: "While"

Phrase: "the fibrin scaffolding functions initially as a structural support"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0542341:Functions [Functional Concept]
   708 E C0031843:function [Physiologic Function]
   708 E C0700205:FUNCTION [Classification]
   708 E C1705273:Function [Intellectual Product]

Phrase: "for infiltrating fibroblasts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "leukocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023516:Leukocytes [Cell]

Phrase: "or"

Phrase: "tumor cells,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0431085:Tumor cells [Cell]
   966 E C0597032:Tumor Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the"

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "network also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1513822:Network [Professional or Occupational Group]
   861   C1705739:Network [Manufactured Object]
   861   C1882071:Network [Conceptual Entity]

Phrase: "acts as a physical barrier"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031809:Physical [Health Care Activity]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0205485:Physical [Functional Concept]
   760   C1509143:Physical [Finding]
   760   C1706912:BARRIER [Medical Device]

Phrase: "to cell traffic"

Phrase: "(214"

Phrase: ")."
Processing 00000000.tx.18: Currently, invading cells are thought to use proteinases to access the fibrin matrix with proteolysis purposefully restricted to the pericellular milieu of the ingressing cells (3, 14, 15). 

Phrase: "Currently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "invading"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "proteinases to"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "access"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444454:Access [Spatial Concept]
  1000   C1554204:access [Idea or Concept]

Phrase: "the fibrin matrix with proteolysis purposefully"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]

Phrase: "restricted to the pericellular milieu of the ingressing cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   742   C0007634:Cells [Cell]
   742   C0443288:Restricted [Functional Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.19: In this manner, the overall structural integrity of the matrix would be preserved as a mechanical support for propulsive movement (3, 5, 6, 1115). 

Phrase: "In this manner,"

Phrase: "the overall structural integrity of the matrix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205266:integrity [Qualitative Concept]
   748   C0872403:integrity [Individual Behavior]
   748   C1947912:Integrity [Qualitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "preserved as a mechanical support"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033085:Preserved [Laboratory Procedure]
   760   C0183683:Support [Medical Device]
   760   C0443254:Mechanical [Functional Concept]
   760   C1521721:Support [Conceptual Entity]

Phrase: "for propulsive movement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026649:Movement [Organism Function]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "1115"

Phrase: ")."
Processing 00000000.tx.20: Based on the ability of the plasminogen activator-plasminogen axis to rapidly dissolve intravascular fibrin deposits, it has been generally assumed that cell surface-associated plasmin plays a key, if not necessary, role in driving the fibrin-invasive phenotype in the extravascular compartment (5, 6, 11, 12). 

Phrase: "Based on the ability of the plasminogen activator-plasminogen axis"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   739   C0004457:Axis [Body Part, Organ, or Organ Component]
   739   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0085732:Ability [Organism Attribute]
   739   C0999597:Axis [Mammal]
   739   C1367553:PLASMINOGEN [Gene or Genome]
   739   C1522496:Axis [Spatial Concept]
   739   C1527178:Based [Functional Concept]
   739   C1705938:Based [Idea or Concept]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "to rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "dissolve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549535:Dissolve [Functional Concept]

Phrase: "intravascular fibrin deposits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "generally"

Phrase: "assumed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]

Phrase: "that cell surface-associated plasmin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   708   C0699040:cell associated [Cell Component]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a key,"

Phrase: "if"

Phrase: "not necessary, role in driving"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "the fibrin-invasive phenotype in the extravascular compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031437:Phenotype [Organism Attribute]
   744   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.21: However, in plasminogen-null animals, fibrin-rich tissues are infiltrated efficiently by normal as well as neoplastic cell types despite significant defects in intravascular fibrinolysis (3, 9, 1618). 

Phrase: "However,"

Phrase: "in plasminogen-null animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "fibrin-rich tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0040300:Tissues [Tissue]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "are"

Phrase: "infiltrated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332448:infiltrated [Pathologic Function]
   966 E C1546677:Infiltrate [Intellectual Product]
   966 E C1549537:Infiltrate [Functional Concept]

Phrase: "efficiently by normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: "as well as"

Phrase: "neoplastic cell types despite significant defects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0449475:Cell types [Intellectual Product]
   756 E C0007634:Cell Type [Cell]
   753   C0332307:Types [Qualitative Concept]
   719 E C1547052:*Type [Quantitative Concept]

Phrase: "in intravascular fibrinolysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016017:Fibrinolysis [Physiologic Function]
   861   C1305868:Fibrinolysis [Laboratory Procedure]
   789 E C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "9,"

Phrase: "1618"

Phrase: ")."
Processing 00000000.tx.22: Consequently, increased attention has focused on the identification of alternate proteolytic systems that would allow cells to infiltrate fibrin matrices via a plasminogen-independent process. 

Phrase: "Consequently,"

Phrase: "increased attention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004268:Attention [Mental Process]

Phrase: "has"

Phrase: "focused on the identification of alternate proteolytic systems"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0020792:Identification [Mental Process]
   744   C0205234:Focused [Spatial Concept]
   744   C0205396:Identification [Qualitative Concept]
   744   C0332270:alternate [Functional Concept]
   744   C0597304:Proteolytic [Molecular Function]
   744   C1285542:focused [Functional Concept]
   744   C1523987:Alternate [Conceptual Entity]
   744   C1947941:proteolytic [Enzyme]
   711   C0449913:System [Functional Concept]
   711   C1553451:System [Manufactured Object]
   711   C1704459:System [Medical Device]

Phrase: "that"

Phrase: "would"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "infiltrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332448:Infiltrate [Pathologic Function]
  1000   C1546677:Infiltrate [Intellectual Product]
  1000   C1549537:Infiltrate [Functional Concept]

Phrase: "fibrin matrices via a plasminogen-independent process."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C1704639:Matrices [Manufactured Object]
   714 E C1704640:Matrix [Spatial Concept]
   714 E C1706515:Matrix [Body Substance]
Processing 00000000.tx.23: Recently, we identified an unexpected role for matrix metalloproteinases (MMPs)* in fibrin-invasive activity (3). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "an unexpected role for matrix metalloproteinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: ")"

Phrase: "*"

Phrase: "in fibrin-invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.24: The MMP gene family consists of 25 proteinases, of which 18 are secreted and 7 are membrane-associated either as transmembrane- or GPI-anchored enzymes (1921). 

Phrase: "The MMP gene family"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C1517488:Gene Family [Gene or Genome]
   812   C0015576:Family [Family Group]
   812   C1704727:Family [Conceptual Entity]
   741 E C0241888:Familial [Functional Concept]

Phrase: "consists of 25 proteinases, of which 18"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   774   C0450335:18 25 [Quantitative Concept]
   748   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0332529:CONSIST [Qualitative Concept]
   714 E C1622131:proteinase [Molecular Function]
   714 E C1947941:Proteinase [Enzyme]

Phrase: "are"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "and"

Phrase: "7"

Phrase: "are"

Phrase: "membrane-associated either as transmembrane-"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0025255:Membrane [Tissue]
   760   C0332281:Associated [Qualitative Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1167322:transmembrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   760   C2752508:transmembrane [Cell Component]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or"

Phrase: "GPI-anchored enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "(1921"

Phrase: ")."
Processing 00000000.tx.25: In our earlier studies, a membrane-anchored MMP, termed MT1-MMP, which is expressed in fibroblasts and endothelial cells, was able to confer a fibrin-invasive phenotype to invasion-incompetent, recipient cells after transfection (3). 

Phrase: "In our earlier studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "a membrane-anchored MMP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "termed MT1-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "which"

Phrase: "is"

Phrase: "expressed in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0016030:Fibroblasts [Cell]

Phrase: "and"

Phrase: "endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "confer"

Phrase: "a fibrin-invasive phenotype to invasion-incompetent,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031437:Phenotype [Organism Attribute]
   748   C1285572:Phenotype [Laboratory Procedure]

Phrase: "recipient cells after transfection"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.26: However, in the absence of specific MT1-MMP inhibitors or gene-deleted animals, the functional importance of this metalloproteinase in a physiologically relevant cell population has remained the subject of conjecture. 

Phrase: "However,"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of specific MT1-MMP inhibitors"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   884   C1513016:Matrix Metalloproteinase Inhibitors [Pharmacologic Substance]
   884   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   823   C1152589:metalloproteinase inhibitor [Molecular Function]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]
   771 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "gene-deleted animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "the functional importance of this metalloproteinase"

Phrase: "in a physiologically relevant cell population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]

Phrase: "has"

Phrase: "remained"

Phrase: "the subject of conjecture."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0681850:Subject [Group]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]
Processing 00000000.tx.27: This issue has been further complicated by the fact that more recent studies have demonstrated that an expanding number of secreted MMPs likewise express fibrin(ogen)olytic activity (3, 2227). 

Phrase: "This issue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "complicated by the fact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0231242:Complicated [Functional Concept]

Phrase: "that more recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "an expanding number of secreted MMPs likewise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "express"

Phrase: "fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "olytic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "2227"

Phrase: ")."
Processing 00000000.tx.28: Given the recent generation of MT1-MMPdeleted mice (28, 29), we undertook studies to determine the ability of this proteinase as well as other fibrin(ogen)olytic MMPs to regulate fibrin invasion. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the recent generation of MT1-MMPdeleted mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "(28,"

Phrase: "29"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "undertook"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the ability of this proteinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "as well as"

Phrase: "other fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "olytic MMPs to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "regulate"

Phrase: "fibrin invasion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1269955:Invasion [Finding]
   861   C2699153:Invasion [Pathologic Function]
Processing 00000000.tx.29: We now demonstrate that whereas wild-type fibroblasts utilize MMPs to penetrate cross-linked fibrin gels under physiologic conditions, MT1-MMPnull fibroblasts unexpectedly display only a transient defect in fibrin-invasive activity. 

Phrase: "We now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "whereas"

Phrase: "wild-type fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0016030:Fibroblasts [Cell]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "utilize"

Phrase: "MMPs to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "penetrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrate [Functional Concept]

Phrase: "cross-linked fibrin gels under physiologic conditions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0017243:Gels [Biomedical or Dental Material]
   714 E C1382104:Gel [Substance]

Phrase: "MT1-MMPnull fibroblasts unexpectedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0016030:Fibroblasts [Cell]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a transient defect in fibrin-invasive activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1457869:Defect [Functional Concept]
   748   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.30: Further studies reveal that an additional subset of membrane-anchored MMPs, including MT2-MMP and MT3-MMP, but not MT4-MMP, allow cells to traverse fibrin matrices independently of MT1-MMP. 

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "that"

Phrase: "an additional subset of membrane-anchored MMPs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1515021:Subset [Classification]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "MT2-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT3-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "but"

Phrase: "not MT4-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "cells to traverse fibrin matrices"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   764   C1383501:Cell Matrix [Cell Component]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "independently of MT1-MMP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]
Processing 00000000.tx.31: These findings identify a triad of MT-MMPs whose expression, alone or in combination, is sufficient to confer fibrin-invasive activity. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "identify"

Phrase: "a triad of MT-MMPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0076994:triad [Biomedical or Dental Material,Organic Chemical]
   753   C1179122:triad [Cell Component]

Phrase: "whose expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in combination,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "confer"

Phrase: "fibrin-invasive activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.32: We posit that normal or neoplastic cells expressing any of these three MT-MMPs will display potent fibrin-invasive activity that functions independently of the plasminogen activator-plasminogen axis.  

Phrase: "We"

Phrase: "posit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0814253:POSIT [Intellectual Product]

Phrase: "that normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "or"

Phrase: "neoplastic cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0597032:Neoplastic cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1709160:Neoplastic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C0027651:Neoplasia [Neoplastic Process]

Phrase: "expressing"

Phrase: "any of these three MT-MMPs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205449:Three [Quantitative Concept]
   748   C1552551:Any [Qualitative Concept]
   748   C1704640:Matrix [Spatial Concept]
   748   C1706515:Matrix [Body Substance]
   748   C3272371:ANY [Intellectual Product]

Phrase: "will"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "potent fibrin-invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "functions independently of the plasminogen activator-plasminogen axis."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   767   C0001283:Function Activator [Medical Device]
   767   C0700205:Function Axis [Classification]
           FUNCTION
   744   C0004457:Axis [Body Part, Organ, or Organ Component]
   744   C0031843:function [Physiologic Function]
   744   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0542341:Function [Functional Concept]
   744   C0999597:Axis [Mammal]
   744   C1367553:PLASMINOGEN [Gene or Genome]
   744   C1522496:Axis [Spatial Concept]
   744   C1705273:Function [Intellectual Product]
Processing 00000000.tx.33: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Cell Culture. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell Culture."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.34: MDCK and CHO-K1 cell lines (both from American Type Culture Collection) were maintained in DMEM and RPMI 1640 (GIBCO BRL), respectively, supplemented with 10% fetal bovine serum (Hyclone), 2 mM L-glutamine, and antibiotics as described (30). 

Phrase: "MDCK"

Phrase: "and"

Phrase: "CHO-K1 cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C0085080:CHO cell [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "("

Phrase: "both from American Type Culture Collection"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   882   C0598079:American Type Culture Collection [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0238767:Both [Spatial Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0596070:American [Population Group]
   753   C1516698:Collection [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C1704814:Collection [Idea or Concept]
   753   C1706086:Both [Qualitative Concept]
   753   C2242979:Culture [Laboratory Procedure]

Phrase: ")"

Phrase: "were"

Phrase: "maintained in DMEM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "and"

Phrase: "RPMI 1640"

Phrase: "(GIBCO BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "respectively,"

Phrase: "supplemented with 10% fetal bovine serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "(Hyclone"

Phrase: ")"

Phrase: ","

Phrase: "2 mM L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "antibiotics as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003232:Antibiotics [Antibiotic]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.35: Stably transfected MDCK cells were maintained in medium containing 700 g/ml G418 (Life Technologies). 

Phrase: "Stably transfected MDCK cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0598829:MDCK Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "in medium containing 700 g/ml G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.36: Mouse fibroblasts were isolated from dermal explants of MT1-MMP null or wild-type littermates as described (31) and used between the third and sixth passages. 

Phrase: "Mouse fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1522260:Mouse Fibroblast [Cell]
   861   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "isolated from dermal explants of MT1-MMP"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   800   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205409:Isolated [Functional Concept]
   744   C0221928:Dermal [Qualitative Concept]
   744   C1522447:Dermal [Functional Concept]
   744   C1548221:Isolated [Idea or Concept]
   744   C1704640:Matrix [Spatial Concept]
   744   C1706515:Matrix [Body Substance]
   744   C3540571:MT1 [Gene or Genome]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "null"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456148:Null [Quantitative Concept]

Phrase: "or"

Phrase: "wild-type littermates as described"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "used between the third"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0205437:Third [Quantitative Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "sixth passages."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439799:Passage [Spatial Concept]
Processing 00000000.tx.37: All cultures were maintained at 37C in 5% CO2/95% air. 

Phrase: "All cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "maintained at 37C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "in 5% CO2/95% air."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0001861:Air [Substance]
   812   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   729 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.38: Expression Vector Construction and Transfection. 

Phrase: "Expression Vector Construction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441513:Construction [Therapeutic or Preventive Procedure]
   734   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "Transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.39: Expression vectors including FLAG-tagged MT1-MMP, MT2-MMP, and MT3-MMP as well as stably transfected MDCK cells overexpressing MMPs 2, 3, 7, 9, 11, 13, MT1-, 2-, and 3-MMPs have been described in detail previously (30). 

Phrase: "Expression vectors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "FLAG-tagged MT1-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]

Phrase: "MT2-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT3-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "as well as"

Phrase: "stably transfected MDCK cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0598829:MDCK Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "MMPs 2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C0172537:Matrix Metalloproteinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   983   C1334522:MATRIX METALLOPROTEINASE 2 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "7,"

Phrase: "9,"

Phrase: "11,"

Phrase: "13,"

Phrase: "MT1-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540571:MT1 [Gene or Genome]

Phrase: "2-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3-MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "have"

Phrase: "been"

Phrase: "described in detail previously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1522508:Detail [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C1561567:detail [Functional Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.40: To generate FLAG-tagged full-length MT4-MMP, primers encoding the FLAG epitope (5'-GACTACAACGACGACGATGACAAG-3') were inserted after the COOH-terminal leucine of full-length MT4-MMP (provided by M. Seiki, University of Tokyo, Tokyo, Japan) and the epitope-tagged construct cloned into the pSG5 vector. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "FLAG-tagged full-length MT4-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   845   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1704640:Matrix [Spatial Concept]
   795   C1706515:Matrix [Body Substance]

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the FLAG epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "(5'-GACTACAACGACGACGATGACAAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "inserted after the COOH-terminal leucine"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0205088:Terminal [Temporal Concept]
   753   C0441587:Inserted [Health Care Activity]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   719 E C1743766:Insert [Medical Device]
   719 E C1883719:Insert [Functional Concept]

Phrase: "of full-length MT4-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]

Phrase: "("

Phrase: "provided by M. Seiki,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1999230:Provided [Activity]

Phrase: "University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "the epitope-tagged construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "cloned into the pSG5 vector."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0009013:cloned [Cell]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1418997:PSG5 [Gene or Genome]
   760   C1705099:Vector [Idea or Concept]
   726 E C1522642:Clone [Tissue]
Processing 00000000.tx.41: Soluble His-tagged MT1-, MT2-, and MT3-MMPs were generated by inserting primers encoding the His epitope (5'-ATGATGATGATGATGATG-3') after the COOH-terminal glycine of soluble MT1-MMP (Met1-Gly535), the COOH-terminal asparagine of soluble MT2-MMP (Met1-Asn625), and the COOH-terminal alanine of soluble MT3-MMP (Met1-Ala564) using a PCR-based method and cloned into pCR3.1-Uni. 

Phrase: "Soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "His-tagged MT1-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540571:MT1 [Gene or Genome]

Phrase: "MT2-,"

Phrase: "and"

Phrase: "MT3-MMPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "were"

Phrase: "generated by inserting primers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C3146294:Generated [Activity]
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   737   C0441587:Insert [Health Care Activity]
   737   C1743766:Insert [Medical Device]
   737   C1883719:Insert [Functional Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the His epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003316:Epitope [Immunologic Factor]

Phrase: "(5'-ATGATGATGATGATGATG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "after the COOH-terminal glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0522461:Glycine [Plant]

Phrase: "of soluble MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "(Met1-Gly535"

Phrase: ")"

Phrase: ","

Phrase: "the COOH-terminal asparagine of soluble MT2-MMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0003995:Asparagine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Met1-Asn625"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the COOH-terminal alanine of soluble MT3-MMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Met1-Ala564"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PCR-based method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "cloned into pCR3.1-Uni."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0009013:cloned [Cell]
   726 E C1522642:Clone [Tissue]
Processing 00000000.tx.42: An expression vector for 1 antitrypsin Portland (1PDX) was constructed from cDNA provided by G. 

Phrase: "An expression vector for 1 antitrypsin Portland"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]

Phrase: "(1PDX"

Phrase: ")"

Phrase: "was"

Phrase: "constructed from cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   756   C2827421:Construct [Classification]

Phrase: "provided by G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439267:g% [Quantitative Concept]
   790   C1999230:Provided [Activity]
Processing 00000000.tx.43: Thomas (Oregon Health Sciences Center, Portland, OR [32]). 

Phrase: "Thomas"

Phrase: "(Oregon Health Sciences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1512352:Health Sciences [Biomedical Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]

Phrase: "Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: ","

Phrase: "Portland,"

Phrase: "OR [32"

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.44: CHO-K1 cells were transiently transfected with purified plasmid DNA using Fugene (Roche) according to the manufacturer's instructions. 

Phrase: "CHO-K1 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with purified plasmid DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1998793:Purified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Fugene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0916399:FuGene [Lipid]

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.45: The activity of the soluble MT-MMPs was monitored with the quenched fluorescent peptide (7-methoxycoumarin-4-yl)acetyl-prolyl-leucyl-glycyl-leucyl-[3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl]-alanyl-arginamide (Bachem) as described (33). 

Phrase: "The activity of the soluble MT-MMPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C1150224:metalloproteinase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "monitored with the quenched fluorescent peptide"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   719   C0030695:monitor [Health Care Activity]
   719   C0150369:monitor [Health Care Activity]
   719   C0181904:Monitor [Medical Device]
   719   C0596972:Monitor [Medical Device]
   719   C1521743:Monitor [Professional or Occupational Group]
   719   C1704646:Monitor [Manufactured Object]

Phrase: "(7-methoxycoumarin-4-yl"

Phrase: ")"

Phrase: "acetyl-prolyl-leucyl-glycyl-leucyl-"

Phrase: "[3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4-dinitrophenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: ")-"

Phrase: "L-2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "3-diaminopropionyl"

Phrase: "]-alanyl-arginamide"

Phrase: "(Bachem"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.46: Reverse Transcription PCR Analysis. 

Phrase: "Reverse Transcription PCR Analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0200931:PCR analysis [Laboratory Procedure]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
Processing 00000000.tx.47: RNA was isolated from MT1-MMP wild-type or null fibroblasts using TRIzol reagent (Life Technologies). 

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from MT1-MMP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   862   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   760   C3540571:MT1 [Gene or Genome]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "null fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TRIzol reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.48: Reverse transcription was performed as described previously (3). 

Phrase: "Reverse transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.49: cDNAs of MMPs were amplified by PCR using specific oligonucleotide primers for MT1-MMP (sense 5'-TGCGACGGGAACTTTGACACCG-3'; 

Phrase: "cDNAs of MMPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific oligonucleotide primers for MT1-MMP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0206415:Oligonucleotide Primers [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "(sense 5'-TGCGACGGGAACTTTGACACCG-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036658:sense [Organ or Tissue Function]

Phrase: ";"
Processing 00000000.tx.50: antisense 5'-TCCTCCTCAGTCCCCTCATC-3'; 

Phrase: "antisense 5'-TCCTCCTCAGTCCCCTCATC-3'"

Phrase: ";"
Processing 00000000.tx.51: 607 bp product from 1201T to 1808A), MT2-MMP (sense 5'-ACATGTCCACCATGCGCTCT-3'; 

Phrase: "607 bp product from 1201T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]

Phrase: "to 1808A"

Phrase: ")"

Phrase: ","

Phrase: "MT2-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(sense 5'-ACATGTCCACCATGCGCTCT-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036658:sense [Organ or Tissue Function]

Phrase: ";"
Processing 00000000.tx.52: antisense 5'-TACCATGATGTCAGCCTCC-3'; 

Phrase: "antisense 5'-TACCATGATGTCAGCCTCC-3'"

Phrase: ";"
Processing 00000000.tx.53: 391 bp product from 222A to 613A), MT3-MMP (sense 5'-CGGTGTACCAGACCAGACAA-3'; 

Phrase: "391 bp product from 222A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]

Phrase: "to 613A"

Phrase: ")"

Phrase: ","

Phrase: "MT3-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(sense 5'-CGGTGTACCAGACCAGACAA-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036658:sense [Organ or Tissue Function]

Phrase: ";"
Processing 00000000.tx.54: antisense 5'-ATTGGGATTTCCCAGTGTCC-3'; 

Phrase: "antisense 5'-ATTGGGATTTCCCAGTGTCC-3'"

Phrase: ";"
Processing 00000000.tx.55: 402 bp product from 357C to 756T). 

Phrase: "402 bp product from 357C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]

Phrase: "to 756T"

Phrase: ")."
Processing 00000000.tx.56: The identity of the isolated cDNAs was confirmed by sequence analysis (3). 

Phrase: "The identity of the isolated cDNAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0424215:Identity [Mental Process]
   753   C2003939:Identity [Finding]

Phrase: "was"

Phrase: "confirmed by sequence analysis"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0750484:Confirmed [Idea or Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1519249:Sequence [Functional Concept]
   770   C1524024:analysis [Functional Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.57: Invasion, Motility, and Fibrinolysis Assays. 

Phrase: "Invasion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]

Phrase: "Motility,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007608:Motility [Cell Function]
  1000   C0678835:Motility [Laboratory or Test Result]
  1000   C1510470:Motility [Organism Function]
   928 E C1979933:Motile [Finding]

Phrase: "and"

Phrase: "Fibrinolysis Assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.58: Fibrin gels were cast in the upper wells of 24-mm Transwell dishes (3 m pore size; Corning, Inc.) by combining 0.5 ml of plasminogen-free human fibrinogen (6 mg/ml; Calbiochem) with 0.5 ml of human thrombin (4 U/ml; Sigma-Aldrich) in Hanks Balanced Salt Solution (pH 7.4) alone or supplemented with 200 g/ml aprotinin (Sigma-Aldrich [3, 10]). 

Phrase: "Fibrin gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "cast in the upper wells of 24-mm Transwell dishes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0179686:Cast [Medical Device]
   739   C0302143:Cast [Body Substance]
   739   C1282910:Upper [Spatial Concept]
   706   C0020498:DISH [Disease or Syndrome]
   706   C0205170:Well [Qualitative Concept]
   706   C3146287:Well [Manufactured Object]

Phrase: "(3 m pore size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456389:size [Spatial Concept]
   812   C1325742:Pore [Cell Component]

Phrase: "; Corning,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0010046:corning [Acquired Abnormality]
   966 E C0010028:Corn [Plant]
   966 E C0087179:Corn [Plant]
   966 E C1095906:corn [Pharmacologic Substance]
   966 E C1138842:Corn [Food]

Phrase: "Inc.) by combining 0.5 ml"

Phrase: "of plasminogen-free human fibrinogen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C2587184:Human fibrinogen [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           FIBRINOGEN
   812   C0016006:Fibrinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C1167394:fibrinogen [Cell Component]

Phrase: "(6 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "; Calbiochem"

Phrase: ")"

Phrase: "with 0.5 ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439526:/mL [Quantitative Concept]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "of human thrombin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0086418:Human [Human]

Phrase: "(4 U/ml"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0439340:U/ml [Quantitative Concept]
   901   C1880521:U/mL [Quantitative Concept]
   901   C2945590:U/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "; Sigma-Aldrich"

Phrase: ")"

Phrase: "in Hanks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1423529:HANK [Gene or Genome]

Phrase: "Balanced"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205415:Balanced [Functional Concept]
   966 E C0014653:Balance [Organism Function]
   966 E C0560184:Balance [Finding]

Phrase: "Salt Solution"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0036140:Salt [Chemical Viewed Structurally]
   861   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0037633:Solution [Substance]
   861   C0206136:Salt [Food,Inorganic Chemical]
   861   C0525069:Solution [Biomedical or Dental Material]
   789 E C1537053:salty [Qualitative Concept]
   761 E C0678584:saltiness [Qualitative Concept]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "supplemented with 200 g/ml aprotinin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "(Sigma-Aldrich"

Phrase: "[3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "10"

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.59: Type I collagen gels were prepared as described previously (30). 

Phrase: "Type I collagen gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]
   756   C0041455:Type 1 Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.60: Because the fibrinogen preparation contains transglutaminase and fibronectin, the fibrin gel contains - crosslinks, -polymers, and covalently-incorporated fibronectin (3, 4). 

Phrase: "Because"

Phrase: "the fibrinogen preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "transglutaminase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "fibronectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the fibrin gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "contains -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "crosslinks, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178576:crosslinks [Natural Phenomenon or Process]

Phrase: "polymers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]

Phrase: "and"

Phrase: "covalently-incorporated fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.61: Where indicated, fibrinogen preparations were depleted of fibronectin by gelatin-affinity chromatography (34). 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "fibrinogen preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "depleted of fibronectin"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0333668:Depleted [Functional Concept]
   718 E C1550032:Unload [Idea or Concept]
   718 E C1880497:Empty [Qualitative Concept]
   718 E C1996907:Emptying [Activity]

Phrase: "by gelatin-affinity chromatography"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0008551:Chromatography, Affinity [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C1510827:Affinity [Natural Phenomenon or Process]
   727 E C0302647:chromatograph [Medical Device]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.62: The gels were incubated at 37C for 2 h to allow complete gelling. 

Phrase: "The gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 2 h to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0011744:2 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "complete gelling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]
Processing 00000000.tx.63: To vary fibrin fiber size, polymerization rates were varied by incubating thrombin-fibrinogen mixtures at pH 6.9, 7.4, or 8.0 (35). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "vary"

Phrase: "fibrin fiber size,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0456389:size [Spatial Concept]

Phrase: "polymerization rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "varied by incubating thrombin-fibrinogen mixtures"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C1276898:Fibrinogen / Thrombin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0016006:Fibrinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0439962:mixtures [Substance]
   753   C1167394:fibrinogen [Cell Component]
   753   C1439852:incubating [Laboratory Procedure]
   753   C2587184:FIBRINOGEN [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "at pH 6.9,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "7.4,"

Phrase: "or"

Phrase: "8.0"

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.64: After the fibrin gels were cast at the indicated pH, 15 x 105 MDCK cells, CHO-K1 cells, wild-type, or MT1-MMP null fibroblasts in complete medium containing 10% fetal bovine serum were cultured atop the fibrin matrix. 

Phrase: "After the fibrin gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "cast at the indicated pH,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0179686:Cast [Medical Device]
   760   C0302143:Cast [Body Substance]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   760   C1444656:Indicated [Finding]

Phrase: "15 x 105 MDCK cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0598829:MDCK Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "CHO-K1 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "wild-type,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "MT1-MMP null fibroblasts in complete medium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0016030:Fibroblasts [Cell]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "were"

Phrase: "cultured atop the fibrin matrix."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.65: After 24 h, recombinant scatter factor/hepatocyte growth factor (SF/HGF) was added to the lower chamber at 50 ng/ml for MDCK cells (30). 

Phrase: "After 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "recombinant scatter factor/hepatocyte growth factor (SF/HGF)"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   919   C1524023:Recombinant Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   904   C1515377:Recombinant Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0062534:Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1442521:HEPATOCYTE GROWTH FACTOR [Gene or Genome]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C0227525:Hepatocyte [Cell]
   799   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2911660:Growth [Activity]

Phrase: "was"

Phrase: "added to the lower chamber"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0441994:Lower [Spatial Concept]
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   760   C1524062:Added [Functional Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
   726 E C1883712:Add [Functional Concept]

Phrase: "at 50 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "for MDCK cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0598829:MDCK Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.66: CHO-K1 cells were transiently transfected with the indicated plasmids and SF/HGF (50 ng/ml) added to the bottom well 24 h later. 

Phrase: "CHO-K1 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with the indicated plasmids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1444656:Indicated [Finding]

Phrase: "and"

Phrase: "SF/HGF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0062534:Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1442521:HEPATOCYTE GROWTH FACTOR [Gene or Genome]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0227525:Hepatocyte [Cell]
   804   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]

Phrase: "(50 ng/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "added to the bottom well 24 h later."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0205170:Well [Qualitative Concept]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]
   744   C1511276:Bottom [Spatial Concept]
   744   C1524062:Added [Functional Concept]
   744   C1552825:bottom [Idea or Concept]
   744   C3146287:Well [Manufactured Object]
   711 E C1883712:Add [Functional Concept]
Processing 00000000.tx.67: Wild-type or MT1-MMP null fibroblasts were similarly treated, but invasion stimulated with platelet-derived growth factor (PDGF)-BB (herein referred to as PDGF, 15 ng/ml; Calbiochem). 

Phrase: "Wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "MT1-MMP null fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0016030:Fibroblasts [Cell]
   717   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "similarly"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: ","

Phrase: "but"

Phrase: "invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]

Phrase: "stimulated with platelet-derived growth factor (PDGF)-BB"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   897   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   853   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   748   C0004739:BB [Geographic Area]
   748   C0005821:Platelet [Cell]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0332297:BB [Spatial Concept]
   748   C1441547:Derived [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   748   C3245521:derived [Idea or Concept]

Phrase: "(herein"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "PDGF,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "15 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "; Calbiochem"

Phrase: ")."
Processing 00000000.tx.68: Fibroblast motility was monitored by culturing cells atop fibrin gels whose surface was partially covered with glass cloning chips (3). 

Phrase: "Fibroblast motility"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007608:Motility [Cell Function]
   861   C0678835:Motility [Laboratory or Test Result]
   861   C1510470:Motility [Organism Function]
   789 E C1979933:Motile [Finding]

Phrase: "was"

Phrase: "monitored by culturing cells"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   802   C0007585:cells culture [Laboratory Procedure]
   802   C0007635:cell culturing [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C0596972:Monitor [Medical Device]
   737 E C1269647:Cell [Cell]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "atop fibrin gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "whose surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205148:Surface [Spatial Concept]

Phrase: "was"

Phrase: "partially"

Phrase: "covered with glass cloning chips"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   760   C0009015:Cloning [Research Activity]
   760   C0017596:Glass [Manufactured Object]
   760   C0349380:chips [Food]
   760   C0439844:Covered [Functional Concept]
   760   C1510451:Chips [Food]
   760   C1947936:Glass [Medical Device]
   760   C1999244:Covered [Functional Concept]
   726 E C0009013:Clone [Cell]
   726 E C0180153:cover [Medical Device]
   726 E C0600596:Chip [Research Device]
   726 E C1522642:Clone [Tissue]
   726 E C1707529:Cover [Medical Device]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.69: After confluent layers of fibroblasts were formed, the chips were removed leaving denuded areas wherein the distance migrated by the advancing front of cells (three cells or more) was measured during a 24 h incubation. 

Phrase: "After confluent layers"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0934502:layers [Body Part, Organ, or Organ Component]
   827 E C1522408:Layer [Qualitative Concept]
   827 E C1561599:Layer [Intellectual Product]

Phrase: "of fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: ","

Phrase: "the chips"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349380:chips [Food]
  1000   C1510451:Chips [Food]
   966 E C0600596:Chip [Research Device]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "leaving"

Phrase: "denuded areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "wherein"

Phrase: "the distance"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012751:Distance [Quantitative Concept]
   928 E C0443203:Distant [Spatial Concept]

Phrase: "migrated by the advancing front of cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   802   C1621433:front of cell [Cell Component]
   748   C0007634:Cells [Cell]
   748   C0205094:front [Spatial Concept]
   748   C0232902:Migrated [Functional Concept]
   748   C3282337:Cells [Cell]
   714   C0725066:Advance [Medical Device]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(three cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: ")"

Phrase: "was"

Phrase: "measured during a 24 h incubation."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0444706:Measured [Qualitative Concept]
   753   C0564385:/h [Quantitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.70: Where indicated, recombinant tissue inhibitor of metalloproteases-1 (TIMP-1; 50 g/ml), tissue inhibitor of metalloproteases-2 (TIMP-2; 20 g/ml), or the synthetic MMP inhibitor, BB-94 (5 M final concentration in 0.1% DMSO; gift of British Biotechnology, Oxford, UK) was included in the fibrin gel and added to the medium (3, 30). 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "recombinant tissue inhibitor of metalloproteases-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1418824:INHIBITOR 1 [Gene or Genome]
   767   C1152589:metalloprotease inhibitor [Molecular Function]
   753   C0040300:Tissue [Tissue]
   753   C1547928:Tissue [Intellectual Product]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(TIMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "; 50 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "tissue inhibitor of metalloproteases-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1152589:metalloprotease inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(TIMP-2"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "; 20 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "the synthetic MMP inhibitor,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0652210:synthetic metalloproteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C1513016:Matrix Metalloproteinase Inhibitor [Pharmacologic Substance]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1152589:metalloproteinase inhibitor [Molecular Function]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "BB-94"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "(5 M final concentration in 0.1% DMSO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]

Phrase: "; gift of British Biotechnology,"

Phrase: "Oxford,"

Phrase: "UK"

Phrase: ")"

Phrase: "was"

Phrase: "included in the fibrin gel"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0332257:included [Functional Concept]
   760   C1382104:Gel [Substance]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]

Phrase: "and"

Phrase: "added to the medium"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1883712:Add [Functional Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.71: Endotoxin-free TIMP-1 and TIMP-2 (Fuji Chemicals) were active-site titrated with gelatinase A before use (specific activity of TIMP-2 was 2.5 times greater than that of TIMP-1). 

Phrase: "Endotoxin-free TIMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "TIMP-2"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fuji Chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0220806:Chemicals [Chemical]
   827 E C3272558:Chemical [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "active-site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "titrated with gelatinase A before use"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0042153:use [Functional Concept]
   753   C0206528:Gelatinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]
   719   C1883350:Titrate [Health Care Activity]

Phrase: "(specific activity of TIMP-2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C1955394:Tissue specific [Body Substance]
   750   C1150224:metalloproteinase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0205369:Specific [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1552740:specific [Intellectual Product]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "2.5 times"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "greater than that of TIMP-1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0439093:Greater Than [Quantitative Concept]
   753   C0443228:greater [Quantitative Concept]
   753   C1704243:Greater [Quantitative Concept]
   719 E C0549177:Great [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.72: All media, including SF/HGF or PDGF and inhibitors was exchanged every 2 d during the assay period (MDCK invasion was routinely terminated at 5 d, CHO-K1 invasion at 5 d, and fibroblast invasion at 6 d unless indicated otherwise). 

Phrase: "All media,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "SF/HGF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0062534:Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1442521:HEPATOCYTE GROWTH FACTOR [Gene or Genome]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0227525:Hepatocyte [Cell]
   804   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]

Phrase: "or"

Phrase: "PDGF"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "and"

Phrase: "inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "exchanged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0678640:exchange [Social Behavior]

Phrase: "every 2 d during the assay period"

Phrase: "(MDCK invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1269955:Invasion [Finding]
   861   C2699153:Invasion [Pathologic Function]

Phrase: "was"

Phrase: "routinely"

Phrase: "terminated at 5 d,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1553404:terminated [Idea or Concept]
   770   C2348570:Terminated [Functional Concept]

Phrase: "CHO-K1 invasion at 5 d,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1269955:Invasion [Finding]
   753   C2699153:Invasion [Pathologic Function]

Phrase: "and"

Phrase: "fibroblast invasion at 6 d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1269955:Invasion [Finding]
   760   C2699153:Invasion [Pathologic Function]

Phrase: "unless"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "otherwise"

Phrase: ")."
Processing 00000000.tx.73: The number of invasive foci and depth of invasion (mean depth of the three front-leading cells/field) were determined from digitized images of 10 randomly selected 40x fields of hematoxylin and eosin (H and E)-stained cross sections (3, 30). 

Phrase: "The number of invasive foci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "depth of invasion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205125:Depth [Spatial Concept]
   718 E C1422002:DEEPEST [Gene or Genome]

Phrase: "(mean depth of the three front-leading cells/field"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205125:Depth [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "determined from digitized images of 10 randomly selected 40x fields"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   706   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   706   C1521738:Field [Conceptual Entity]
   706   C1704254:Image [Intellectual Product]
   706   C1704922:Image [Entity]
   706   C1707391:Select [Activity]
   706   C2346620:Field [Conceptual Entity]
   706   C2349184:Field [Conceptual Entity]
   706   C3539073:FIELD [Spatial Concept]
   706   C3542466:Image [Intellectual Product]

Phrase: "of hematoxylin and eosin (H and E)-stained cross sections"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   869   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   829   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   818   C0552389:cross sections [Spatial Concept]
   795   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   795   C0332285:Of [Spatial Concept]
   795   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   795   C2828360:Cross [Conceptual Entity]
   795   C2986582:Stained [Qualitative Concept]
   762 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   762   C0205155:Section [Spatial Concept]
   762   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   762   C1522472:Section [Substance]
   762   C1552923:Section [Quantitative Concept]
   762   C1705191:Section [Physical Object]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.74: All results were confirmed with stable transfectants in three or more cloned cell lines. 

Phrase: "All results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "confirmed with stable transfectants"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205360:Stable [Qualitative Concept]
   770   C0521093:confirmed [Qualitative Concept]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1547311:Stable [Intellectual Product]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "in three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "or"

Phrase: "more cloned cell lines."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0007600:Cell lines [Cell]
   844   C0009013:Clone Cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.75: Fibrinolytic activity was determined by culturing cells atop fibrin gels containing 125I-labeled fibrinogen (Amersham Pharmacia Biotech) in the presence of aprotinin (200 g/ml) with or without BB-94 as described above. 

Phrase: "Fibrinolytic activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined by culturing cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   802   C0007585:cells culture [Laboratory Procedure]
   802   C0007635:cell culturing [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "atop fibrin gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "125I-labeled fibrinogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016006:Fibrinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1167394:fibrinogen [Cell Component]
   827   C2587184:FIBRINOGEN [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of aprotinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(200 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0439526:/mL [Quantitative Concept]

Phrase: "or without BB-94"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   770   C0004739:BB [Geographic Area]
   770   C0332297:BB [Spatial Concept]

Phrase: "as described above."
Processing 00000000.tx.76: Fibrin degradation products in the cell-free media and in 5 M urea extracts of the fibrin gel were pooled and quantitated by -scintillation counting (3). 

Phrase: "Fibrin degradation products in the cell-free media"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   800   C0163275:Fibrin Degradation Products [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   789 E C0200453:degradation fibrin products [Laboratory Procedure]
   744   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]
   744   C1514468:Products [Entity]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "and in 5 M urea"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C1440942:M-5 [Immunologic Factor]
   760   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1515981:And [Idea or Concept]
   704 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "extracts of the fibrin gel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C1382104:Gel [Substance]
   760   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "quantitated by -scintillation counting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0036406:Scintillation Counting [Laboratory Procedure]
   770   C0678573:scintillation [Natural Phenomenon or Process]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.77: Spontaneous release of 125I-fibrin from gels incubated in the absence of cells was subtracted from all values and the results presented as mean cpm  1 SD. 

Phrase: "Spontaneous release of 125I-fibrin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "incubated in the absence of cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0007634:Cells [Cell]
   753   C0332197:absence [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1689985:Absence [Anatomical Abnormality]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "subtracted from all values"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]
   737   C1719767:Subtract [Intellectual Product]
   737   C2348589:Subtract [Phenomenon or Process]

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented as mean cpm  1 SD."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C0019728:SD-1 [Immunologic Factor]
   753   C0444504:Mean [Quantitative Concept]
   753   C0449450:Presented [Idea or Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]
   719 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.78: Western Blots. 

Phrase: "Western Blots."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.79: The expression of MMP proteins in transiently transfected CHO cells was assessed by Western blotting. 

Phrase: "The expression of MMP proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in transiently transfected CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "assessed by Western blotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1516048:Assessed [Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.80: FLAG-tagged MT-MMP proteins were recovered from Triton-X114 extracted cells as described previously (32). 

Phrase: "FLAG-tagged MT-MMP proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "recovered from Triton-X114 extracted cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   753   C0007634:Cells [Cell]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0242759:Triton [Geographic Area]
   753   C0521108:recovered [Qualitative Concept]
   753   C3282337:Cells [Cell]
   753   C3541890:EXTRACTED [Finding]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
   719 E C2004454:recover [Organism Function]
   719 E C2828366:Extract [Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.81: To detect soluble, His-tagged MT1, MT2, and MT3-MMPs, CHO-K1 cells were transferred to serum-free medium 24 h after transfection and incubated for an additional 24 to 48 h. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "soluble,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "His-tagged MT1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540571:MT1 [Gene or Genome]

Phrase: "MT2,"

Phrase: "and"

Phrase: "MT3-MMPs,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "CHO-K1 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transferred to serum-free medium 24 h"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   748   C0009458:Medium [Intellectual Product]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0229671:Serum [Body Substance]
   748   C0332296:free [Functional Concept]
   748   C0348011:transferred [Functional Concept]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439536:Medium [Quantitative Concept]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   748   C1705217:Medium [Substance]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]
   748   C3244283:medium [Intellectual Product]
   714 E C0040671:Transfer [Mental Process]
   714 E C1705822:Transfer [Activity]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "incubated for an additional 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1524062:Additional [Functional Concept]

Phrase: "to 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.82: Cell-free supernatants and detergent extracts (in the case of the full-length MT-MMPs) were resolved on 10% polyacrylamide gels under reducing conditions and the proteins transferred to nitrocellulose membranes (32). 

Phrase: "Cell-free supernatants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1550101:Supernatant [Body Substance]
   734   C1183428:cell free [Cell]

Phrase: "and"

Phrase: "detergent extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "("

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of the full-length MT-MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]

Phrase: ")"

Phrase: "were"

Phrase: "resolved on 10% polyacrylamide gels"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   760   C1514893:Resolved [Idea or Concept]
   760   C2699488:Resolved [Conceptual Entity]
   726 E C1382104:Gel [Substance]

Phrase: "under reducing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and"

Phrase: "the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.83: FLAG-tagged proteins were detected with mouse monoclonal antibody M2 against a FLAG epitope (1:1,000; 

Phrase: "FLAG-tagged proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "detected with mouse monoclonal antibody M2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0442726:Detected [Finding]
   753   C0457242:m2 [Quantitative Concept]
   753   C0746619:monoclonal [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "against a FLAG epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.84: Sigma-Aldrich), while soluble MT-MMPs were detected with mouse monoclonal Penta-His antibody (1:2,000; 

Phrase: "Sigma-Aldrich"

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "soluble MT-MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "were"

Phrase: "detected with mouse monoclonal Penta-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0442726:Detected [Finding]
   760   C0701492:PENTA [Carbohydrate,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "His antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2,000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ";"
Processing 00000000.tx.85: QIAGEN). 

Phrase: "QIAGEN"

Phrase: ")."
Processing 00000000.tx.86: Blots were probed with a horseradish peroxidase-conjugated antimouse IgG secondary antibody and bands visualized using the ECL system according to the manufacturer's instructions (Pierce Chemical Co.). 

Phrase: "Blots"

Phrase: "were"

Phrase: "probed with a horseradish peroxidase-conjugated antimouse IgG secondary antibody"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   777   C0063351:IGG-horseradish peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   757   C2754943:IgG antibody [Cell Component]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0027627:secondary [Neoplastic Process]
   739   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0175668:Secondary [Temporal Concept]
   739   C0205436:Secondary [Quantitative Concept]
   739   C0330510:Horseradish [Food]
   739   C0522529:Conjugated [Spatial Concept]
   739   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   739   C1110641:Horseradish [Plant]
   739   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   739   C1979849:Antimouse [Immunologic Factor]
   706   C0182400:Probe [Medical Device]
   706   C1704681:Probe [Gene or Genome]
   706   C2347609:Probe [Chemical Viewed Functionally]
   706   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ECL system according to the manufacturer's instructions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0449913:System [Functional Concept]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]

Phrase: "(Pierce Chemical Co."

Phrase: ")."
Processing 00000000.tx.87: Histology and Electron Microscopy. 

Phrase: "Histology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019638:Histology [Biomedical Occupation or Discipline]
  1000   C0205462:histology [Functional Concept]
  1000   C0344441:Histology [Laboratory Procedure]

Phrase: "and"

Phrase: "Electron Microscopy."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]
Processing 00000000.tx.88: For histological sections, fibrin or type I collagen gels were fixed in 4% paraformaldehyde in phosphate buffered saline (pH 7.4), dehydrated through a graded ethanol series, and embedded in paraffin. 

Phrase: "For histological sections,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "or"

Phrase: "type I collagen gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]
   756   C0041455:Type 1 Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "fixed in 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in phosphate buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "dehydrated through a graded ethanol series,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001962:Ethanol [Organic Chemical]
   753   C0011175:Dehydrated [Disease or Syndrome]
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "and"

Phrase: "embedded in paraffin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0085185:embedded paraffin [Laboratory Procedure]
   790   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   790   C1707903:Embedded [Laboratory Procedure]
Processing 00000000.tx.89: Sections were cut at 7 m and stained with hematoxylin and eosin (3, 30). 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "cut at 7 m"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0950275:M 7 [Organic Chemical,Pharmacologic Substance]
   770   C0000925:Cut [Injury or Poisoning]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "stained with hematoxylin and eosin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   891   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   781   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   760   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.90: For electron microscopy, fibrin gels were fixed in 2% glutaraldehyde/1.5% paraformaldehyde in 0.1 M sodium cacodylate buffer, postfixed in 1% osmium tetroxide, and dehydrated through graded ethanol. 

Phrase: "For electron microscopy,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]

Phrase: "fibrin gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "fixed in 2% glutaraldehyde/1.5% paraformaldehyde"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0017814:Glutaraldehyde [Biomedical or Dental Material,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   748   C0231441:Fixed [Finding]
   748   C0443218:Fixed [Qualitative Concept]
   748   C2827483:Fixed [Body Substance]

Phrase: "in 0.1 M sodium cacodylate buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "postfixed in 1% osmium tetroxide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0029385:Osmium Tetroxide [Hazardous or Poisonous Substance,Inorganic Chemical]
   760   C0029383:Osmium [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "dehydrated through graded ethanol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001962:Ethanol [Organic Chemical]
   770   C0011175:Dehydrated [Disease or Syndrome]
Processing 00000000.tx.91: Samples were then embedded in epoxy resin, 500 nm sections cut, and stained with uranyl acetate and lead citrate. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "embedded in epoxy resin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0014631:Epoxy resin [Biomedical or Dental Material]
           Epoxy
   770   C0035191:Resin [Biomedical or Dental Material]
   770   C1707903:Embedded [Laboratory Procedure]

Phrase: "500 nm sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "cut"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000925:Cut [Injury or Poisoning]
  1000   C1883724:CUT [Phenomenon or Process]

Phrase: ","

Phrase: "and"

Phrase: "stained with uranyl acetate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   865   C2984971:URANYL ACETATE STAIN [Laboratory Procedure]
   833   C0077854:uranyl acetate [Organic Chemical,Pharmacologic Substance]
   770   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "lead citrate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0008857:Citrate [Organic Chemical]
   861   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.92: For scanning electron microscopy (SEM) analyses, after dehydration in ethanol, samples were incubated in 50:50 ethanol:hexamethyldisilazane followed by a 20-min incubation in 100% hexamethyldisilazane. 

Phrase: "For scanning electron microscopy (SEM) analyses,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]
   756   C0026020:Scanning Electron Microscopy [Laboratory Procedure]

Phrase: "after"

Phrase: "dehydration in ethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0011175:Dehydration [Disease or Syndrome]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "incubated in 50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: ":"

Phrase: "50 ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]

Phrase: ":"

Phrase: "hexamethyldisilazane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0062647:hexamethyldisilazane [Organic Chemical]

Phrase: "followed by a 20-min incubation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0702093:/min [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "in 100% hexamethyldisilazane."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0062647:hexamethyldisilazane [Organic Chemical]
Processing 00000000.tx.93: Air dried specimens were mounted, sputter coated with gold, and viewed on an Amray 1000-B scanning electron microscope.  

Phrase: "Air dried"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0001861:Air [Substance]
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   827 E C0011682:Dry [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0370003:specimens [Substance]
   966 E C2347026:Specimen [Conceptual Entity]

Phrase: "were"

Phrase: "mounted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449878:mounted [Finding]
   966 E C0181909:Mount [Medical Device]

Phrase: ","

Phrase: "sputter"

Phrase: "coated with gold,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C1304897:Gold [Functional Concept]
   790   C1522408:Coated [Qualitative Concept]
   756 E C0453946:Coat [Manufactured Object]
   756 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "viewed on an Amray 1000-B scanning electron microscope."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0262878:Scanning Electron Microscope [Medical Device]
   764   C0181845:Electron Microscope [Medical Device]
   742   C0013852:Electron [Quantitative Concept]
   742   C0034606:Scanning [Diagnostic Procedure]
   742   C0181839:Microscope [Medical Device]
   742   C0441633:Scanning [Diagnostic Procedure]
   742   C1706379:Microscope [Medical Device]
   742   C3463986:Electron [Bird]
   708   C0449911:View [Spatial Concept]
   708 E C2826292:SCAN [Finding]
Processing 00000000.tx.94: Results Top Abstract Introduction Materials and Methods Results Discussion References  Fibrinolytic and Fibrin-Invasive Activity of MMPs in Stably Transfected Cells. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Fibrinolytic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Fibrin-Invasive Activity of MMPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1150224:metalloproteinase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "in Stably Transfected Cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.95: Matrix remodeling events at sites of fibrin deposition in vivo are associated with the expression of a complex mix of soluble MMPs, including MMP-1 (collagenase-1), MMP-13 (collagenase-3), MMP-2 (gelatinase A), MMP-9 (gelatinase B), MMP-3 (stromelysin-1), MMP-11 (stromelysin-3), and MMP-7 (matrilysin) (1, 16, 18, 36). 

Phrase: "Matrix remodeling events at sites of fibrin deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441471:Events [Event]
   744   C3541888:Events [Classification]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "are"

Phrase: "associated with the expression of a complex mix of soluble MMPs,"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   753   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   736   C0205430:Mix [Functional Concept]
   736   C0439855:Complex [Qualitative Concept]
   736   C1421951:MIX [Gene or Genome]
   736   C1704241:Complex [Chemical Viewed Structurally]
   736   C1704640:Matrix [Spatial Concept]
   736   C1706515:Matrix [Body Substance]
   736   C1720722:Mix [Qualitative Concept]
   736   C1749467:soluble [Cell Component]
   736   C1948047:Soluble [Qualitative Concept]
   703 E C0750490:Associate [Idea or Concept]
   703 E C1706221:Associate [Professional or Occupational Group]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "MMP-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0127082:Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:MATRIX METALLOPROTEINASE 1 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(collagenase-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0962754:collagenase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "MMP-13"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0255672:Matrix Metalloproteinase 13 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417202:MATRIX METALLOPROTEINASE 13 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(collagenase-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0255672:Collagenase 3 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417202:COLLAGENASE 3 [Gene or Genome]
   861   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "MMP-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0172537:Matrix Metalloproteinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334522:MATRIX METALLOPROTEINASE 2 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(gelatinase A"

Phrase: ")"

Phrase: ","

Phrase: "MMP-9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0165519:Matrix Metalloproteinase 9 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:MATRIX METALLOPROTEINASE 9 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(gelatinase B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0165519:Gelatinase B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:GELATINASE B [Gene or Genome]
  1000   C2698028:Gelatinase B [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "MMP-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0164371:Matrix Metalloproteinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366358:MATRIX METALLOPROTEINASE 3 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(stromelysin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0164371:Stromelysin 1 [Amino Acid, Peptide, or Protein,Enzyme]
           Stromelysin
  1000   C1619831:Stromelysin 1 [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "MMP-11"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0174383:Matrix Metalloproteinase 11 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366519:MATRIX METALLOPROTEINASE 11 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(stromelysin-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0174383:Stromelysin 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0164371:Stromelysin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "MMP-7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0166059:Matrix Metalloproteinase 7 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417212:MATRIX METALLOPROTEINASE 7 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(matrilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0166059:Matrilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2698026:Matrilysin [Laboratory Procedure]

Phrase: ")"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "16,"

Phrase: "18,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.96: Each of these MMPs has been reported to degrade fibrin(ogen) under serum-free and cell-free conditions (3, 2224, 26, 27), but the ability of these proteinases to mediate fibrin-degradative or invasive events by intact cells under physiologically relevant conditions is unknown. 

Phrase: "Each of these MMPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1457900:Each [Quantitative Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "degrade"

Phrase: "fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "under serum-free"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0229671:Serum [Body Substance]
   861   C0332296:free [Functional Concept]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "cell-free conditions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   734   C1183428:cell free [Cell]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "2224,"

Phrase: "26,"

Phrase: "27"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the ability of these proteinases to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "fibrin-degradative"

Phrase: "or"

Phrase: "invasive events by intact cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441471:Events [Event]
   760   C3541888:Events [Classification]

Phrase: "under physiologically relevant conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.97: Consequently, invasion-incompetent cells engineered to stably overexpress each of these fibrinolytic MMPs were cultured atop 125I-labeled fibrin gels in the presence of 10% serum and motility stimulated by exogenous HGF/SF. 

Phrase: "Consequently,"

Phrase: "invasion-incompetent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "engineered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878517:engineered [Professional or Occupational Group]

Phrase: "to stably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "each of these fibrinolytic MMPs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
   753   C1457900:Each [Quantitative Concept]
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]

Phrase: "were"

Phrase: "cultured atop 125I-labeled fibrin gels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C1708632:Labeled [Qualitative Concept]
   719   C0010453:Culture [Idea or Concept]
   719 E C0181496:Label [Manufactured Object]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719 E C1382104:Gel [Substance]
   719   C2242979:Culture [Laboratory Procedure]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 10% serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "motility"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007608:Motility [Cell Function]
  1000   C0678835:Motility [Laboratory or Test Result]
  1000   C1510470:Motility [Organism Function]
   928 E C1979933:Motile [Finding]

Phrase: "stimulated by exogenous HGF/SF."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0062534:HGF/SF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1524023:HGF/SF [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0205101:Exogenous [Spatial Concept]
   760   C0205228:Exogenous [Functional Concept]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
Processing 00000000.tx.98: Fibrinolysis as well as invasion were then monitored during a 5-d incubation period. 

Phrase: "Fibrinolysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0016017:Fibrinolysis [Physiologic Function]
  1000   C1305868:Fibrinolysis [Laboratory Procedure]
   928 E C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]

Phrase: "as well as"

Phrase: "invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "monitored during a 5-d incubation period."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1320226:Incubation period [Finding]
   748   C0439531:/period [Temporal Concept]
   748   C1948053:Period [Temporal Concept]
   714   C0030695:monitor [Health Care Activity]
   714   C0150369:monitor [Health Care Activity]
   714   C0181904:Monitor [Medical Device]
   714   C0596972:Monitor [Medical Device]
   714   C1521743:Monitor [Professional or Occupational Group]
   714   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.99: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.100: 1 A, each of the MMP transfectants as well as the control-transfected cells expressed fibrinolytic activity that could be suppressed by the peptidomimetic MMP inhibitor, BB-94 (5 M). 

Phrase: "1 A,"

Phrase: "each of the MMP transfectants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1457900:Each [Quantitative Concept]
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]

Phrase: "as well as"

Phrase: "the control-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressed"

Phrase: "fibrinolytic activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "suppressed by the peptidomimetic MMP inhibitor,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C1513016:Matrix Metalloproteinase Inhibitor [Pharmacologic Substance]
   778   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1152589:metalloproteinase inhibitor [Molecular Function]
   748   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1260953:Suppressed [Functional Concept]
   748   C1704640:Matrix [Spatial Concept]
   748   C1706515:Matrix [Body Substance]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "BB-94"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "M)."
Processing 00000000.tx.101: However, neither the control-transfected cells nor any of the clones that overexpressed the secreted MMPs penetrated the underlying fibrin gels (Fig. 1, A and B). 

Phrase: "However,"

Phrase: "neither"

Phrase: "the control-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "nor"

Phrase: "any of the clones"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0009013:Clones [Cell]
   770   C1552551:Any [Qualitative Concept]
   770   C3272371:ANY [Intellectual Product]
   737 E C1522642:Clone [Tissue]

Phrase: "that"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "the secreted MMPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1721004:Matrix Metalloproteinases, Secreted [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "penetrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrated [Functional Concept]

Phrase: "the underlying fibrin gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.102: By contrast, stable clones overexpressing the membrane-anchored proteinase, MT1-MMP, not only expressed fibrinolytic activity, but as described previously (3), displayed fibrin-invasive activity as well (Fig. 1, A and B). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "stable clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "the membrane-anchored proteinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1622131:proteinase [Molecular Function]
   827   C1947941:Proteinase [Enzyme]

Phrase: "MT1-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "expressed"

Phrase: "fibrinolytic activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "displayed fibrin-invasive activity as well"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.103: As expected, MT1-MMPdependent fibrinolytic and invasive activity were both inhibited in the presence of BB-94 (77  6% and 100  0% for fibrinolysis and invasion, respectively; mean  1 SD, n = 4). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "MT1-MMPdependent"

Phrase: "fibrinolytic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "both"

Phrase: "inhibited in the presence of BB-94"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   748   C0004739:BB [Geographic Area]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C0332297:BB [Spatial Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(77  6%"

Phrase: "and"

Phrase: "100  0% for fibrinolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0016017:Fibrinolysis [Physiologic Function]
   770   C1305868:Fibrinolysis [Laboratory Procedure]

Phrase: "and"

Phrase: "invasion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]

Phrase: "respectively"

Phrase: "; mean  1 SD,"

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.104: View larger version (53K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(53K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.105: Fibrin-degradative and invasive activities of MDCK stable transfectants overexpressing secreted MMPs or MT1-MMP. 

Phrase: "Fibrin-degradative"

Phrase: "and"

Phrase: "invasive activities of MDCK stable transfectants"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "secreted MMPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1721004:Matrix Metalloproteinases, Secreted [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MT1-MMP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]
Processing 00000000.tx.106: (A) Control vector-transfected or MMP-expressing transfectants were cultured atop 125I-labeled fibrin gels in complete medium with 10% FBS and SF/HGF (50 ng/ml) for 5 d in the absence (light gray bars) or presence of 5 M BB-94 (dark gray bars). 

Phrase: "(A)"

Phrase: "Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "vector-transfected"

Phrase: "or"

Phrase: "MMP-expressing transfectants"

Phrase: "were"

Phrase: "cultured atop 125I-labeled fibrin gels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C1708632:Labeled [Qualitative Concept]
   719   C0010453:Culture [Idea or Concept]
   719 E C0181496:Label [Manufactured Object]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719 E C1382104:Gel [Substance]
   719   C2242979:Culture [Laboratory Procedure]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "in complete medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "with 10% FBS"

Phrase: "and"

Phrase: "SF/HGF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0062534:Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1442521:HEPATOCYTE GROWTH FACTOR [Gene or Genome]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0227525:Hepatocyte [Cell]
   804   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]

Phrase: "(50 ng/ml) for 5 d"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439275:ng/mL [Quantitative Concept]
   783   C0439446:mL/d [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(light gray bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1707156:BARS [Gene or Genome]
   827   C3274014:BARS [Intellectual Product]
   827   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "presence of 5 M BB-94"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(dark gray bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1707156:BARS [Gene or Genome]
   827   C3274014:BARS [Intellectual Product]
   827   C3541345:BARS [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.107: Solubilized 125I-fibrin was monitored as described in the Materials and Methods and expressed as the mean cpm  1 SD (n = 4). 

Phrase: "Solubilized 125I-fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   755 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "was"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "as"

Phrase: "described in the Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520510:Materials [Substance]
   770   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "expressed as the mean cpm  1 SD (n = 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0019728:SD-1 [Immunologic Factor]
   742   C0444504:Mean [Quantitative Concept]
   742   C2347634:Mean [Quantitative Concept]
   742   C2348143:Mean [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.108: (B) H and Estained transverse sections of control vector-transfected and MMP-overexpressing clones cultured atop fibrin gels as described above in the presence of SF/HGF for 5 d. 

Phrase: "(B) H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Estained transverse sections of control vector-transfected"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0205106:Transverse [Spatial Concept]
   748   C0446380:Transverse [Spatial Concept]
           Transverse section
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "MMP-overexpressing clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0009013:Clones [Cell]
   779 E C1522642:Clone [Tissue]
   729 E C1704387:Clonal [Qualitative Concept]
   706 E C0796368:clonality [Diagnostic Procedure]

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "as described above"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of SF/HGF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0062534:Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1442521:HEPATOCYTE GROWTH FACTOR [Gene or Genome]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0227525:Hepatocyte [Cell]
   804   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]

Phrase: "for 5 d."
Processing 00000000.tx.109: Only MT1-MMP transfectants expressed invasive behavior (arrows) which was completely blocked in the presence of BB-94. 

Phrase: "Only MT1-MMP transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "expressed"

Phrase: "invasive behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "which"

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "blocked in the presence of BB-94."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   748   C0004739:BB [Geographic Area]
   748   C0028778:Blocked [Pathologic Function]
   748   C0332206:Blocked [Functional Concept]
   748   C0332297:BB [Spatial Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.110: The double-headed arrow in the first panel demarcates the underlying fibrin gel which is largely transparent in H and Estained sections. 

Phrase: "The double-headed arrow in the first panel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0336721:Arrow [Manufactured Object]

Phrase: "demarcates"

Phrase: "the underlying fibrin gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]

Phrase: "which"

Phrase: "is"

Phrase: "largely transparent in H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522503:Transparent [Qualitative Concept]

Phrase: "and"

Phrase: "Estained sections."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]
Processing 00000000.tx.111: Bar = 100 m.  

Phrase: "Bar = 100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.112: Regulation of Fibroblast-Fibrin Interactions by MT1-MMP. 

Phrase: "Regulation of Fibroblast-Fibrin Interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by MT1-MMP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]
Processing 00000000.tx.113: Despite the fact that MT1-MMP (a) uniquely conferred fibrin-invasive activity to transfected cells relative to all of the secreted MMPs tested and (b) is known to be expressed in fibroblasts at sites of fibrin deposition in vivo (16, 18, 36), the role of this, or other, MMPs in regulating fibroblast-fibrin interactions has not been defined previously. 

Phrase: "Despite the fact"

Phrase: "that MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(a) uniquely conferred fibrin-invasive activity to transfected cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "relative to all of the secreted MMPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "and ("

Phrase: "b) is"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "expressed in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0016030:Fibroblasts [Cell]

Phrase: "at sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "of fibrin deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333565:Fibrin deposition [Pathologic Function]
   861   C0333562:Deposition [Functional Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(16,"

Phrase: "18,"

Phrase: "36"

Phrase: ")"

Phrase: ","

Phrase: "the role of this,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "or"

Phrase: "other,"

Phrase: "MMPs in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1704640:Matrix [Spatial Concept]
   790   C1706515:Matrix [Body Substance]

Phrase: "regulating"

Phrase: "fibroblast-fibrin interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "previously."
Processing 00000000.tx.114: To determine whether fibroblast-derived MMPs regulate fibrin-invasive activity, wild-type mouse cells were cultured atop fibrin gels and motility stimulated with PDGF in the absence or presence of class-specific antiproteinases. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "fibroblast-derived MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "regulate"

Phrase: "fibrin-invasive activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "wild-type mouse cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   858   C0449475:type cell [Intellectual Product]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756   C1520150:Wild Type Mouse [Mammal]

Phrase: "were"

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "motility"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007608:Motility [Cell Function]
  1000   C0678835:Motility [Laboratory or Test Result]
  1000   C1510470:Motility [Organism Function]
   928 E C1979933:Motile [Finding]

Phrase: "stimulated with PDGF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of class-specific antiproteinases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.115: After 2 d in culture, PDGF-stimulated fibroblasts had penetrated the underlying gel with peak invasion occurring by day 6 (Fig. 2, A and C) . As assessed by transmission electron microscopy (TEM), 4 to 6-d-old cultures revealed zones of cleared fibrin juxtaposed to the invading cells (Fig. 2 B) which correlated with the detection of degraded fibrin in the fluids expressed from the gels (at day 4, wild-type fibroblasts released 6,540 cpm 125I-fibrin and 17,380 cpm at day 6; n = 2). 

Phrase: "After 2 d"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1705052:2-D [Spatial Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "in culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "PDGF-stimulated fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0016030:Fibroblasts [Cell]
   734   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "had"

Phrase: "penetrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrated [Functional Concept]

Phrase: "the underlying gel with peak invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C1382104:Gel [Substance]

Phrase: "occurring by day 6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   737   C1709305:Occur [Activity]
   737   C2745955:OCCUR [Temporal Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "C) ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "As"

Phrase: "assessed by transmission electron microscopy (TEM),"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0678118:Transmission Electron Microscopy [Laboratory Procedure]
   806   C0026019:Electron Microscopy [Laboratory Procedure]
   806   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   760   C0013852:Electron [Quantitative Concept]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0040722:transmission [Idea or Concept]
   760   C0242781:Transmission [Pathologic Function]
   760   C1516048:Assessed [Activity]
   760   C1521797:Transmission [Natural Phenomenon or Process]
   760   C3463986:Electron [Bird]

Phrase: "4 to 6-"

Phrase: "d-"

Phrase: "old"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580836:Old [Temporal Concept]

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "revealed zones of cleared fibrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710706:Zone [Spatial Concept]

Phrase: "juxtaposed to the invading cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2 B)"

Phrase: "which"

Phrase: "correlated with the detection of degraded fibrin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
   748   C1707520:Correlated [Qualitative Concept]
   748   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "in the fluids"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0005889:Fluids [Body Substance]
  1000   C0302908:fluids [Substance]
  1000   C1521806:Fluids [Tissue]
   966 E C0444611:Fluid [Qualitative Concept]
   966 E C1704353:Fluid [Substance]

Phrase: "expressed from the gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0017243:Gels [Biomedical or Dental Material]
   737 E C1382104:Gel [Substance]

Phrase: "("

Phrase: "at day 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "wild-type fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0016030:Fibroblasts [Cell]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "6,540 cpm 125I-fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   733 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "and"

Phrase: "17,380 cpm at day 6"

Phrase: "; n = 2)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.116: While fibroblast invasion was unaffected by inhibitors directed against serine proteinases (aprotinin, soybean trypsin inhibitor, or plasminogen-depletion), cysteine proteinases (E-64), or aspartyl proteinases (pepstatin A), PDGF-stimulated cells were unable to penetrate the fibrin gels in the presence of BB-94 during the 6 d culture period (Fig. 2 A; 100  0% inhibition; mean  1 SD, n = 3). 

Phrase: "While"

Phrase: "fibroblast invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1269955:Invasion [Finding]
   861   C2699153:Invasion [Pathologic Function]

Phrase: "was"

Phrase: "unaffected by inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986417:Unaffected [Conceptual Entity]

Phrase: "directed against serine proteinases"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C2717971:Serine Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   737   C0439851:Direct [Qualitative Concept]
   737 E C1622131:proteinase [Molecular Function]
   737   C1947931:Direct [Qualitative Concept]
   737 E C1947941:Proteinase [Enzyme]

Phrase: "(aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "soybean trypsin inhibitor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0041242:trypsin inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0037733:Soy bean [Food]
   827   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0947608:SOYBEAN [Pharmacologic Substance]
   827   C1262902:Soybean [Plant]
   827   C1999216:Inhibitor [Qualitative Concept]
   827   C3257531:soybean [Pharmacologic Substance]

Phrase: "or"

Phrase: "plasminogen-depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "cysteine proteinases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C2717970:Cysteine Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "(E-64"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "aspartyl proteinases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C2717969:Aspartyl Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "(pepstatin A"

Phrase: ")"

Phrase: ","

Phrase: "PDGF-stimulated cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   841   C0007595:growth cell [Cell Function]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   734   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "penetrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrate [Functional Concept]

Phrase: "the fibrin gels in the presence of BB-94"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0017243:Gels [Biomedical or Dental Material]
   708 E C1382104:Gel [Substance]

Phrase: "during the 6 d culture period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   712 E C0031084:Periodicities [Temporal Concept]

Phrase: "(Fig. 2 A"

Phrase: "; 100  0% inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "; mean  1 SD,"

Phrase: "n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.117: View larger version (118K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(118K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.118: Invasive and migratory behavior of MT1-MMP+/+ and MT1-MMP-/- fibroblasts. 

Phrase: "Invasive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205281:Invasive [Qualitative Concept]

Phrase: "and"

Phrase: "migratory behavior of MT1-MMP+/+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]

Phrase: "and"

Phrase: "MT1-MMP-/- fibroblasts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016030:Fibroblasts [Cell]
   756   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.119: (A) H and Estained transverse sections of wild-type littermate and MT1-MMP-null fibroblasts cultured atop fibrin gels in the presence of 10% FBS with invasion stimulated by the addition of PDGF to the basilar compartment. 

Phrase: "(A) H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Estained transverse sections of wild-type littermate"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0205106:Transverse [Spatial Concept]
   748   C0446380:Transverse [Spatial Concept]
           Transverse section
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "MT1-MMP-null fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0016030:Fibroblasts [Cell]
   717   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 10% FBS"

Phrase: "with invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]

Phrase: "stimulated by the addition of PDGF"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   818   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   742   C0005821:Platelet [Cell]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0220844:growth [Physiologic Function]
   742   C1441547:Derived [Qualitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1883712:Addition [Functional Concept]
   742   C1948023:Stimulated [Natural Phenomenon or Process]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   742   C3245521:derived [Idea or Concept]

Phrase: "to the basilar compartment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.120: Invasion of MT1-MMP+/+ fibroblasts commenced at day 2 (top left panel) and peaked at day 6 (middle panel). 

Phrase: "Invasion of MT1-MMP+/+ fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1269955:Invasion [Finding]
   753   C2699153:Invasion [Pathologic Function]

Phrase: "commenced at day 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   737   C3274784:Commence [Activity]

Phrase: "(top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "peaked at day 6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   770   C0444505:peaked [Quantitative Concept]

Phrase: "(middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.121: Invasion of MT1-MMP-null fibroblasts was not observed in most sections at day 2 (bottom left panel), but accelerated to near-normal values by day 6. 

Phrase: "Invasion of MT1-MMP-null fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1269955:Invasion [Finding]
   748   C2699153:Invasion [Pathologic Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in most sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1441672:Observed [Functional Concept]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: "at day 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "accelerated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:Accelerated [Functional Concept]

Phrase: "to near-normal values by day 6."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0086715:Normal Values [Quantitative Concept]
   748   C0042295:Values [Qualitative Concept]
   748   C0205307:Normal [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C2347086:% Normal [Quantitative Concept]
   714 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.122: In the presence of BB-94, invasion of wild-type and null fibroblasts was inhibited completely. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of BB-94,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "invasion of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1269955:Invasion [Finding]
   770   C2699153:Invasion [Pathologic Function]

Phrase: "and"

Phrase: "null fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "was"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "completely."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]
Processing 00000000.tx.123: Bar = 100 m. 

Phrase: "Bar = 100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.124: (B) TEM analysis of fibrin-invasive MT1-MMP+/+ and MT1-MMP-/- fibroblasts. 

Phrase: "(B) TEM analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   717   C0678118:Transmission Electron Microscopy [Laboratory Procedure]

Phrase: "of fibrin-invasive MT1-MMP+/+"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT1-MMP-/- fibroblasts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016030:Fibroblasts [Cell]
   756   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.125: Invasive wild-type and null fibroblasts were both pocketed by zones of cleared fibrin (arrows). 

Phrase: "Invasive wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "null fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "both"

Phrase: "pocketed by zones of cleared fibrin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   783   C0521097:Cleared by [Functional Concept]
           cleared
   753   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   719   C1710706:Zone [Spatial Concept]
   719 E C2963144:Clear [Qualitative Concept]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.126: Bars = 5 m for MT1-MMP+/+ and 2 m for MT1-MMP-/- samples. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "= 5 m for MT1-MMP+/+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1440942:M-5 [Immunologic Factor]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "2 m for MT1-MMP-/- samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.127: (C) MT1-MMP+/+ and MT1-MMP-/- fibroblasts were cultured atop fibrin gels in the absence or presence of PDGF and the number of invasive foci monitored at the indicated times. 

Phrase: "(C) MT1-MMP+/+"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT1-MMP-/- fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016030:Fibroblasts [Cell]
   756   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of PDGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   716   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the number of invasive foci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "monitored at the indicated times."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0040223:times [Temporal Concept]
   760   C1444656:Indicated [Finding]
   760   C1632851:Times [Quantitative Concept]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1521743:Monitor [Professional or Occupational Group]
   726   C1704646:Monitor [Manufactured Object]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.128: Results are expressed as the mean number of invading cells/field  1 SD (n = 3). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as the mean number"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0237753:*Number [Quantitative Concept]
   760   C0444504:Mean [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]

Phrase: "of invading cells/field  1 SD (n = 3"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   795   C0007634:Cells [Cell]
   795   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   795   C1521738:Field [Conceptual Entity]
   795   C2346620:Field [Conceptual Entity]
   795   C2349184:Field [Conceptual Entity]
   795   C3282337:Cells [Cell]
   795   C3539073:FIELD [Spatial Concept]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.129: (D) Two-dimensional migration of PDGF-stimulated MT1-MMP+/+ and MT1-MMP-/- fibroblasts that were cultured atop fibrin gels and denuded by wounding in the absence or presence of BB-94 for 24 h. 

Phrase: "("

Phrase: "D)"

Phrase: "Two-dimensional migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0600210:Migration [Social Behavior]
   827   C1533574:Migration [Physiologic Function]
   827   C1881827:MIGRATION [Phenomenon or Process]
   734   C1705052:2-Dimensional [Spatial Concept]

Phrase: "of PDGF-stimulated MT1-MMP+/+"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1704640:Matrix [Spatial Concept]
   793   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT1-MMP-/- fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016030:Fibroblasts [Cell]
   756   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "were"

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "denuded by wounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0043250:Wound [Injury or Poisoning]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of BB-94"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.130: Arrow marks the edge of the confluent fibroblast layer after wounding as viewed by phase contrast microscopy. 

Phrase: "Arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "marks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "the edge of the confluent fibroblast layer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205154:Edge [Spatial Concept]
   748   C2697523:Edge [Conceptual Entity]

Phrase: "after wounding"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   966   C0043250:Wound [Injury or Poisoning]
   907 E C0021501:wounds [Qualitative Concept]
   907 E C0332797:Wounded [Functional Concept]

Phrase: "as"

Phrase: "viewed by phase contrast microscopy."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0026024:Microscopy, Phase-Contrast [Laboratory Procedure]
   806   C0444701:Phase contrast [Laboratory Procedure]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C1979874:Contrast [Qualitative Concept]
   726   C0449911:View [Spatial Concept]
Processing 00000000.tx.131: Bar = 100 m.  

Phrase: "Bar = 100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.132: Wound-associated fibroblasts have been shown to express MMP-2, MMP-11, and MT1-MMP in vivo (16, 18, 36), but only the latter proteinase scored positive in our screen of pro-invasive MMPs. 

Phrase: "Wound-associated fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "MMP-2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0172537:Matrix Metalloproteinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334522:MATRIX METALLOPROTEINASE 2 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "MMP-11,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0174383:Matrix Metalloproteinase 11 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366519:MATRIX METALLOPROTEINASE 11 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(16,"

Phrase: "18,"

Phrase: "36"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the latter proteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]

Phrase: "scored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:scored [Quantitative Concept]

Phrase: "positive in our screen of pro-invasive MMPs."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0439178:% Positive [Quantitative Concept]
   742   C1446409:Positive [Qualitative Concept]
   742   C1514241:Positive [Finding]
   742   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.133: Consequently, MT1-MMP-null fibroblasts were isolated from the gene-deleted animals and assessed for their ability to invade the fibrin gels under conditions identical to those used for the wild-type cells. 

Phrase: "Consequently,"

Phrase: "MT1-MMP-null fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0016030:Fibroblasts [Cell]
   717   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "isolated from the gene-deleted animals"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   767   C0314605:Animal gene [Gene or Genome]
   753   C0003062:Animals [Animal]
   753   C0017337:Gene [Gene or Genome]
   753   C0205409:Isolated [Functional Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C1880274:Deleted [Activity]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "assessed for their ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C1516048:Assessed [Activity]

Phrase: "invade"

Phrase: "the fibrin gels under conditions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0017243:Gels [Biomedical or Dental Material]
   726 E C1382104:Gel [Substance]

Phrase: "identical to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "used for the wild-type cells."
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   790   C1883559:Wild Type [Organism Attribute]
   783   C0449475:cells type [Intellectual Product]
   767 E C0007634:Cell Type [Cell]
           Cells
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1273517:used [Finding]
   753   C1547052:*Type [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1947944:Use [Intellectual Product]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.134: After the first 2 d in culture, PDGF-stimulated MT1-MMP null cells displayed a striking deficiency in invasive potential (Fig. 2, A and C) with the number of invasive foci reaching levels only 27  0.3% of control value (mean  1 SD; n = 3). 

Phrase: "After the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "2 d in culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1705052:2-D [Spatial Concept]
   770   C0740116:+2 [Quantitative Concept]
   770   C2827735:2+ [Quantitative Concept]
   770   C2981700:2+ [Classification]

Phrase: "PDGF-stimulated MT1-MMP null cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   852   C0007595:growth cell [Cell Function]
   804   C0024265:Null Cells [Cell]
   790   C0007634:Cells [Cell]
   790   C0456148:Null [Quantitative Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a striking deficiency in invasive potential"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011155:Deficiency [Functional Concept]
   753   C0162429:Deficiency [Disease or Syndrome]
   753   C1623416:deficiency [Qualitative Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "C) with the number of invasive foci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1553033:[c] [Quantitative Concept]

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "levels only 27  0.3% of control value"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   750   C0456949:Level 3 [Intellectual Product]
   744   C0205171:Only [Quantitative Concept]
   744   C0243148:control [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1522609:Value [Quantitative Concept]
   744   C1550141:Control [Substance]
   744   C1720467:Only [Intellectual Product]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "(mean  1 SD"

Phrase: "; n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.135: Surprisingly, however, the defect in invasive activity was only transient as the null cells began to invade the fibrin matrix after a 3-d lag where invasion reached 6070% of control values by day 6 (Fig. 2 C). 

Phrase: "Surprisingly,"

Phrase: "however,"

Phrase: "the defect in invasive activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]

Phrase: "was"

Phrase: "only transient as the null cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040704:Transient [Population Group]
   753   C0205374:Transient [Temporal Concept]

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "invade"

Phrase: "the fibrin matrix after a 3-d lag where invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1704640:Matrix [Spatial Concept]
   739   C1706515:Matrix [Body Substance]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "6070% of control values"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0042295:Values [Qualitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "by day 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "(Fig. 2 C)."
Processing 00000000.tx.136: Similar to the behavior of the wild-type cells, zones of fibrin clearing were found in association with the invading null fibroblasts which also proteolyzed fibrin comparably to control cells (i.e., 16,260 cpm 125I-fibrin released by null fibroblasts versus 17,380 cpm for wild-type cells by day 6; n = 2; Fig. 2 B). 

Phrase: "Similar to the behavior of the wild-type cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2348205:Similar [Qualitative Concept]

Phrase: "zones of fibrin clearing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710706:Zone [Spatial Concept]

Phrase: "were"

Phrase: "found in association"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0004083:Association [Mental Process]
   790   C0150312:Found [Quantitative Concept]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   756 E C0243095:Find [Finding]

Phrase: "with the invading null fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]

Phrase: "which also"

Phrase: "proteolyzed"

Phrase: "fibrin comparably to control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   804   C0007634:Cells [Cell]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(i.e., 16,260 cpm 125I-fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   724 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "released by null fibroblasts"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0016030:Fibroblasts [Cell]
   770   C0391871:Released [Functional Concept]
   770   C0456148:Null [Quantitative Concept]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "versus"

Phrase: "17,380 cpm for wild-type cells"

Phrase: "by day 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "; n = 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; Fig. 2 B"

Phrase: ")."
Processing 00000000.tx.137: To determine whether the delayed fibrin-invasive activity of MT1-MMPdeficient fibroblasts could be linked to the expression of other MMP family members, the null fibroblasts were stimulated with PDGF atop fibrin gel in the presence of BB-94. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the delayed fibrin-invasive activity of MT1-MMPdeficient fibroblasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "could"

Phrase: "be"

Phrase: "linked to the expression of other MMP family members,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   776   C0557102:Member of link family [Finding]
   760   C0086282:Family Members [Family Group]
   760   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0015576:Family [Family Group]
   739   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0680022:members [Population Group]
   739   C1704640:Matrix [Spatial Concept]
   739   C1704727:Family [Conceptual Entity]
   739   C1706515:Matrix [Body Substance]
   726 E C1611821:Family Member [Intellectual Product]
   706   C1517892:Link [Intellectual Product]
   706   C1704666:Link [Intellectual Product]
   706 E C2698041:Member [Professional or Occupational Group]

Phrase: "the null fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "stimulated with PDGF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "atop fibrin gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of BB-94."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]
Processing 00000000.tx.138: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.139: 2 A, BB-94 completely prevented fibrin invasion by the null cells (100  0% inhibition; mean  1 SD, n = 3). 

Phrase: "2 A,"

Phrase: "BB-94 completely prevented fibrin invasion by the null cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   741   C2699153:Cell Invasion [Pathologic Function]
           Invasion
   739   C1269955:Invasion [Finding]

Phrase: "(100  0% inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "; mean  1 SD,"

Phrase: "n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.140: Significantly, while MMP activity has been linked to the migratory response of other cell types across matrix-coated surfaces (e.g., references 3741), the two-dimensional movement of PDGF-stimulated wild-type or null cells cultured atop fibrin gels was not inhibited by BB-94 (Fig. 2 D) and leading front determinations demonstrated that wild-type cells incubated in the absence or presence of BB-94 migrated 0.69  0.04 mm and 0.67  0.03 mm, respectively, while null cells migrated 0.65  0.07 mm and 0.66  0.04 mm in the absence or presence of BB-94 (mean  1 SD, n = 3). 

Phrase: "Significantly,"

Phrase: "while"

Phrase: "MMP activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1150224:metalloproteinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "linked to the migratory response of other cell types"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   770   C0449475:Type of cell [Intellectual Product]
           Cell types
   742   C0007634:Cell [Cell]
       E   Cell Type
   742   C0232901:Migratory [Functional Concept]
   742   C0332307:Types [Qualitative Concept]
   742   C0871261:Response [Organism Attribute]
   742   C1269647:Cell [Cell]
   742   C1704632:Response [Finding]
   742   C1704653:Cell [Medical Device]
   742   C1706817:Response [Intellectual Product]
   742   C1948049:Cell [Spatial Concept]
   742   C2911692:Response [Mental Process]
   708   C1517892:Link [Intellectual Product]
   708 E C1547052:*Type [Quantitative Concept]
   708   C1704666:Link [Intellectual Product]

Phrase: "across matrix-coated surfaces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205148:Surface [Spatial Concept]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "references"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "3741"

Phrase: ")"

Phrase: ","

Phrase: "the two-dimensional movement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026649:Movement [Organism Function]
   734   C1705052:2-Dimensional [Spatial Concept]

Phrase: "of PDGF-stimulated wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C1883559:Wild Type [Organism Attribute]
   795   C0332307:Type [Qualitative Concept]
   795   C0445392:Wild [Intellectual Product]
   795   C1547052:*Type [Quantitative Concept]
   710   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "null cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0024265:Null Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0456148:Null [Quantitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibited by BB-94"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   770   C0004739:BB [Geographic Area]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C0332297:BB [Spatial Concept]

Phrase: "(Fig. 2 D"

Phrase: ")"

Phrase: "and"

Phrase: "leading front determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680730:determinations [Governmental or Regulatory Activity]
   793 E C1148554:determination [Laboratory Procedure]

Phrase: "demonstrated"

Phrase: "that wild-type cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C0449475:type cell [Intellectual Product]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "incubated in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "presence of BB-94"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "migrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:Migrated [Functional Concept]

Phrase: "0.69  0.04 mm"

Phrase: "and"

Phrase: "0.67  0.03 mm,"

Phrase: "respectively,"

Phrase: "while"

Phrase: "null cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0024265:Null Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0456148:Null [Quantitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "migrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:Migrated [Functional Concept]

Phrase: "0.65  0.07 mm"

Phrase: "and"

Phrase: "0.66  0.04 mm in the absence"

Phrase: "or"

Phrase: "presence of BB-94"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(mean  1 SD,"

Phrase: "n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.141: Characterization of MT1-MMP-Independent Fibrin-Invasive Activity. 

Phrase: "Characterization of MT1-MMP-Independent Fibrin-Invasive Activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880022:Characterization [Activity]
Processing 00000000.tx.142: As BB-94 inhibits secreted as well as membrane-anchored MMPs with near equivalent efficiency (3, 30), the MT1-MMP-independent process used by the null fibroblasts could be mediated by either group of MMPs. 

Phrase: "As BB-94"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "as well as"

Phrase: "membrane-anchored MMPs with near equivalent efficiency"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1704640:Matrix [Spatial Concept]
   744   C1706515:Matrix [Body Substance]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "30"

Phrase: ")"

Phrase: ","

Phrase: "the MT1-MMP-independent process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1184743:Process [Body Part, Organ, or Organ Component]
   804   C1522240:Process [Phenomenon or Process]
   717   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "used by the null fibroblasts"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C1273517:Used by [Finding]
           used
   760   C0016030:Fibroblasts [Cell]
   760   C0456148:Null [Quantitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "mediated by either group of MMPs."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1704640:Matrix [Spatial Concept]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   748   C1706515:Matrix [Body Substance]
Processing 00000000.tx.143: Consequently, we took advantage of the ability of the endogenous MMP inhibitor, TIMP-1, to preferentially inhibit secreted MMPs in contrast to the ability of the related inhibitor, TIMP-2, to target secreted as well as membrane-anchored MMPs (3, 19, 30). 

Phrase: "Consequently,"

Phrase: "we"

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "advantage of the ability of the endogenous MMP inhibitor,"

Phrase: "TIMP-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to preferentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "secreted MMPs in contrast to the ability of the related inhibitor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1721004:Matrix Metalloproteinases, Secreted [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   751   C1513016:Matrix Metalloproteinase Inhibitor [Pharmacologic Substance]
   736   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   736   C1704640:Matrix [Spatial Concept]
   736   C1706515:Matrix [Body Substance]
   734   C1152589:metalloproteinase inhibitor [Molecular Function]

Phrase: "TIMP-2,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "as well as"

Phrase: "membrane-anchored MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "19,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.144: Hence, wild-type and MT1-MMP null fibroblasts were cultured atop fibrin gels and stimulated with PDGF in the absence or presence of equimolar concentrations of active TIMP-1 or TIMP-2. 

Phrase: "Hence,"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "MT1-MMP null fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0016030:Fibroblasts [Cell]
   717   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "stimulated with PDGF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of equimolar concentrations of active TIMP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "TIMP-2."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.145: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.146: 3 , while the invasive activity of wild-type or null fibroblasts was unaffected by TIMP-1, invasion was completely inhibited by TIMP-2 (Fig. 3, A and B). 

Phrase: "3 ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "while"

Phrase: "the invasive activity of wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0459205:Type of activity [Intellectual Product]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "or"

Phrase: "null fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "was"

Phrase: "unaffected by TIMP-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986417:Unaffected [Conceptual Entity]

Phrase: "invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "inhibited by TIMP-2"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   897   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   889 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   889 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   853   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   853   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1152589:metalloproteinase inhibitor [Molecular Function]
   748   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0040300:Tissue [Tissue]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C1547928:Tissue [Intellectual Product]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.147: The inhibitory effects of TIMP-2 were confined to three-dimensional invasion as neither TIMP-2 nor TIMP-1 affected the two-dimensional migratory response of fibroblasts stimulated atop fibrin gels (data not shown). 

Phrase: "The inhibitory effects of TIMP-2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "confined to three-dimensional invasion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0450363:3-Dimensional [Spatial Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1269955:Invasion [Finding]
   760   C2699153:Invasion [Pathologic Function]

Phrase: "as neither TIMP-2"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   905 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   905 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   893   C0104281:AS 2 [Organic Chemical,Pharmacologic Substance]
   877   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   877   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0040300:Tissue [Tissue]
   795   C1547928:Tissue [Intellectual Product]
   795   C1999216:Inhibitor [Qualitative Concept]

Phrase: "nor"

Phrase: "TIMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the two-dimensional migratory response of fibroblasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "stimulated atop fibrin gels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   770   C1948023:Stimulated [Natural Phenomenon or Process]
   737 E C1382104:Gel [Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.148: View larger version (86K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(86K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.149: Effect of TIMP-1 and TIMP-2 on the fibrin-invasive activity of MT1-MMP+/+ and MT1-MMP-/- fibroblasts. 

Phrase: "Effect of TIMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "TIMP-2"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "on the fibrin-invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "of MT1-MMP+/+"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT1-MMP-/- fibroblasts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016030:Fibroblasts [Cell]
   756   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.150: (A) H and Estained transverse sections of PDGF-stimulated MT1-MMP+/+ and null fibroblasts cultured atop fibrin gels in either 10% FBS alone or supplemented with TIMP-1 (50 g/ml) or TIMP-2 (20 g/ml) for 6 d. 

Phrase: "(A) H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Estained transverse sections"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   867   C0446380:Transverse section [Spatial Concept]
           Transverse
   827   C0205106:Transverse [Spatial Concept]
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "of PDGF-stimulated MT1-MMP+/+"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1704640:Matrix [Spatial Concept]
   793   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "null fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "in either 10% FBS"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "supplemented with TIMP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "(50 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "TIMP-2"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(20 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) for 6 d."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0439446:mL/d [Quantitative Concept]
   770   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.151: Bar = 100 m. 

Phrase: "Bar = 100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.152: (B) The number of invasive foci and depth of invasion was quantified for MT1-MMP+/+ and MT1-MMP-/- fibroblasts cultured in the absence or presence of TIMP-1 and TIMP-2. 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The number of invasive foci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "depth of invasion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205125:Depth [Spatial Concept]
   718 E C1422002:DEEPEST [Gene or Genome]

Phrase: "was"

Phrase: "quantified for MT1-MMP+/+"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   760   C3540571:MT1 [Gene or Genome]
   726   C1709793:Quantify [Quantitative Concept]

Phrase: "and"

Phrase: "MT1-MMP-/- fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016030:Fibroblasts [Cell]
   756   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cultured in the absence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "or"

Phrase: "presence of TIMP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "TIMP-2."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.153: Results are expressed as the mean  1 SD of three experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as the mean  1 SD of three experiments."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   762   C0019728:SD-1 [Immunologic Factor]
   742   C0205449:Three [Quantitative Concept]
   742   C0444504:Mean [Quantitative Concept]
   742   C0681814:Experiments [Research Activity]
   742   C2347634:Mean [Quantitative Concept]
   742   C2348143:Mean [Quantitative Concept]
   708 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.154: (C) RT-PCR analysis of MT1-MMP and MT3-MMP expression in wild-type and null cells cultured atop fibrin gels and stimulated with PDGF for 72 h. 

Phrase: "(C) RT-PCR analysis of MT1-MMP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0200931:PCR analysis [Laboratory Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0677874:pCR [Finding]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "MT3-MMP expression in wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "null cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0024265:Null Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0456148:Null [Quantitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "stimulated with PDGF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "for 72 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.155: The 402 bp MT-3 transcript was confirmed by sequence analysis. 

Phrase: "The 402 bp MT-3 transcript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "confirmed by sequence analysis."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0750484:Confirmed [Idea or Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1519249:Sequence [Functional Concept]
   770   C1524024:analysis [Functional Concept]
   737 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.156: MT2-MMP-specific transcripts were not detected under these conditions.  

Phrase: "MT2-MMP-specific transcripts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected under these conditions."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.157: Among the other membrane-anchored MMPs that are preferentially sensitive to TIMP-2, MT2-MMP, and MT3-MMP appear to be among the most widely expressed in vitro or in vivo (30, 4247). 

Phrase: "Among the"

Phrase: "other membrane-anchored MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "that"

Phrase: "are"

Phrase: "preferentially sensitive to TIMP-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332324:Sensitive to [Functional Concept]
           Sensitive
   744   C1550474:sensitive [Idea or Concept]
   703   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "MT2-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT3-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be among the most widely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2987476:Be [Conceptual Entity]

Phrase: "expressed"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "or"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(30,"

Phrase: "4247"

Phrase: ")."
Processing 00000000.tx.158: To determine whether fibroblasts expressed either of these MT-MMPs, wild-type or MT1-MMP null cells were cultured atop fibrin gels, stimulated with PDGF for 3 d, and isolated RNA amplified by reverse transcription (RT)-PCR using the corresponding MT-MMP-specific primers (Fig. 3 C). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "expressed"

Phrase: "either of these MT-MMPs,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "MT1-MMP null cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C0024265:Null Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C0456148:Null [Quantitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "cultured atop fibrin gels,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "stimulated with PDGF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "for 3 d,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450363:3-D [Spatial Concept]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "isolated RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "amplified by reverse transcription (RT)-PCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0035380:Reverse Transcription [Genetic Function]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0040649:Transcription [Genetic Function]
   760   C0677874:pCR [Finding]
   760   C1555029:Reverse [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the corresponding MT-MMP-specific primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 3 C)."
Processing 00000000.tx.159: Interestingly, while MT2-MMP could not be detected in either fibroblast population, both the wild-type and MT1-MMP-null fibroblasts expressed MT3-MMP. 

Phrase: "Interestingly,"

Phrase: "while"

Phrase: "MT2-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "detected in either fibroblast population,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0016030:Fibroblast [Cell]
   760   C0032659:Population [Quantitative Concept]
   760   C0442726:Detected [Finding]
   760   C1257890:Population [Population Group]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "both"

Phrase: "the wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "MT1-MMP-null fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0016030:Fibroblasts [Cell]
   717   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "expressed"

Phrase: "MT3-MMP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]
Processing 00000000.tx.160: Consistent with these data, MT1-MMP-null fibroblasts retained a diminished ability to activate proMMP-2 via a process inhibitable by TIMP-2 or BB-94, but not TIMP-1 (data not shown). 

Phrase: "Consistent with these data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "MT1-MMP-null fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0016030:Fibroblasts [Cell]
   717   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "a diminished ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "proMMP-2 via a process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0526871:pro-MMP-2 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1522240:Process [Phenomenon or Process]

Phrase: "inhibitable by TIMP-2"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   731   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   722 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   722 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]

Phrase: "or"

Phrase: "BB-94,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "but"

Phrase: "not TIMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.161: To determine directly whether MT3-MMP can confer a fibrin-invasive activity comparable to that observed for MT1-MMP, an invasion-incompetent cell population (i.e., CHO-K1 cells) was transiently transfected with either of the epitope-tagged MT-MMPs and fibrin invasion monitored in the presence of 10% serum as described. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "whether"

Phrase: "MT3-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "can"

Phrase: "confer"

Phrase: "a fibrin-invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "comparable to that"

Phrase: "observed for MT1-MMP,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1441672:Observed [Functional Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   760   C3540571:MT1 [Gene or Genome]

Phrase: "an invasion-incompetent cell population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]

Phrase: "(i.e., CHO-K1 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   853   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "was"

Phrase: "transiently"

Phrase: "transfected with either of the epitope-tagged MT-MMPs"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0003316:Epitope [Immunologic Factor]
   739   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   739   C1704640:Matrix [Spatial Concept]
   739   C1706515:Matrix [Body Substance]
   739   C1708632:Tagged [Qualitative Concept]
   706 E C0037293:Tag [Neoplastic Process]
   706 E C0181496:Tag [Manufactured Object]
   706 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "fibrin invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1269955:Invasion [Finding]
   861   C2699153:Invasion [Pathologic Function]

Phrase: "monitored in the presence of 10% serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0229671:Serum [Body Substance]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   714   C0030695:monitor [Health Care Activity]
   714   C0150369:monitor [Health Care Activity]
   714   C0181904:Monitor [Medical Device]
   714   C0596972:Monitor [Medical Device]
   714   C1521743:Monitor [Professional or Occupational Group]
   714   C1704646:Monitor [Manufactured Object]

Phrase: "as"

Phrase: "described."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]
Processing 00000000.tx.162: While control transfected CHO-K1 cells showed little, if any, BB-94-sensitive invasive activity, MT1-MMP transfected cells readily penetrated the gels (Fig. 4, A and D) . Significantly, MT3-MMP-transient as well as stable transfectants displayed similar activity despite the fact that the levels of MT3-MMP protein expressed (as assessed by Western blot analysis with anti-M2 FLAG monoclonal antibody) were consistently lower than those detected for MT1-MMP (Fig. 4, AC). 

Phrase: "While"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "transfected CHO-K1 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   875   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "little,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "if"

Phrase: "any,"

Phrase: "BB-94-sensitive invasive activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "MT1-MMP transfected cells readily"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "penetrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrated [Functional Concept]

Phrase: "the gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "D) . Significantly,"

Phrase: "MT3-MMP-transient"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0040704:Transient [Population Group]
   812   C0205374:Transient [Temporal Concept]
   756   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as well as"

Phrase: "stable transfectants"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "similar activity despite the fact"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "the levels of MT3-MMP protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "expressed"

Phrase: "("

Phrase: "as"

Phrase: "assessed by Western blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1516048:Assessed [Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "with anti-M2 FLAG monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0746619:monoclonal [Finding]

Phrase: ")"

Phrase: "were"

Phrase: "consistently lower than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "detected for MT1-MMP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   760   C3540571:MT1 [Gene or Genome]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "AC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.163: Finally, in a fashion similar to that observed in the wild-type or MT1-MMP null fibroblasts, MT3-MMPdependent invasion was completely resistant to TIMP-1, but equally sensitive to BB-94 or TIMP-2 (Fig. 4 D). 

Phrase: "Finally,"

Phrase: "in a fashion"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed in the wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1441672:Observed [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "MT1-MMP null fibroblasts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0016030:Fibroblasts [Cell]
   717   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "MT3-MMPdependent invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1269955:Invasion [Finding]
   827   C2699153:Invasion [Pathologic Function]

Phrase: "was"

Phrase: "completely resistant to TIMP-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "but"

Phrase: "equally sensitive to BB-94"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "or"

Phrase: "TIMP-2"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 4 D"

Phrase: ")."
Processing 00000000.tx.164: Cells cotransfected with MT1-MMP and MT3-MMP did not display synergistic invasive behavior (data not shown). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "cotransfected with MT1-MMP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   760   C3540571:MT1 [Gene or Genome]

Phrase: "and"

Phrase: "MT3-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "synergistic invasive behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0004927:Behavior [Individual Behavior]
   827   C2707008:Behavior [Clinical Attribute]
   755 E C2986890:Behavioral [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.165: Hence, the fibrin-invasive properties of MT1-MMP can be extended to include the membrane-anchored metalloproteinase, MT3-MMP. 

Phrase: "Hence,"

Phrase: "the fibrin-invasive properties of MT1-MMP"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0871161:properties [Qualitative Concept]
   744   C1292721:properties [Functional Concept]
   711 E C1882134:Property [Conceptual Entity]
   711 E C2347695:Property [Entity]

Phrase: "can"

Phrase: "be"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the membrane-anchored metalloproteinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "MT3-MMP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]
Processing 00000000.tx.166: View larger version (48K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(48K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.167: MT3-MMP-dependent fibrin-invasive activity. 

Phrase: "MT3-MMP-dependent fibrin-invasive activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150224:metalloproteinase activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.168: (A) TEM sections of control vector-, MT1-MMP-, and MT3-MMPtransfected CHO-K1 cells cultured atop fibrin gels in 10% FBS and stimulated with SF/HGF in the absence or presence of BB-94 for 5 d. 

Phrase: "(A) TEM sections of control vector-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   711   C0205155:Section [Spatial Concept]
   711   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   711   C1522472:Section [Substance]
   711   C1552923:Section [Quantitative Concept]
   711   C1705191:Section [Physical Object]

Phrase: "MT1-MMP-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT3-MMPtransfected CHO-K1 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   853   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "in 10% FBS"

Phrase: "and"

Phrase: "stimulated with SF/HGF"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C0062534:Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Scatter Factor
   814   C1442521:HEPATOCYTE GROWTH FACTOR [Gene or Genome]
           SCATTER FACTOR
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1524023:Scatter Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0227525:Hepatocyte [Cell]
   748   C0439742:scatter [Spatial Concept]
   748   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of BB-94"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "for 5 d."
Processing 00000000.tx.169: Bar = 10 m. 

Phrase: "Bar = 10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.170: (B) Western blot analysis of CHO-K1 cells transfected with a control vector, FLAG-tagged MT1-MMP, or FLAG-tagged MT3-MMP. 

Phrase: "(B) Western blot analysis of CHO-K1 cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1705493:Western [Spatial Concept]

Phrase: "transfected with a control vector,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0031249:control vector [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243148:control [Qualitative Concept]
   760   C0442335:Vector [Spatial Concept]
   760   C1550141:Control [Substance]
   760   C1705099:Vector [Idea or Concept]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "FLAG-tagged MT1-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "FLAG-tagged MT3-MMP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]
Processing 00000000.tx.171: (C) H and Estained transverse sections of MDCK stable transfectants overexpressing MT3-MMP cultured atop fibrin gels and stimulated with SF/HGF for 5 d in the absence or presence of BB-94. 

Phrase: "(C) H"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Estained transverse sections of MDCK stable transfectants"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0205106:Transverse [Spatial Concept]
   748   C0446380:Transverse [Spatial Concept]
           Transverse section
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "MT3-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "stimulated with SF/HGF"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C0062534:Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Scatter Factor
   814   C1442521:HEPATOCYTE GROWTH FACTOR [Gene or Genome]
           SCATTER FACTOR
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1524023:Scatter Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0227525:Hepatocyte [Cell]
   748   C0439742:scatter [Spatial Concept]
   748   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "for 5 d"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of BB-94."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.172: Bar = 100 m. 

Phrase: "Bar = 100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.173: (D) CHO-K1 cells transiently transfected with control-, MT1-MMP-, or MT3-MMP- expression vectors were cultured atop fibrin gels for 5 d and the number of invasive foci/field and invasion depth were quantified in the absence or presence of TIMP-1, TIMP-2, or BB-94. 

Phrase: "("

Phrase: "D)"

Phrase: "CHO-K1 cells transiently"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   875   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with control-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "MT1-MMP-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MT3-MMP- expression vectors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vectors [Spatial Concept]
   771 E C1705099:Vector [Idea or Concept]
   717   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "for 5 d"

Phrase: "and"

Phrase: "the number of invasive foci/field"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "invasion depth"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205125:Depth [Spatial Concept]
   789 E C1422002:DEEPEST [Gene or Genome]

Phrase: "were"

Phrase: "quantified in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "or"

Phrase: "presence of TIMP-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "TIMP-2,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "BB-94."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]
Processing 00000000.tx.174: Results are expressed as the mean  1 SD of three experiments.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as the mean  1 SD of three experiments."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   762   C0019728:SD-1 [Immunologic Factor]
   742   C0205449:Three [Quantitative Concept]
   742   C0444504:Mean [Quantitative Concept]
   742   C0681814:Experiments [Research Activity]
   742   C2347634:Mean [Quantitative Concept]
   742   C2348143:Mean [Quantitative Concept]
   708 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.175: Fibrin-Invasive Activity Can Be Extended to MT2-MMP, but not MT4-MMP. 

Phrase: "Fibrin-Invasive Activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "Can"

Phrase: "Be"

Phrase: "Extended to MT2-MMP,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0231448:Extended [Functional Concept]
   760   C0231449:Extended [Spatial Concept]
   760   C0439792:extended [Spatial Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]

Phrase: "but"

Phrase: "not MT4-MMP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]
Processing 00000000.tx.176: While fibroblasts can preferentially rely on either MT1-MMP or MT3-MMP to negotiate fibrin barriers, a variety of normal as well as neoplastic cell populations display different repertoires of membrane-anchored metalloproteinases which include MT2-MMP and/or MT4-MMP (25, 4247). 

Phrase: "While"

Phrase: "fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "can"

Phrase: "preferentially"

Phrase: "rely on either MT1-MMP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]
   753   C3540571:MT1 [Gene or Genome]

Phrase: "or"

Phrase: "MT3-MMP to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "negotiate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680727:negotiate [Social Behavior]

Phrase: "fibrin barriers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706912:BARRIER [Medical Device]

Phrase: "a variety of normal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883525:Variety [Conceptual Entity]
   770   C2346866:Variety [Conceptual Entity]

Phrase: "as well as"

Phrase: "neoplastic cell populations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
   734   C0597032:Neoplastic Cell [Cell]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "different repertoires of membrane-anchored metalloproteinases"

Phrase: "which"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "MT2-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and/or"

Phrase: "MT4-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(25,"

Phrase: "4247"

Phrase: ")."
Processing 00000000.tx.177: To determine whether fibrin-invasive activity is restricted to MT1- and MT3-MMP, cells were transfected with either MT2- or MT4-MMP and invasive activity monitored. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "fibrin-invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "restricted to MT1-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0443288:Restricted [Functional Concept]
   790   C3540571:MT1 [Gene or Genome]

Phrase: "and"

Phrase: "MT3-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with either MT2-"

Phrase: "or"

Phrase: "MT4-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "monitored."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.178: Significantly, despite the fact that the isolated catalytic domain of MT2-MMP has been reported to express little, if any, fibrinolytic activity (23), transiently transfected CHO-K1 cells (as well as stably transfected cells) expressed an invasive phenotype comparable to that observed for MT1-MMP and MT3-MMP (Fig. 5, AC) . Likewise, the invasion by MT2-MMP transfectants could be blocked completely by TIMP-2 or BB-94, but not TIMP-1 (Fig. 5, B, C, and E). 

Phrase: "Significantly,"

Phrase: "despite the fact"

Phrase: "that"

Phrase: "the isolated catalytic domain of MT2-MMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0600499:Catalytic Domain [Amino Acid Sequence]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "little,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "if"

Phrase: "any,"

Phrase: "fibrinolytic activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "transiently transfected CHO-K1 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   853   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "as well as"

Phrase: "stably transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "expressed"

Phrase: "an invasive phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "comparable to that"

Phrase: "observed for MT1-MMP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1441672:Observed [Functional Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   760   C3540571:MT1 [Gene or Genome]

Phrase: "and"

Phrase: "MT3-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "AC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: ") . Likewise,"

Phrase: "the invasion by MT2-MMP transfectants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1269955:Invasion [Finding]
   748   C2699153:Invasion [Pathologic Function]

Phrase: "could"

Phrase: "be"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "completely by TIMP-2"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   897   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   889 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   889 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   853   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   853   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1152589:metalloproteinase inhibitor [Molecular Function]
   748   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0040300:Tissue [Tissue]
   748   C0205197:Completely [Qualitative Concept]
   748   C1547928:Tissue [Intellectual Product]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "BB-94,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "but"

Phrase: "not TIMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "C,"

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.179: View larger version (38K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.180: Fibrin-invasive potential of MT2-MMP, MT4-MMP, and transmembrane-deleted mutants. 

Phrase: "Fibrin-invasive potential of MT2-MMP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3245505:Potential [Qualitative Concept]

Phrase: "MT4-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "transmembrane-deleted mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.181: (A) Western blot analysis of CHO-K1 cells transiently transfected with a control vector, FLAG-tagged full-length MT2-MMP, or FLAG-tagged full-length MT4-MMP (left panel). 

Phrase: "(A) Western blot analysis of CHO-K1 cells transiently"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1705493:Western [Spatial Concept]

Phrase: "transfected with a control vector,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0031249:control vector [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243148:control [Qualitative Concept]
   760   C0442335:Vector [Spatial Concept]
   760   C1550141:Control [Substance]
   760   C1705099:Vector [Idea or Concept]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "FLAG-tagged full-length MT2-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   845   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1704640:Matrix [Spatial Concept]
   795   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "FLAG-tagged full-length MT4-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   845   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1704640:Matrix [Spatial Concept]
   795   C1706515:Matrix [Body Substance]

Phrase: "(left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.182: Alternatively, CHO-K1 cells were transiently transfected with a control vector, transmembrane-deleted MT1-MMP (MT1-MMPs), MT2-MMPs, or MT3-MMPs containing a His-tag epitope at their carboxy termini in the absence or presence of an 1PDX expression vector. 

Phrase: "Alternatively,"

Phrase: "CHO-K1 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with a control vector,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0031249:control vector [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243148:control [Qualitative Concept]
   760   C0442335:Vector [Spatial Concept]
   760   C1550141:Control [Substance]
   760   C1705099:Vector [Idea or Concept]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "transmembrane-deleted MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]

Phrase: "(MT1-MMPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: ")"

Phrase: ","

Phrase: "MT2-MMPs,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MT3-MMPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a His-tag epitope at their carboxy termini"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0003316:Epitope [Immunologic Factor]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of an 1PDX expression vector."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.183: In the presence of 1PDX, the proform of each of the soluble MT-MMPs was the predominant species detected. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1PDX,"

Phrase: "the proform of each of the soluble MT-MMPs"

Phrase: "was"

Phrase: "the predominant species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.184: (B) TEM sections of CHO-K1 cells transiently transfected with MT2-MMP cultured atop a fibrin gel in 10% FBS with SF/HGF in the absence or presence of BB-94. 

Phrase: "(B) TEM sections of CHO-K1 cells transiently"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   706   C0205155:Section [Spatial Concept]
   706   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   706   C1522472:Section [Substance]
   706   C1552923:Section [Quantitative Concept]
   706   C1705191:Section [Physical Object]

Phrase: "transfected with MT2-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]

Phrase: "cultured atop a fibrin gel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C1382104:Gel [Substance]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "in 10% FBS"

Phrase: "with SF/HGF"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0062534:Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1442521:HEPATOCYTE GROWTH FACTOR [Gene or Genome]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0227525:Hepatocyte [Cell]
   804   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of BB-94."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.185: Bar = 10 m. 

Phrase: "Bar = 10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.186: (C) H and Estained sections of MDCK cells stably transfected with MT2-MMP or CHO-K1 cells transiently transfected with MT4-MMP and cultured atop fibrin gels as described above, in the absence or presence of BB-94. 

Phrase: "(C) H"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Estained sections of MDCK cells stably"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]

Phrase: "transfected with MT2-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "CHO-K1 cells transiently"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   875   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with MT4-MMP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1425724:MT4 [Gene or Genome]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "as described above,"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of BB-94."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.187: Bar = 100 m. 

Phrase: "Bar = 100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.188: (D) CHO-K1 cells transiently transfected with MT1-MMPs, MT2-MMPs, or MT3-MMPs did not invade the underlying fibrin gel after a 5 d incubation period. 

Phrase: "("

Phrase: "D)"

Phrase: "CHO-K1 cells transiently"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   875   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with MT1-MMPs,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   845   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   760   C3540571:MT1 [Gene or Genome]

Phrase: "MT2-MMPs,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MT3-MMPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "invade"

Phrase: "the underlying fibrin gel after a 5 d incubation period."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0017243:Gel [Biomedical or Dental Material]
   739   C1382104:Gel [Substance]
Processing 00000000.tx.189: Bar = 50 m. 

Phrase: "Bar = 50 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.190: (E) Invasive foci/field and invasion depth for SF/HGF-stimulated CHO-K1 cells transiently transfected with a control vector, MT2-MMP, or MT4-MMP and cultured atop fibrin gels in the absence or presence of TIMP-1, TIMP-2, or BB-94 was determined as described above. 

Phrase: "(E) Invasive foci/field"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   812   C1521738:Field [Conceptual Entity]
   812   C2346620:Field [Conceptual Entity]
   812   C2349184:Field [Conceptual Entity]
   812   C3539073:FIELD [Spatial Concept]

Phrase: "and"

Phrase: "invasion depth"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205125:Depth [Spatial Concept]
   789 E C1422002:DEEPEST [Gene or Genome]

Phrase: "for SF/HGF-stimulated CHO-K1 cells transiently"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   830   C0007595:growth cell [Cell Function]
   813   C0085080:CHO Cells [Cell]
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with a control vector,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0031249:control vector [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243148:control [Qualitative Concept]
   760   C0442335:Vector [Spatial Concept]
   760   C1550141:Control [Substance]
   760   C1705099:Vector [Idea or Concept]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "MT2-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MT4-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of TIMP-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "TIMP-2,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "BB-94"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "was"

Phrase: "determined as described above."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552738:described [Idea or Concept]
Processing 00000000.tx.191: Results are expressed as the mean  1 SD of three experiments.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as the mean  1 SD of three experiments."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   762   C0019728:SD-1 [Immunologic Factor]
   742   C0205449:Three [Quantitative Concept]
   742   C0444504:Mean [Quantitative Concept]
   742   C0681814:Experiments [Research Activity]
   742   C2347634:Mean [Quantitative Concept]
   742   C2348143:Mean [Quantitative Concept]
   708 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.192: The ability of MT1-, 2-, and 3-MMP to promote fibrin invasion contrasts with the inability of each of the secreted MMPs to confer similar activities (see Fig. 1). 

Phrase: "The ability of MT1-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "2-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3-MMP to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "fibrin invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1269955:Invasion [Finding]
   861   C2699153:Invasion [Pathologic Function]

Phrase: "contrasts with the inability of each of the secreted MMPs to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1721004:Matrix Metalloproteinases, Secreted [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   736   C1327616:Secreted [Cell Function]
   736   C1704640:Matrix [Spatial Concept]
   736   C1706515:Matrix [Body Substance]
   736   C1979874:Contrast [Qualitative Concept]

Phrase: "confer"

Phrase: "similar activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.193: Among the MMPs tested, only MMP-11 (stromelysin-3) and MT-MMP prodomains include a proprotein recognition motif that allows these proteinases to undergo efficient processing to their enzymically active forms (19, 32, 48). 

Phrase: "Among the MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "only MMP-11"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0174383:Matrix Metalloproteinase 11 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1366519:MATRIX METALLOPROTEINASE 11 [Gene or Genome]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0205171:Only [Quantitative Concept]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]
   812   C1720467:Only [Intellectual Product]

Phrase: "(stromelysin-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0174383:Stromelysin 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0164371:Stromelysin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "MT-MMP prodomains"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "a proprotein recognition motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "that"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "these proteinases to"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "undergo"

Phrase: "efficient processing to their enzymically active forms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709694:Processing [Activity]

Phrase: "(19,"

Phrase: "32,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.194: To determine whether MT-MMPs confer invasive activity when secreted as fully active, but no longer membrane tethered, enzymes, each of the proteinases were alternatively expressed as epitope-tagged, transmembrane-deleted mutants. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "MT-MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "confer"

Phrase: "invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "when"

Phrase: "secreted as fully active,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205177:Active [Functional Concept]
   770   C1327616:Secreted [Cell Function]

Phrase: "but"

Phrase: "no longer membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "tethered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0577538:Tethered [Functional Concept]

Phrase: ","

Phrase: "enzymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "each of the proteinases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1457900:Each [Quantitative Concept]
   737 E C1622131:proteinase [Molecular Function]
   737 E C1947941:Proteinase [Enzyme]

Phrase: "were"

Phrase: "alternatively"

Phrase: "expressed as epitope-tagged,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0003316:Epitope [Immunologic Factor]
   770   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   770   C1708632:Tagged [Qualitative Concept]
   737 E C0037293:Tag [Neoplastic Process]
   737 E C0181496:Tag [Manufactured Object]
   737 E C1710492:TAG [Gene or Genome]

Phrase: "transmembrane-deleted mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.195: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.196: 5 A (right panel), the soluble MT-MMPs were all expressed as a higher Mr proform and a lower Mr active enzyme whose activity was confirmed by fluorometric assay (see Materials and Methods). 

Phrase: "5 A (right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "the soluble MT-MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "were"

Phrase: "all"

Phrase: "expressed as a higher Mr proform"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C2347167:Mr. [Conceptual Entity]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "a lower Mr active enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "whose activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "confirmed by fluorometric assay"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.197: The identity of the slower migrating bands as the MT-MMP proforms was confirmed by cotransfecting cells with the proprotein convertase inhibitor, 1PDX32, which blocked soluble MT-MMP processing (Fig. 5 A). 

Phrase: "The identity of the slower migrating bands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0424215:Identity [Mental Process]
   748   C2003939:Identity [Finding]

Phrase: "as the MT-MMP proforms"

Phrase: "was"

Phrase: "confirmed by cotransfecting cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0007634:Cells [Cell]
   770   C0750484:Confirmed [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1456348:Confirm [Qualitative Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "with the proprotein convertase inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C1100660:Proprotein Convertase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "1PDX32,"

Phrase: "which"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "soluble MT-MMP processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1709694:Processing [Activity]

Phrase: "(Fig. 5 A"

Phrase: ")."
Processing 00000000.tx.198: However, despite the fact that transfected cells secreted active MT-MMPs efficiently, no fibrin-invasive activity was detected (Fig. 5 D). 

Phrase: "However,"

Phrase: "despite the fact"

Phrase: "that transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "active MT-MMPs efficiently,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]

Phrase: "no fibrin-invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D)."
Processing 00000000.tx.199: Given the apparent requirement that fibrinolytic MMPs must be membrane-anchored to drive invasion, the activity of MT4-MMP, a GPI-anchored metalloproteinase, was assessed. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the apparent requirement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514873:Requirement [Functional Concept]

Phrase: "that fibrinolytic MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "must"

Phrase: "be"

Phrase: "membrane-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "anchored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1293132:anchored [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "invasion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]

Phrase: "the activity of MT4-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1150224:metalloproteinase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "a GPI-anchored metalloproteinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "assessed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]
Processing 00000000.tx.200: However, despite the fact that soluble MT4-MMP can degrade fibrin(ogen) (25), the GPI-anchored proteinase did not promote fibrin-invasive activity under any of the conditions tested (Fig. 5, A, C, and E). 

Phrase: "However,"

Phrase: "despite the fact"

Phrase: "that soluble MT4-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "can"

Phrase: "degrade"

Phrase: "fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "the GPI-anchored proteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1622131:proteinase [Molecular Function]
   827   C1947941:Proteinase [Enzyme]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "fibrin-invasive activity under any of the conditions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C1292728:Condition activity [Functional Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A,"

Phrase: "C,"

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.201: Although MT4-MMP, unlike MT1-, 2-, or 3-MMP cannot process gelatinase A to its active form (25), the pro-invasive phenotypes displayed by MT1-, MT2-, or MT3-MMPtransfected cells was not affected under either gelatinase Adepleted conditions or when cells were cotransfected with gelatinase A (data not shown). 

Phrase: "Although"

Phrase: "MT4-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "unlike MT1-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540571:MT1 [Gene or Genome]

Phrase: "2-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "or"

Phrase: "3-MMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "cannot"

Phrase: "process gelatinase A to its active form"

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "the pro-invasive phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0031437:Phenotypes [Organism Attribute]
   793 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "displayed by MT1-,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0870432:displayed [Functional Concept]
   790   C3540571:MT1 [Gene or Genome]
   756 E C1705417:Display [Manufactured Object]

Phrase: "MT2-,"

Phrase: "or"

Phrase: "MT3-MMPtransfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected under either gelatinase Adepleted conditions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0206528:Gelatinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0392760:Affected [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   719 E C0001721:Affect [Mental Process]
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "or"

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cotransfected with gelatinase A (data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0206528:Gelatinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.202: MT-MMPdependent Invasion. 

Phrase: "MT-MMPdependent Invasion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1269955:Invasion [Finding]
   827   C2699153:Invasion [Pathologic Function]
Processing 00000000.tx.203: In vivo, networks of polymerized fibrin can vary dramatically in terms of fiber size, density, rigidity, and sensitivity to proteolytic degradation (35, 4951). 

Phrase: "In vivo, networks of polymerized fibrin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1882071:networks [Conceptual Entity]
   719 E C1513822:Network [Professional or Occupational Group]
   719 E C1705739:Network [Manufactured Object]

Phrase: "can"

Phrase: "vary"

Phrase: "dramatically in terms of fiber size,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0012173:Fiber [Food]
   753   C0225326:Fiber [Pharmacologic Substance]
   753   C0304068:Fiber [Plant]
   753   C0456389:size [Spatial Concept]
   753   C1260603:Fiber [Plant]
   753   C1304649:Fiber [Tissue]
   719   C1515273:Term [Temporal Concept]
   719   C1705313:Term [Idea or Concept]
   719   C2826302:TERM [Intellectual Product]

Phrase: "density,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "rigidity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0026837:Rigidity, NOS [Sign or Symptom]
  1000   C0700109:rigidity [Natural Phenomenon or Process]
   928 E C0231517:Rigid [Individual Behavior]
   928 E C1882952:RIGID [Phenomenon or Process]

Phrase: "and"

Phrase: "sensitivity to proteolytic degradation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0332324:Sensitive to [Functional Concept]
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "(35,"

Phrase: "4951"

Phrase: ")."
Processing 00000000.tx.204: To determine the ability of MT-MMPtransfected cells to degrade and invade fibrin gel networks exhibiting different physical properties, fibrinogen was polymerized at pH 6.98.0 (Fig. 6) . At acidic pH, the polymerization process is slowed, favoring the formation of thicker, more rigid fibrillar networks while at alkaline pH, polymerization is accelerated generating thinner, more malleable structures (35, 4951). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the ability of MT-MMPtransfected cells to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "degrade"

Phrase: "and"

Phrase: "invade"

Phrase: "fibrin gel networks"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1882071:networks [Conceptual Entity]
   793 E C1513822:Network [Professional or Occupational Group]
   793 E C1705739:Network [Manufactured Object]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "different physical properties,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0597237:physical properties [Natural Phenomenon or Process]
   901   C1998468:Physical properties [Clinical Attribute]
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]

Phrase: "fibrinogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016006:Fibrinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1167394:fibrinogen [Cell Component]
  1000   C2587184:FIBRINOGEN [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "polymerized at pH 6.98.0"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0020283:[pH] [Quantitative Concept]
   753   C0314672:Polymerized [Phenomenon or Process]
   753   C0450407:ph+ [Finding]
   753   C0450408:ph++ [Finding]
   753   C0450409:ph+++ [Finding]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ") ."

Phrase: "At acidic pH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "the polymerization process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "is"

Phrase: "slowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439834:Slow [Qualitative Concept]

Phrase: ","

Phrase: "favoring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:favoring [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the formation of thicker, more rigid fibrillar networks"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "while at alkaline pH,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C0750519:while [Idea or Concept]
   770   C1979842:Alkaline [Qualitative Concept]

Phrase: "polymerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "is"

Phrase: "accelerated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:Accelerated [Functional Concept]

Phrase: "generating"

Phrase: "thinner,"

Phrase: "more malleable structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "(35,"

Phrase: "4951"

Phrase: ")."
Processing 00000000.tx.205: Though thinner fibrils are more resistant to proteolytic attack by the plasminogen activator-plasminogen system (35, 51), stably transfected cells overexpressing MT1-MMP, MT2-MMP, or MT3-MMP rapidly spread on each of the matrices and degraded the underlying gel at comparable rates (Fig. 6, A and B). 

Phrase: "Though"

Phrase: "thinner fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "are"

Phrase: "more resistant to proteolytic attack"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "by the plasminogen activator-plasminogen system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(35,"

Phrase: "51"

Phrase: ")"

Phrase: ","

Phrase: "stably transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "MT1-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "MT2-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MT3-MMP rapidly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "spread on each of the matrices"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0332261:Spread [Qualitative Concept]
   753   C1704639:Matrices [Manufactured Object]
   753   C1947932:Spread [Activity]
   719 E C1704640:Matrix [Spatial Concept]
   719 E C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "the underlying gel at comparable rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C1382104:Gel [Substance]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.206: Likewise, no differences were detected in the ability of the transfectants to penetrate or invade the gels (Fig. 6, C and D). 

Phrase: "Likewise,"

Phrase: "no differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "detected in the ability of the transfectants to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0085732:Ability [Organism Attribute]
   744   C0442726:Detected [Finding]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "penetrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrate [Functional Concept]

Phrase: "or"

Phrase: "invade"

Phrase: "the gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.207: Fibrin fiber size and gel characteristics are also affected by the covalent incorporation of fibronectin into the fibrillar network by transglutaminase (35, 50). 

Phrase: "Fibrin fiber size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "gel characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521970:Characteristics [Qualitative Concept]

Phrase: "are"

Phrase: "also"

Phrase: "affected by the covalent incorporation of fibronectin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243126:incorporation [Functional Concept]
   748   C0392760:Affected [Functional Concept]
   748   C1314939:Affected [Functional Concept]
   748   C1511539:Covalent [Molecular Function]
   714 E C0001721:Affect [Mental Process]

Phrase: "into the fibrillar network"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1513822:Network [Professional or Occupational Group]
   861   C1705739:Network [Manufactured Object]
   861   C1882071:Network [Conceptual Entity]

Phrase: "by transglutaminase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(35,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.208: As MT1, 2, and 3-MMPs are able to degrade fibronectin (33, 5254), we considered the possibility that the degradation of gel-incorporated fibronectin may have contributed to the invasive phenotype. 

Phrase: "As MT1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540571:MT1 [Gene or Genome]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3-MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "degrade"

Phrase: "fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(33,"

Phrase: "5254"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the degradation of gel-incorporated fibronectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "may"

Phrase: "have"

Phrase: "contributed to the invasive phenotype."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031437:Phenotype [Organism Attribute]
   760   C0205281:Invasive [Qualitative Concept]
   760   C1285572:Phenotype [Laboratory Procedure]
   726   C1880177:Contribute [Activity]
Processing 00000000.tx.209: However, stable transfectants cultured atop transglutaminase cross-linked fibrin gels formed from fibronectin-depleted fibrinogen exhibited similar degradative and invasive behavior (data not shown). 

Phrase: "However,"

Phrase: "stable transfectants"

Phrase: "cultured atop transglutaminase cross-linked fibrin gels"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0178576:Cross Linked [Natural Phenomenon or Process]
   778   C0332220:cross linked [Functional Concept]
   748   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C2828360:Cross [Conceptual Entity]
   714   C0010453:Culture [Idea or Concept]
   714   C0220814:culture [Functional Concept]
   714   C0430400:Culture [Laboratory Procedure]
   714 E C1382104:Gel [Substance]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]
   714   C2242979:Culture [Laboratory Procedure]

Phrase: "formed from fibronectin-depleted fibrinogen"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0016006:Fibrinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205431:Formed [Functional Concept]
   760   C0333668:Depleted [Functional Concept]
   760   C1167394:fibrinogen [Cell Component]
   760   C2587184:FIBRINOGEN [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "similar degradative"

Phrase: "and"

Phrase: "invasive behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.210: Finally, while the ability of MT1-, 2-, and 3-MMP transfectants to degrade and/or invade fibrin barriers in comparable fashion suggests that each of these metalloproteinases share overlapping substrate profiles, their interchangeable phenotypic behavior was limited to the fibrin substratum (Fig. 7) . In paired experiments, when MT-MMP transfectants were cultured atop type I collagen gels, only MT1-MMP accelerated invasion while the MT2-MMP and MT3-MMP transfectants displayed a reduced invasive activity relative to the control transfected cells (Fig. 7). 

Phrase: "Finally,"

Phrase: "while"

Phrase: "the ability of MT1-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "2-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3-MMP transfectants to"

Phrase: "degrade"

Phrase: "and/or"

Phrase: "invade"

Phrase: "fibrin barriers in comparable fashion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1706912:BARRIER [Medical Device]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "each of these metalloproteinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1457900:Each [Quantitative Concept]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "overlapping substrate profiles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]

Phrase: "their interchangeable phenotypic behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0004927:Behavior [Individual Behavior]
   827   C2707008:Behavior [Clinical Attribute]
   755 E C2986890:Behavioral [Idea or Concept]

Phrase: "was"

Phrase: "limited to the fibrin substratum"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0439801:Limited [Functional Concept]
   760   C3542948:Limited [Intellectual Product]
   726 E C1549649:Limit [Idea or Concept]
   726 E C2349209:Limit [Conceptual Entity]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ") ."

Phrase: "In paired experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "when"

Phrase: "MT-MMP transfectants"

Phrase: "were"

Phrase: "cultured atop type I collagen gels,"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   833   C0041455:Type 1 Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   820 E C1167375:collagen type I [Cell Component]
   790   C0441729:Type I [Classification]
   753   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0332307:Type [Qualitative Concept]
   753   C1167364:collagen [Cell Component]
   753   C1547052:*Type [Quantitative Concept]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719 E C1382104:Gel [Substance]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "only MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "accelerated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:Accelerated [Functional Concept]

Phrase: "invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]

Phrase: "while"

Phrase: "the MT2-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT3-MMP transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a reduced invasive activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0086439:Reduced Activity [Sign or Symptom]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "relative to the control transfected cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.211: Hence, whereas a different repertoire of MT-MMP activities must be used for traversing the type I collagen-rich interstitium (30), each of the three MT-MMPs arm cells with the ability to negotiate fibrin barriers with equal efficiency. 

Phrase: "Hence,"

Phrase: "whereas"

Phrase: "a different repertoire of MT-MMP activities"

Phrase: "must"

Phrase: "be"

Phrase: "used for traversing"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
   756   C2828360:Traverse [Conceptual Entity]

Phrase: "the type I collagen-rich interstitium"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C2328510:Interstitium [Body Part, Organ, or Organ Component]
   733 E C0596790:interstitial [Body Location or Region]
   733 E C1522203:Interstitial [Functional Concept]
   717   C0041455:Type 1 Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "each of the three MT-MMPs arm cells"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   764   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   745   C1383501:Cell Matrix [Cell Component]
   742   C0007634:Cells [Cell]
   742   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205449:Three [Quantitative Concept]
   742   C0446516:Arm [Body Location or Region]
   742   C1269078:Arm [Body Part, Organ, or Organ Component]
   742   C1269612:Arm [Body Location or Region]
   742   C1457900:Each [Quantitative Concept]
   742   C1704640:Matrix [Spatial Concept]
   742   C1706515:Matrix [Body Substance]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "with the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "negotiate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680727:negotiate [Social Behavior]

Phrase: "fibrin barriers with equal efficiency."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1706912:BARRIER [Medical Device]
Processing 00000000.tx.212: View larger version (54K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(54K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.213: Effect of fibrin diameter on fibrinolytic and invasive activity of MT1-MMP-, MT2-MMP-, or MT3-MMPexpressing stable transfectants. 

Phrase: "Effect of fibrin diameter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on fibrinolytic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "invasive activity of MT1-MMP-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1150224:metalloproteinase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "MT2-MMP-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MT3-MMPexpressing stable transfectants."
Processing 00000000.tx.214: (A) Fibrin gels prepared at pH 6.9, 7.4, or 8.0 form fibrils with mean diameters of 211  60 nm, 149  51 nm, and 81  30 nm (mean  1 SD) as assessed by SEM (top three panels; Bar = 1 m), and supported comparable cell adhesion (bottom three panels; Bar = 10 m). 

Phrase: "(A) Fibrin gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]

Phrase: "prepared at pH 6.9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   726   C1521827:Prepare [Functional Concept]

Phrase: "7.4,"

Phrase: "or"

Phrase: "8.0 form fibrils with mean diameters of 211  60 nm,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0225328:fibrils [Cell Component]
   704 E C1948066:Fibril [Physical Object]

Phrase: "149  51 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "81  30 nm (mean  1 SD)"

Phrase: "as"

Phrase: "assessed by SEM"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0026020:Scanning Electron Microscopy [Laboratory Procedure]
   806   C0026019:Electron Microscopy [Laboratory Procedure]
   806   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   760   C0013852:Electron [Quantitative Concept]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0034606:Scanning [Diagnostic Procedure]
   760   C0441633:Scanning [Diagnostic Procedure]
   760   C1516048:Assessed [Activity]
   760   C3463986:Electron [Bird]
   726 E C2826292:SCAN [Finding]

Phrase: "(top three panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: "; Bar = 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0687760:bar [Manufactured Object]
   861   C1551065:bar [Quantitative Concept]

Phrase: "m)"

Phrase: ","

Phrase: "and"

Phrase: "supported comparable cell adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007577:Cell Adhesion [Cell Function]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "(bottom three panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: "; Bar = 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0687760:bar [Manufactured Object]
   861   C1551065:bar [Quantitative Concept]

Phrase: "m)."
Processing 00000000.tx.215: B, C, and D depict the fibrinolytic activity, number of invasive foci and depth of invasion for control-, MT1-MMP-, MT2-MMP-, and MT3-MMP-stable MDCK transfectants stimulated with SF/HGF and cultured atop fibrin gels prepared at pH 6.9 (dark gray bars), 7.4 (white bars), or 8.9 (light gray bars) for 10 d. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "C,"

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "depict"

Phrase: "the fibrinolytic activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "number of invasive foci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "depth of invasion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205125:Depth [Spatial Concept]
   718 E C1422002:DEEPEST [Gene or Genome]

Phrase: "for control-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "MT1-MMP-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "MT2-MMP-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT3-MMP-stable MDCK transfectants"

Phrase: "stimulated with SF/HGF"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C0062534:Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Scatter Factor
   814   C1442521:HEPATOCYTE GROWTH FACTOR [Gene or Genome]
           SCATTER FACTOR
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1524023:Scatter Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0227525:Hepatocyte [Cell]
   748   C0439742:scatter [Spatial Concept]
   748   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "cultured atop fibrin gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "prepared at pH 6.9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   726   C1521827:Prepare [Functional Concept]

Phrase: "(dark gray bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1707156:BARS [Gene or Genome]
   827   C3274014:BARS [Intellectual Product]
   827   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "7.4"

Phrase: "(white bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "8.9"

Phrase: "(light gray bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1707156:BARS [Gene or Genome]
   827   C3274014:BARS [Intellectual Product]
   827   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "for 10 d."
Processing 00000000.tx.216: Results are expressed as the mean  1 SD of three experiments.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as the mean  1 SD of three experiments."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   762   C0019728:SD-1 [Immunologic Factor]
   742   C0205449:Three [Quantitative Concept]
   742   C0444504:Mean [Quantitative Concept]
   742   C0681814:Experiments [Research Activity]
   742   C2347634:Mean [Quantitative Concept]
   742   C2348143:Mean [Quantitative Concept]
   708 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.217: View larger version (80K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(80K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.218: Differential regulation of type I collagen- and fibrin-invasive activity by MT-MMPs. 

Phrase: "Differential regulation of type I collagen-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "fibrin-invasive activity by MT-MMPs."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C1150224:metalloproteinase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.219: H and Estained cross-sections of the invasion pattern displayed by MDCK cell clones stably transfected with control-, MT1-MMP-, MT2-MMP-, or MT3-MMP-expression vectors and cultured atop type I collagen (left series of panels) or fibrin (right series of panels) in 10% FBS and stimulated with SF/HGF for 10 d. 

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Estained cross-sections of the invasion pattern"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0552389:cross sections [Spatial Concept]
   748   C2828360:Cross [Conceptual Entity]
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "displayed by MDCK cell"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0598829:MDCK Cell [Cell]
   770   C0007634:Cell [Cell]
   770   C0870432:displayed [Functional Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C1705417:Display [Manufactured Object]

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "stably"

Phrase: "transfected with control-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "MT1-MMP-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "MT2-MMP-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MT3-MMP-expression vectors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vectors [Spatial Concept]
   771 E C1705099:Vector [Idea or Concept]
   717   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "cultured atop type I collagen"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   862   C0041455:Type 1 Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   844 E C1167375:collagen type I [Cell Component]
   806   C0441729:Type I [Classification]
   760   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332307:Type [Qualitative Concept]
   760   C1167364:collagen [Cell Component]
   760   C1547052:*Type [Quantitative Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "(left series of panels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205549:Series [Quantitative Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(right series of panels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205549:Series [Quantitative Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: ")"

Phrase: "in 10% FBS"

Phrase: "and"

Phrase: "stimulated with SF/HGF"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C0062534:Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Scatter Factor
   814   C1442521:HEPATOCYTE GROWTH FACTOR [Gene or Genome]
           SCATTER FACTOR
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1524023:Scatter Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0227525:Hepatocyte [Cell]
   748   C0439742:scatter [Spatial Concept]
   748   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "for 10 d."
Processing 00000000.tx.220: While control MDCK invaded type I collagen, no invasive activity occurred atop fibrin gels. 

Phrase: "While"

Phrase: "control MDCK invaded type I collagen,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   861   C0041455:Type 1 Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C1707504:Control Type [Research Activity]
   858   C1879930:Control Type [Intellectual Product]
   827   C0441729:Type I [Classification]
   799   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   799   C0021966:I- [Inorganic Chemical]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0332307:Type [Qualitative Concept]
   799   C1167364:collagen [Cell Component]
   799   C1547052:*Type [Quantitative Concept]
   727 E C0439689:Collagenous [Qualitative Concept]

Phrase: "no invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "occurred atop fibrin gels."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0017243:Gels [Biomedical or Dental Material]
   770   C1709305:Occurred [Activity]
   737 E C1382104:Gel [Substance]
   737 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.221: Clones overexpressing MT1-MMP and cultured atop collagen gels underwent a disrupted tubulogenesis program and expressed heightened invasive activity. 

Phrase: "Clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "cultured atop collagen gels"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   770   C0017243:Gels [Biomedical or Dental Material]
   770   C1167364:collagen [Cell Component]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1382104:Gel [Substance]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "underwent"

Phrase: "a disrupted tubulogenesis program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]

Phrase: "and"

Phrase: "expressed"

Phrase: "heightened invasive activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.222: In the case of MT2-MMP or MT3-MMPoverexpressing clones, collagen invasive activity was inhibited. 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of MT2-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MT3-MMPoverexpressing clones,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "collagen invasive activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1325301:collagen activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "inhibited."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]
Processing 00000000.tx.223: These patterns of invasion contrasted with the comparable fibrin-invasive activity of the MT1-, MT2-, and MT3-MMPoverexpressing clones.   

Phrase: "These patterns of invasion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Patterns [Spatial Concept]

Phrase: "contrasted with the comparable fibrin-invasive activity of the MT1-,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   739   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0205177:Activity [Functional Concept]
   739   C0205281:Invasive [Qualitative Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C0449900:contrasted [Diagnostic Procedure]
   739   C1561536:*Activity [Idea or Concept]
   739   C3540571:MT1 [Gene or Genome]
   706 E C1979874:Contrast [Qualitative Concept]

Phrase: "MT2-,"

Phrase: "and"

Phrase: "MT3-MMPoverexpressing clones."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]
Processing 00000000.tx.224: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  The proteolytic processes used by normal or neoplastic cells to penetrate the fibrin deposits that surround wounds, inflammatory sites, or tumor foci have remained largely undefined (213). 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The proteolytic processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "used by normal"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   882   C1273517:Used by [Finding]
           used
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C2347086:% Normal [Quantitative Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "or"

Phrase: "neoplastic cells to"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0597032:Neoplastic cells [Cell]
   827   C0007634:Cells [Cell]
   827   C1709160:Neoplastic [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0027651:Neoplasia [Neoplastic Process]

Phrase: "penetrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrate [Functional Concept]

Phrase: "the fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposit [Functional Concept]

Phrase: "that"

Phrase: "surround"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surround [Spatial Concept]

Phrase: "wounds,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021501:wounds [Qualitative Concept]
  1000   C0043250:Wounds [Injury or Poisoning]

Phrase: "inflammatory sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "or"

Phrase: "tumor foci"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205234:Foci [Spatial Concept]
   827 E C1285542:focus [Functional Concept]

Phrase: "have"

Phrase: "remained"

Phrase: "largely undefined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750600:undefined [Idea or Concept]

Phrase: "(213"

Phrase: ")."
Processing 00000000.tx.225: Given the efficiency with which plasmin degrades fibrin relative to other proteinases, it has been generally assumed that the plasminogen activator-plasminogen axis would serve as the sole determinant of invasive activity (5, 6, 11, 12). 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the efficiency with which plasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013682:Efficiency [Quantitative Concept]

Phrase: "degrades"

Phrase: "fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "relative to other proteinases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "generally"

Phrase: "assumed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]

Phrase: "that"

Phrase: "the plasminogen activator-plasminogen axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0004457:Axis [Body Part, Organ, or Organ Component]
   812   C0999597:Axis [Mammal]
   812   C1522496:Axis [Spatial Concept]

Phrase: "would"

Phrase: "serve as the sole determinant of invasive activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0205177:Activity [Functional Concept]
   744   C0205281:Invasive [Qualitative Concept]
   744   C0230463:Sole [Body Location or Region]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1521761:Determinant [Functional Concept]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.226: While plasmin can participate in fibrin-invasive events in vitro or in vivo (5, 6, 11, 12, 55), studies in plasminogen-deficient mice have demonstrated that alternate proteolytic systems exist that allow cells to readily infiltrate fibrin-rich tissues in pathophysiologic settings (e.g., references 9, 1618, and 56). 

Phrase: "While"

Phrase: "plasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "can"

Phrase: "participate in fibrin-invasive events"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205281:Invasive [Qualitative Concept]
   760   C0441471:Events [Event]
   760   C3541888:Events [Classification]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "or"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "11,"

Phrase: "12,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "studies in plasminogen-deficient mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0011155:Deficient [Functional Concept]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0557651:Study [Manufactured Object]
   760   C0947630:studies [Laboratory Procedure]
   760   C1367553:PLASMINOGEN [Gene or Genome]
   760   C1636779:% deficient [Quantitative Concept]
   760   C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that alternate proteolytic systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "that"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "cells to readily"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "infiltrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332448:Infiltrate [Pathologic Function]
  1000   C1546677:Infiltrate [Intellectual Product]
  1000   C1549537:Infiltrate [Functional Concept]

Phrase: "fibrin-rich tissues in pathophysiologic settings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0040300:Tissues [Tissue]
   719 E C1547928:Tissue [Intellectual Product]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "references"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "9,"

Phrase: "1618,"

Phrase: "and"

Phrase: "56"

Phrase: ")."
Processing 00000000.tx.227: Coincident with these findings, increased awareness has focused on the fact that the substrate repertoire of MMPs can be extended from structural components of the "mature" extracellular matrix (i.e., collagens, elastins, glycoproteins, and proteoglycans) to fibrin(ogen), the major component of the provisional matrix (3, 22, 23, 25, 26). 

Phrase: "Coincident with these findings,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205420:Coincident [Temporal Concept]

Phrase: "increased awareness"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004448:Awareness [Mental Process]

Phrase: "has"

Phrase: "focused on the fact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205234:Focused [Spatial Concept]
   770   C1285542:focused [Functional Concept]

Phrase: "that"

Phrase: "the substrate repertoire of MMPs"

Phrase: "can"

Phrase: "be"

Phrase: "extended from structural components of the ""mature"" extracellular matrix"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0015350:Extracellular Matrix [Tissue]
   742   C0205286:Mature [Temporal Concept]
   742   C0231448:Extended [Functional Concept]
   742   C0231449:Extended [Spatial Concept]
   742   C0439792:extended [Spatial Concept]
   742   C0449432:Components [Manufactured Object]
   742   C0521119:Extracellular [Cell Component]
   742   C0678594:Structural [Spatial Concept]
   742   C1704640:Matrix [Spatial Concept]
   742   C1706515:Matrix [Body Substance]
   708 E C1705248:Component [Conceptual Entity]

Phrase: "(i.e., collagens,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009325:Collagens [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   793 E C1167364:collagen [Cell Component]
   743 E C0439689:Collagenous [Qualitative Concept]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "elastins,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0013765:Elastins [Amino Acid, Peptide, or Protein]
   966 E C1328798:elastin [Molecular Function]
   966 E C1414382:ELASTIN [Gene or Genome]

Phrase: "glycoproteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017968:Glycoproteins [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: "and"

Phrase: "proteoglycans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033692:Proteoglycans [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "to fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: ","

Phrase: "the major component of the provisional matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "22,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.228: Nonetheless, fibrin(ogen)olytic activity need not correlate with the ability of a given proteinase to confer an invasive phenotype as pericellular degradation must proceed in an orchestrated fashion that allows the cell to tunnel through the substratum while retaining sufficient matrix to act as a structural support for movement (3, 10, 14, 15, 57). 

Phrase: "Nonetheless,"

Phrase: "fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "olytic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "correlate with the ability of a given proteinase to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0377149:proteinase a [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   742   C0085732:Ability [Organism Attribute]
   742   C1622131:proteinase [Molecular Function]
   742   C1947941:Proteinase [Enzyme]

Phrase: "confer"

Phrase: "an invasive phenotype as pericellular degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "must"

Phrase: "proceed in an orchestrated fashion"

Phrase: "that"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the cell to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "tunnel through the substratum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0337138:Tunnel [Manufactured Object]

Phrase: "while"

Phrase: "retaining sufficient matrix to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "act as a structural support"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0183683:Support [Medical Device]
   760   C0678594:Structural [Spatial Concept]
   760   C1521721:Support [Conceptual Entity]

Phrase: "for movement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026649:Movement [Organism Function]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "10,"

Phrase: "14,"

Phrase: "15,"

Phrase: "57"

Phrase: ")."
Processing 00000000.tx.229: Recently, we reported that invasion-incompetent cells can be induced to penetrate fibrin matrices after transfection with MT1-MMP cDNA (3). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that invasion-incompetent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "penetrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrate [Functional Concept]

Phrase: "fibrin matrices after transfection"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1704639:Matrices [Manufactured Object]
   737 E C1704640:Matrix [Spatial Concept]
   737 E C1706515:Matrix [Body Substance]

Phrase: "with MT1-MMP cDNA (3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   888   C0164371:Matrix Metalloproteinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   888   C1366358:MATRIX METALLOPROTEINASE 3 [Gene or Genome]
   884   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]
   804   C3540571:MT1 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.230: However, the role that the proteinase plays in regulating the fibrin-invasive activity of wild-type cells has remained unclear. 

Phrase: "However,"

Phrase: "the role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "that"

Phrase: "the proteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1622131:proteinase [Molecular Function]
  1000   C1947941:Proteinase [Enzyme]

Phrase: "plays in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0032214:Play [Daily or Recreational Activity]
   833   C0600138:Plays [Finding]

Phrase: "regulating"

Phrase: "the fibrin-invasive activity of wild-type cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   789   C0459205:Type of activity [Intellectual Product]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "remained unclear."
Processing 00000000.tx.231: Further, the relative importance of MT1-MMP in promoting fibrin invasion has been questioned as a large series of soluble MMPs have been subsequently reported to degrade fibrin(ogen) with similar, if not greater, efficiency (3, 2227). 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the relative importance of MT1-MMP"

Phrase: "in promoting fibrin invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1269955:Invasion [Finding]
   827   C2699153:Invasion [Pathologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "questioned as a large series of soluble MMPs"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205549:Series [Quantitative Concept]
   742   C0549177:Large [Quantitative Concept]
   742   C1704640:Matrix [Spatial Concept]
   742   C1706515:Matrix [Body Substance]
   742   C1749467:soluble [Cell Component]
   742   C1948047:Soluble [Qualitative Concept]
   742   C2348044:Series [Intellectual Product]
   708   C1522634:Question [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "subsequently"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "degrade"

Phrase: "fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "with similar,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "if"

Phrase: "not greater, efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013682:Efficiency [Quantitative Concept]
   755 E C0442799:Efficient [Qualitative Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "2227"

Phrase: ")."
Processing 00000000.tx.232: To order the fibrin(ogen)olytic MMPs in terms of their pro-invasive potential, invasion-incompetent cells were transiently or stably transfected with fibrin(ogen)olytic metalloproteinases. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "the fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "olytic MMPs in terms of their pro-invasive potential,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1704640:Matrix [Spatial Concept]
   739   C1706515:Matrix [Body Substance]

Phrase: "invasion-incompetent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "or"

Phrase: "stably"

Phrase: "transfected with fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   718 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "olytic metalloproteinases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.233: Significantly, whereas MT1-MMP overexpressing cells readily invaded cross-linked fibrin gels, neither collagenases (MMP-1 or MMP-13), gelatinases (MMP-2 or MMP-9), stromelysins (MMP-3 or MMP-11), nor matrilysin conferred invasive activity. 

Phrase: "Significantly,"

Phrase: "whereas"

Phrase: "MT1-MMP overexpressing cells readily invaded cross-linked fibrin gels,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0017243:Gels [Biomedical or Dental Material]
   755 E C1382104:Gel [Substance]

Phrase: "neither collagenases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162745:Collagenases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(MMP-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0127082:Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:MATRIX METALLOPROTEINASE 1 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MMP-13"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0255672:Matrix Metalloproteinase 13 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417202:MATRIX METALLOPROTEINASE 13 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: ")"

Phrase: ","

Phrase: "gelatinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206528:Gelatinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(MMP-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0172537:Matrix Metalloproteinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334522:MATRIX METALLOPROTEINASE 2 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MMP-9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0165519:Matrix Metalloproteinase 9 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:MATRIX METALLOPROTEINASE 9 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: ")"

Phrase: ","

Phrase: "stromelysins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0164371:Stromelysin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(MMP-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0164371:Matrix Metalloproteinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366358:MATRIX METALLOPROTEINASE 3 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MMP-11"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0174383:Matrix Metalloproteinase 11 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366519:MATRIX METALLOPROTEINASE 11 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: ")"

Phrase: ","

Phrase: "nor"

Phrase: "matrilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0166059:Matrilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2698026:Matrilysin [Laboratory Procedure]

Phrase: "conferred"

Phrase: "invasive activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.234: Given that fibroblasts migrating into fibrin-rich tissues in vivo express MT1-MMP (1618, 36), the ability of fibroblasts isolated from wild-type or MT1-MMPdeleted mice to penetrate fibrin gels was examined. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "migrating into fibrin-rich tissues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0040300:Tissues [Tissue]
   760   C0232902:migrating [Functional Concept]
   760   C0699759:Rich [Qualitative Concept]
   726 E C1547928:Tissue [Intellectual Product]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "express"

Phrase: "MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(1618,"

Phrase: "36"

Phrase: ")"

Phrase: ","

Phrase: "the ability of fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "isolated from wild-type"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0205409:Isolated [Functional Concept]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "or"

Phrase: "MT1-MMPdeleted mice to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "penetrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrate [Functional Concept]

Phrase: "fibrin gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.235: While the mechanisms used by wild-type fibroblasts has remained controversial (e.g., see references 4, 5, and 12), PDGF-stimulated fibroblasts invaded fibrin gels via an MMP-dependent process that proved sensitive to BB-94 or TIMP-2, but not TIMP-1. 

Phrase: "While"

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "used by wild-type fibroblasts"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C1273517:Used by [Finding]
           used
   806   C1883559:Wild Type [Organism Attribute]
   760   C0016030:Fibroblasts [Cell]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "has"

Phrase: "remained controversial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0680243:controversies [Social Behavior]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "references 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514811:Reference [Idea or Concept]
   827   C1706462:Reference [Conceptual Entity]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "12"

Phrase: ")"

Phrase: ","

Phrase: "PDGF-stimulated fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0016030:Fibroblasts [Cell]
   734   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "invaded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517574:Invaded [Qualitative Concept]

Phrase: "fibrin gels via an MMP-dependent process"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0017243:Gels [Biomedical or Dental Material]
   711 E C1382104:Gel [Substance]

Phrase: "that proved sensitive to BB-94"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332324:Sensitive to [Functional Concept]
           Sensitive
   753   C1550474:sensitive [Idea or Concept]

Phrase: "or"

Phrase: "TIMP-2,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "but"

Phrase: "not TIMP-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.236: As BB-94 and TIMP-2 effectively inhibit all MMP family members while TIMP-1dependent inhibition is predominately restricted to secreted MMPs (3, 19, 25, 30), this profile supported a potential role for MT1-MMP in fibrin invasion. 

Phrase: "As BB-94"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "and"

Phrase: "TIMP-2 effectively"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   938   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   929 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   929 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   882   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   882   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1152589:metalloproteinase inhibitor [Molecular Function]
   753   C0040300:Tissue [Tissue]
   753   C1547928:Tissue [Intellectual Product]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "all MMP family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086282:Family Members [Family Group]
   827 E C1611821:Family Member [Intellectual Product]
   812   C0015576:Family [Family Group]
   812   C0680022:members [Population Group]
   812   C1704727:Family [Conceptual Entity]
   779 E C2698041:Member [Professional or Occupational Group]
   741 E C0241888:Familial [Functional Concept]

Phrase: "while"

Phrase: "TIMP-1dependent inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "is"

Phrase: "predominately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332251:Predominately [Qualitative Concept]

Phrase: "restricted to secreted MMPs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1721004:Matrix Metalloproteinases, Secreted [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0443288:Restricted [Functional Concept]
   760   C1327616:Secreted [Cell Function]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "19,"

Phrase: "25,"

Phrase: "30"

Phrase: ")"

Phrase: ","

Phrase: "this profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1979963:Profile [Laboratory Procedure]
  1000   C2003903:Profile [Functional Concept]

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "a potential role for MT1-MMP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in fibrin invasion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1269955:Invasion [Finding]
   861   C2699153:Invasion [Pathologic Function]
Processing 00000000.tx.237: Interestingly, secreted as well as membrane-anchored MMPs have recently been implicated in migratory responses of cells cultured atop various two-dimensional substrata including type I collagen and laminin-5 (3741). 

Phrase: "Interestingly,"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "as well as"

Phrase: "membrane-anchored MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "implicated in migratory responses of cells"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0232901:Migratory [Functional Concept]
   753   C0871261:responses [Organism Attribute]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704632:Response [Finding]
   719 E C1704653:Cell [Medical Device]
   719 E C1706817:Response [Intellectual Product]
   719 E C1948049:Cell [Spatial Concept]
   719 E C2911692:Response [Mental Process]

Phrase: "cultured atop various two-dimensional substrata"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1705052:2-Dimensional [Spatial Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "type I collagen"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0041455:Type 1 Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "and"

Phrase: "laminin-5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0171955:laminin-5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(3741"

Phrase: ")."
Processing 00000000.tx.238: The promigratory response has been alternatively linked with degradation of the underlying substratum, integrin processing, or proteolysis of surface-associated transglutaminase (3741, 58). 

Phrase: "The promigratory response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "alternatively"

Phrase: "linked with degradation of the underlying substratum,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "integrin processing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "or"

Phrase: "proteolysis of surface-associated transglutaminase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597304:Proteolysis [Molecular Function]

Phrase: "(3741,"

Phrase: "58"

Phrase: ")."
Processing 00000000.tx.239: However, in our system, the inhibitory effects of BB-94 and TIMP-2 were confined solely to effects on invasive behavior. 

Phrase: "However,"

Phrase: "in our system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "the inhibitory effects of BB-94"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "TIMP-2"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "confined"

Phrase: "solely to effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on invasive behavior."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]
Processing 00000000.tx.240: Caution should, however, be exercised in necessarily ascribing all effects of these inhibitors to their ability to target MMPs. 

Phrase: "Caution"

Phrase: "should"

Phrase: ","

Phrase: "however,"

Phrase: "be"

Phrase: "exercised in necessarily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0015259:Exercise [Daily or Recreational Activity]
   756   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "ascribing"

Phrase: "all effects of these inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "to their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "MMPs."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]
Processing 00000000.tx.241: For example, BB-94 and other peptidomimetic inhibitors can affect cell responses by inhibiting metalloproteinases in the adamalysin family responsible for the proteolytic shedding of membrane-anchored ligands that can trigger growth factor receptors (5961). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "BB-94"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "and"

Phrase: "other peptidomimetic inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "can"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "cell responses by inhibiting metalloproteinases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "in the adamalysin family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "responsible for the proteolytic shedding of membrane-anchored ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1273518:Responsible [Finding]

Phrase: "that"

Phrase: "can"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "growth factor receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206454:Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   734   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(5961"

Phrase: ")."
Processing 00000000.tx.242: In contrast, TIMP-2 has been reported to suppress mitogenesis independently of its antiproteolytic activity (62). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "TIMP-2"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "mitogenesis independently of its antiproteolytic activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1156237:Mitogenesis [Cell Function]

Phrase: "(62"

Phrase: ")."
Processing 00000000.tx.243: Nonetheless, despite these potential caveats, neither fibroblast adhesion, proliferation, nor migration were affected by BB-94 or TIMP-2 under our experimental conditions. 

Phrase: "Nonetheless,"

Phrase: "despite these potential caveats,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0871599:Caveat [Governmental or Regulatory Activity]

Phrase: "neither fibroblast adhesion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "proliferation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "nor"

Phrase: "migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "were"

Phrase: "affected by BB-94"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   770   C0004739:BB [Geographic Area]
   770   C0332297:BB [Spatial Concept]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]

Phrase: "or"

Phrase: "TIMP-2"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "under our experimental conditions."
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.244: Though we had previously reported that MMP inhibitors did not completely block fibroblast/myofibroblast migration from fibrin-embedded tissue explants (3), subsequent studies have demonstrated that cell egress in the presence of BB-94 or TIMP-2 is significantly impaired and confined to a narrow zone surrounding the tissue (unpublished observation). 

Phrase: "Though"

Phrase: "we"

Phrase: "had"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that MMP inhibitors"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1513016:Matrix Metalloproteinase Inhibitors [Pharmacologic Substance]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1152589:metalloproteinase inhibitor [Molecular Function]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "did"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "fibroblast/myofibroblast migration from fibrin-embedded tissue explants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C2612061:fibroblast migration [Cell Function]
   767   C2755541:tissue migration [Organ or Tissue Function]
   744   C0600210:Migration [Social Behavior]
   744   C1533574:Migration [Physiologic Function]
   744   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "subsequent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that cell egress in the presence of BB-94"

Phrase: "or"

Phrase: "TIMP-2"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "is"

Phrase: "significantly"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "and"

Phrase: "confined to a narrow zone"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205168:Narrow [Qualitative Concept]
   760   C0332463:Narrow [Spatial Concept]
   760   C0333164:Narrow [Quantitative Concept]
   760   C1710706:Zone [Spatial Concept]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "(unpublished observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")."
Processing 00000000.tx.245: Given that fibroblasts use an MMP-dependent process to invade fibrin gels and express MT1-MMP in vivo (18, 36), we predicted that MT1-MMPnull fibroblasts would fail to penetrate fibrin matrices. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "an MMP-dependent process to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1184743:Process [Body Part, Organ, or Organ Component]
   804   C1522240:Process [Phenomenon or Process]

Phrase: "invade"

Phrase: "fibrin gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "express"

Phrase: "MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(18,"

Phrase: "36"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "that MT1-MMPnull fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]

Phrase: "would"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "penetrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrate [Functional Concept]

Phrase: "fibrin matrices."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1704639:Matrices [Manufactured Object]
   827 E C1704640:Matrix [Spatial Concept]
   827 E C1706515:Matrix [Body Substance]
Processing 00000000.tx.246: Indeed, during the first 2 d of the culture period, the MT1-MMPdeleted cells expressed limited invasive behavior despite normal adhesive and migratory responses atop fibrin gels. 

Phrase: "Indeed,"

Phrase: "during the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "2 d of the culture period,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1705052:2-D [Spatial Concept]
   753   C0740116:+2 [Quantitative Concept]
   753   C2827735:2+ [Quantitative Concept]
   753   C2981700:2+ [Classification]

Phrase: "the MT1-MMPdeleted cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressed"

Phrase: "limited invasive behavior despite normal adhesive"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0233512:Normal behavior [Social Behavior]
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]

Phrase: "and"

Phrase: "migratory responses atop fibrin gels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]
Processing 00000000.tx.247: Surprisingly, however, the activity of null cells rebounded and reached levels comparable to those observed in the wild-type cells. 

Phrase: "Surprisingly,"

Phrase: "however,"

Phrase: "the activity of null cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "rebounded"

Phrase: "and"

Phrase: "reached levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "comparable to those"

Phrase: "observed in the wild-type cells."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C1883559:Wild Type [Organism Attribute]
   783   C0449475:cells type [Intellectual Product]
   767 E C0007634:Cell Type [Cell]
           Cells
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1441672:Observed [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.248: While the compensatory activity of the knockout cells to express an invasive phenotype might have reflected the use of an alternate class of proteinases, the residual activity remained sensitive to BB-94 and TIMP-2, and hence, was consistent with the participation of an alternate MT-MMP. 

Phrase: "While"

Phrase: "the compensatory activity of the knockout cells to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "express"

Phrase: "an invasive phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "might"

Phrase: "have"

Phrase: "reflected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflected [Mental Process]

Phrase: "the use of an alternate class of proteinases,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1524063:Use of [Functional Concept]
   744   C0042153:use [Functional Concept]
   744   C0457083:Use [Functional Concept]
   744   C1947944:Use [Intellectual Product]

Phrase: "the residual activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "remained"

Phrase: "sensitive to BB-94"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332324:Sensitive to [Functional Concept]
           Sensitive
   770   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "TIMP-2,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "hence,"

Phrase: "was"

Phrase: "consistent with the participation of an alternate MT-MMP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.249: As predicted, MT1-MMP+/+ as well as MT1-MMP-null fibroblasts expressed MT3-MMP in a fashion similar to that reported for wild-type smooth muscle cells stimulated with PDGF (47). 

Phrase: "As"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: ","

Phrase: "MT1-MMP+/+"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "as well as"

Phrase: "MT1-MMP-null fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0016030:Fibroblasts [Cell]
   717   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "expressed"

Phrase: "MT3-MMP in a fashion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "reported for wild-type smooth muscle cells"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   814   C1135918:Smooth Muscle Cells [Cell]
   778   C0596981:Muscle Cells [Cell]
   778   C1267092:Muscle, Smooth [Tissue]
   778   C1883559:Wild Type [Organism Attribute]
   774   C0449475:cells type [Intellectual Product]
   757 E C0007634:Cell Type [Cell]
           Cells
   757   C0585733:Report type [Intellectual Product]
   748   C0026845:Muscle [Tissue]
   748   C0205357:Smooth [Qualitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C0684224:Reported [Intellectual Product]
   748   C0700287:Reported [Health Care Activity]
   748   C1547052:*Type [Quantitative Concept]
   748   C3282337:Cells [Cell]
   748   C3496591:Reported [Clinical Attribute]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   714 E C3273238:Report [Intellectual Product]

Phrase: "stimulated with PDGF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   753   C0005821:Platelet [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.250: Though neither MT3-MMP specific inhibitors nor gene-deleted animals have been described, we confirmed the ability of MT3-MMP to directly confer fibrin-invasive activity. 

Phrase: "Though"

Phrase: "neither MT3-MMP specific inhibitors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   888   C1513016:Matrix Metalloproteinase Inhibitors [Pharmacologic Substance]
   836   C1152589:metalloproteinase inhibitor [Molecular Function]
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   771 E C1999216:Inhibitor [Qualitative Concept]
   717   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "nor"

Phrase: "gene-deleted animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ","

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the ability of MT3-MMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "to directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "confer"

Phrase: "fibrin-invasive activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.251: We are currently unable to compare MT1-MMP and MT3-MMP expression at the protein level in wild-type or null fibroblasts, as mouse-specific antibodies are unavailable. 

Phrase: "We"

Phrase: "are"

Phrase: "currently unable to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0521116:Currently [Temporal Concept]
   827   C1299582:Unable [Finding]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT3-MMP expression at the protein level"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1171362:expression protein [Genetic Function]
   767   C3244092:expression level [Idea or Concept]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "null fibroblasts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "as"

Phrase: "mouse-specific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "are"

Phrase: "unavailable."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686905:Unavailable [Functional Concept]
Processing 00000000.tx.252: However, using epitope-tagged constructs, both MT-MMPs displayed comparable activity when expressed at similar levels in transiently transfected cells. 

Phrase: "However,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "epitope-tagged constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "both MT-MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "comparable activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "when"

Phrase: "expressed at similar levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0441889:Levels [Qualitative Concept]
   770   C2348205:Similar [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in transiently transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.253: Taken together, these data support our contention that either MT1-MMP or MT3-MMP can drive the fibrin-invasive phenotype in PDGF-stimulated fibroblasts. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our contention"

Phrase: "that either MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MT3-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "can"

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "the fibrin-invasive phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "in PDGF-stimulated fibroblasts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0016030:Fibroblasts [Cell]
   734   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.254: Consistent with this interpretation, MT1-MMP null cells were unable to traverse a type I collagen matrix as MT3-MMP expresses minimal activity toward this substrate (30; unpublished observation). 

Phrase: "Consistent with this interpretation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "MT1-MMP null cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C0024265:Null Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C0456148:Null [Quantitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "traverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Traverse [Conceptual Entity]

Phrase: "a type I collagen matrix as MT3-MMP"

Phrase: "expresses"

Phrase: "minimal activity toward this substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(30"

Phrase: "; unpublished observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")."
Processing 00000000.tx.255: While other TIMP-2sensitive MMPs might further modify fibrin-invasive activity in fibroblasts, neither MT5-MMP, MT6-MMP, nor MMP-19 (a secreted MMP recently shown to be preferentially sensitive to inhibition by TIMP-2 [63]) were able to promote fibrin-invasive activity under our assay conditions (unpublished observation). 

Phrase: "While"

Phrase: "other TIMP-2sensitive MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "might"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "fibrin-invasive activity in fibroblasts,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "neither MT5-MMP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "MT6-MMP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "nor"

Phrase: "MMP-19"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0666239:matrix metalloproteinase 19 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417207:MATRIX METALLOPROTEINASE 19 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "("

Phrase: "a secreted MMP recently"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "preferentially sensitive to inhibition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332324:Sensitive to [Functional Concept]
           Sensitive
   770   C1550474:sensitive [Idea or Concept]

Phrase: "by TIMP-2"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   947   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   939 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   939 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   901   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0006539:BY [Geographic Area]
   799   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0040300:Tissue [Tissue]
   799   C1547928:Tissue [Intellectual Product]
   799   C1999216:Inhibitor [Qualitative Concept]

Phrase: "[63"

Phrase: "]"

Phrase: ")"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "fibrin-invasive activity under our assay conditions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C1292728:Condition activity [Functional Concept]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "(unpublished observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")."
Processing 00000000.tx.256: Fibroblasts can alternatively use MT1-MMP or MT3-MMP to invade fibrin-rich deposits, but other cell populations (e.g., synoviocytes, leukocytes, trophoblasts, and tumor cells) express distinct repertoires of membrane-anchored metalloproteinases which include MT2-MMP and MT4-MMP (19, 25, 4247). 

Phrase: "Fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "can"

Phrase: "alternatively"

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MT3-MMP to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "invade"

Phrase: "fibrin-rich deposits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "but"

Phrase: "other cell populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "synoviocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0224522:Synoviocytes [Cell]

Phrase: "leukocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023516:Leukocytes [Cell]

Phrase: "trophoblasts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041178:Trophoblasts [Embryonic Structure]

Phrase: "and"

Phrase: "tumor cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0431085:Tumor cells [Cell]
   966 E C0597032:Tumor Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "express"

Phrase: "distinct repertoires of membrane-anchored metalloproteinases"

Phrase: "which"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "MT2-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT4-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(19,"

Phrase: "25,"

Phrase: "4247"

Phrase: ")."
Processing 00000000.tx.257: Whereas the isolated catalytic domain of MT2-MMP has been reported to be devoid of fibrinolytic activity (23), a similar construct of MT4-MMP was recently shown to degrade fibrinogen as well as fibrin (25). 

Phrase: "Whereas"

Phrase: "the isolated catalytic domain of MT2-MMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0600499:Catalytic Domain [Amino Acid Sequence]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "devoid of fibrinolytic activity"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a similar construct of MT4-MMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "degrade"

Phrase: "fibrinogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016006:Fibrinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1167394:fibrinogen [Cell Component]
  1000   C2587184:FIBRINOGEN [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "as well as"

Phrase: "fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.258: In contrast to these reports, full-length MT2-MMP, but not MT4-MMP, efficiently conferred fibrin-invasive potential. 

Phrase: "In contrast to these reports,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "full-length MT2-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]

Phrase: "but"

Phrase: "not MT4-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "efficiently conferred fibrin-invasive potential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.259: These findings highlight the importance of using the intact enzymes rather than isolated domains for functional characterization and are consistent with reports documenting marked differences in activity between catalytic domains, transmembrane-deleted constructs and the intact MMPs (33, 53, 64). 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "highlight"

Phrase: "the importance of"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the intact enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "rather than"

Phrase: "isolated domains for functional characterization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "are"

Phrase: "consistent with reports"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "documenting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1301725:documenting [Health Care Activity]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "marked differences in activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "between catalytic domains,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0600499:Domains, Catalytic [Amino Acid Sequence]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "transmembrane-deleted constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "the intact MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(33,"

Phrase: "53,"

Phrase: "64"

Phrase: ")."
Processing 00000000.tx.260: Likewise, our studies with MT4-MMP-transfected cells indicate that the fibrin(ogen)olytic activity of an isolated enzyme may not predict its ability to mediate invasive activity. 

Phrase: "Likewise,"

Phrase: "our studies with MT4-MMP-transfected cells"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that"

Phrase: "the fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "olytic activity of an isolated enzyme"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0243102:enzyme activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "predict"

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "invasive activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.261: Unlike MT1, 2, or 3-MMP, MT4-MMP is GPI-anchored, its catalytic domain does not include a characteristic insert (i.e., the so-called IS-2 domain), and the proteinase cannot activate progelatinase A (25, 65). 

Phrase: "Unlike MT1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540571:MT1 [Gene or Genome]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "or"

Phrase: "3-MMP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "MT4-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1569872:MT4-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "is"

Phrase: "GPI-anchored,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1293132:anchored [Therapeutic or Preventive Procedure]
   861   C1415351:GP1 [Gene or Genome]

Phrase: "its catalytic domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0600499:Catalytic Domain [Amino Acid Sequence]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "a characteristic insert"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441587:Insert [Health Care Activity]
   861   C1743766:Insert [Medical Device]
   861   C1883719:Insert [Functional Concept]

Phrase: "(i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the so-called IS-2 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the proteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1622131:proteinase [Molecular Function]
  1000   C1947941:Proteinase [Enzyme]

Phrase: "cannot"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "progelatinase A (25,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0138526:progelatinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.262: However, these properties do not likely underlie its inability to confer invasive activity as MT1-MMP retains fibrin-invasive activity when GPI-anchored or its IS-2 domain is deleted (unpublished observation). 

Phrase: "However,"

Phrase: "these properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0871161:properties [Qualitative Concept]
  1000   C1292721:properties [Functional Concept]
   966 E C1882134:Property [Conceptual Entity]
   966 E C2347695:Property [Entity]

Phrase: "do"

Phrase: "not likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "underlie"

Phrase: "its inability to"

Phrase: "confer"

Phrase: "invasive activity as MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1150224:metalloproteinase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "fibrin-invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "when"

Phrase: "GPI-anchored"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1293132:anchored [Therapeutic or Preventive Procedure]
   861   C1415351:GP1 [Gene or Genome]

Phrase: "or"

Phrase: "its IS-2 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "(unpublished observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")."
Processing 00000000.tx.263: Further, gelatinase A does not express significant fibrinolytic activity nor does its exclusion affect fibrin-invasive activity (3, 23). 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "gelatinase A"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "significant fibrinolytic activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "nor"

Phrase: "does"

Phrase: "its exclusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680251:EXCLUSION [Functional Concept]
  1000   C2828389:Exclusion [Activity]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "fibrin-invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.264: Instead, the inability of MT4-MMP to drive invasive activity may reside in the fact that the proteinase cannot, in contrast to MT1-MMP, efficiently degrade the high molecular weight -polymers of fibrin (3, 25). 

Phrase: "Instead,"

Phrase: "the inability of MT4-MMP to"

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "reside in the fact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2982691:Reside [Activity]

Phrase: "that"

Phrase: "the proteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1622131:proteinase [Molecular Function]
  1000   C1947941:Proteinase [Enzyme]

Phrase: "cannot"

Phrase: ","

Phrase: "in contrast to MT1-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "efficiently"

Phrase: "degrade"

Phrase: "the high molecular weight -polymers of fibrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.265: We speculate that the specific cleavage sites chosen in the fibrin scaffolding may be important in allowing the cell to penetrate the matrix while maintaining the structural stability of the supporting network. 

Phrase: "We"

Phrase: "speculate"

Phrase: "that"

Phrase: "the specific cleavage sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   896   C0449604:Specific site [Spatial Concept]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "chosen in the fibrin scaffolding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0337143:scaffolding [Manufactured Object]
   760   C1707391:Chosen [Activity]

Phrase: "may"

Phrase: "be"

Phrase: "important in allowing"

Phrase: "the cell to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "penetrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrate [Functional Concept]

Phrase: "the matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]

Phrase: "while"

Phrase: "maintaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0024501:Maintain [Activity]

Phrase: "the structural stability of the supporting network."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205360:Stability [Qualitative Concept]
   748   C2347098:Stability [Qualitative Concept]
Processing 00000000.tx.266: As MT1-MMP, MT2-MMP, or MT3-MMP are widely distributed among normal and neoplastic cells (e.g., references 19, 25, and 4247), these metalloproteinases likely constitute the plasminogen-independent arm of the fibrin-invasive phenotype observed in vivo. 

Phrase: "As MT1-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "MT2-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MT3-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "are"

Phrase: "widely"

Phrase: "distributed among normal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C1704711:Distributed [Functional Concept]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "neoplastic cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0597032:Neoplastic cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1709160:Neoplastic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C0027651:Neoplasia [Neoplastic Process]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "references"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "19,"

Phrase: "25,"

Phrase: "and"

Phrase: "4247"

Phrase: ")"

Phrase: ","

Phrase: "these metalloproteinases likely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "constitute"

Phrase: "the plasminogen-independent arm of the fibrin-invasive phenotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0446516:Arm [Body Location or Region]
   742   C1269078:Arm [Body Part, Organ, or Organ Component]
   742   C1269612:Arm [Body Location or Region]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.267: However, unlike the plasminogen activator-plasminogen axis wherein fibrinolytic activity is affected by fibrin structure or composition (4951), MT-MMPdependent proteolysis and invasion proceeded in an autonomous fashion. 

Phrase: "However,"

Phrase: "unlike the plasminogen activator-plasminogen axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0004457:Axis [Body Part, Organ, or Organ Component]
   812   C0999597:Axis [Mammal]
   812   C1522496:Axis [Spatial Concept]

Phrase: "wherein"

Phrase: "fibrinolytic activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "affected by fibrin structure"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0392760:Affected [Functional Concept]
   770   C0678594:Structure [Spatial Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]

Phrase: "or"

Phrase: "composition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0486616:Composition [Clinical Attribute]
  1000   C1555710:composition [Idea or Concept]

Phrase: "(4951"

Phrase: ")"

Phrase: ","

Phrase: "MT-MMPdependent proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0597304:Proteolysis [Molecular Function]
   755 E C1947941:proteolytic [Enzyme]

Phrase: "and"

Phrase: "invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]

Phrase: "proceeded in an autonomous fashion."
Processing 00000000.tx.268: The lack of a plasminogen-dependent component in this invasion program is also consistent with the proMT-MMP activation process. 

Phrase: "The lack of a plasminogen-dependent component"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332268:lack [Qualitative Concept]

Phrase: "in this invasion program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "is"

Phrase: "also consistent with the proMT-MMP activation process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.269: While plasminogen mediates the activation of a number of secreted MMPs (19), each of the MT-MMPs contains a basic motif (i.e., RXK/RR) at the COOH terminus of their respective prodomains that serves as a recognition sequence for one or more members of the proprotein convertase family of serine proteinases (19, 32, 48). 

Phrase: "While"

Phrase: "plasminogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the activation of a number of secreted MMPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1879547:Activation [Activity]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "each of the MT-MMPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1457900:Each [Quantitative Concept]
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a basic motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "(i.e., RXK/RR) at the COOH terminus"

Phrase: "of their respective prodomains"

Phrase: "that"

Phrase: "serves as a recognition sequence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0524637:Recognition [Mental Process]
   760   C1519249:Sequence [Functional Concept]

Phrase: "for one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more members of the proprotein convertase family of serine proteinases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   757   C0086282:Family Members [Family Group]
   741 E C1611821:Family Member [Intellectual Product]
   739   C0680022:members [Population Group]
   706 E C2698041:Member [Professional or Occupational Group]

Phrase: "(19,"

Phrase: "32,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.270: The convertases activate the MT-MMP zymogens either intracellularly in the trans-Golgi network or at the cell surface, thus allowing the cell to directly control its proteolytic potential in a trans-dependent fashion (19, 32, 48). 

Phrase: "The convertases"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the MT-MMP zymogens either intracellularly in the trans-Golgi network"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0887838:trans-Golgi Network [Cell Component]
   753   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1179875:Golgi network [Cell Component]
   736   C0014436:Zymogens [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0018042:Golgi [Cell Component]
   736   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C1513822:Network [Professional or Occupational Group]
   736   C1704640:Matrix [Spatial Concept]
   736   C1705739:Network [Manufactured Object]
   736   C1706515:Matrix [Body Substance]
   736   C1882071:Network [Conceptual Entity]
   736   C2826298:TRANS [Idea or Concept]

Phrase: "or at the cell surface,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "thus"

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "the cell to directly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0007634:THE CELL [Cell]
           Cell
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "its proteolytic potential in a trans-dependent fashion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3245505:Potential [Qualitative Concept]

Phrase: "(19,"

Phrase: "32,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.271: Interestingly, though the transmembrane-deleted MT-MMP mutants are also processed efficiently by the proprotein convertases, only the membrane-anchored forms of the proteinases expressed functional activity in our invasion assay system. 

Phrase: "Interestingly,"

Phrase: "though"

Phrase: "the transmembrane-deleted MT-MMP mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "also"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "efficiently by the proprotein convertases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1100660:Proprotein Convertases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0379214:pro protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709708:Proprotein [Amino Acid, Peptide, or Protein]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the membrane-anchored forms of the proteinases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "expressed"

Phrase: "functional activity in our invasion assay system."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.272: Given that soluble MT1-MMP expresses fibrinolytic activity (3, 23, 26), these results lend credence to the notion that proteinases must be tethered to the cell surface to efficiently match degradative activity with motility (14, 15, 30). 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that soluble MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "expresses"

Phrase: "fibrinolytic activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "26"

Phrase: ")"

Phrase: ","

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "lend"

Phrase: "credence to the notion"

Phrase: "that proteinases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   966 E C1622131:proteinase [Molecular Function]
   966 E C1947941:Proteinase [Enzyme]

Phrase: "must"

Phrase: "be"

Phrase: "tethered to the cell surface"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C0577538:Tethered [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "to efficiently"

Phrase: "match"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:match [Research Activity]
  1000   C1708943:Match [Qualitative Concept]

Phrase: "degradative activity with motility"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "(14,"

Phrase: "15,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.273: MT-MMPs may further require localization to specific regions of the membrane actively involved in the invasive process (66, 67), but cytosolic domain-deleted forms of MT1-MMP remain functional (3, 30). 

Phrase: "MT-MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "may"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "require"

Phrase: "localization to specific regions of the membrane actively"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1658979:localization to membrane [Cell Function]
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "involved in the invasive process"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205281:Invasive [Qualitative Concept]
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1314939:Involved [Functional Concept]
   760   C1522240:Process [Phenomenon or Process]

Phrase: "(66,"

Phrase: "67"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "cytosolic domain-deleted forms of MT1-MMP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   711 E C1522492:Form [Functional Concept]

Phrase: "remain"

Phrase: "functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.274: Either surface localization signals are no longer required when the proteinase is overexpressed or targeting information is encoded within the extracellular domain itself. 

Phrase: "Either surface localization signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710082:Signal [Phenomenon or Process]

Phrase: "are"

Phrase: "no longer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "when"

Phrase: "the proteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1622131:proteinase [Molecular Function]
  1000   C1947941:Proteinase [Enzyme]

Phrase: "is"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "or"

Phrase: "targeting information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "is"

Phrase: "encoded within the extracellular domain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1517050:Extracellular Domain [Spatial Concept]
   760   C0521119:Extracellular [Cell Component]
   760   C0679058:encoded [Mental Process]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C2700640:Encoded [Activity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "itself."
Processing 00000000.tx.275: Our findings have focused on the fibrin-invasive activity of MT-MMPs, but increasing evidence suggests that multiple metalloproteinases may participate in the bulk resorption of fibrin deposits and affect coagulation by targeting fibrinogen as well as Factor XII (2227). 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "focused on the fibrin-invasive activity of MT-MMPs,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   741   C1150224:metalloproteinase activity [Molecular Function]
   739   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205177:Activity [Functional Concept]
   739   C0205234:Focused [Spatial Concept]
   739   C0205281:Invasive [Qualitative Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1285542:focused [Functional Concept]
   739   C1561536:*Activity [Idea or Concept]
   739   C1704640:Matrix [Spatial Concept]
   739   C1706515:Matrix [Body Substance]

Phrase: "but"

Phrase: "increasing evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that multiple metalloproteinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "participate in the bulk resorption of fibrin deposits"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0012173:Bulk [Food]
   744   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0333562:Deposits [Functional Concept]
   744   C1337615:Bulk [Biomedical or Dental Material]
   744   C2985494:Resorption [Organism Function]

Phrase: "and"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "coagulation by targeting fibrinogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005778:Coagulation [Organ or Tissue Function]
   770   C0441509:Coagulation [Therapeutic or Preventive Procedure]
   770   C1328723:coagulation [Physiologic Function]

Phrase: "as well as"

Phrase: "Factor XII"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015525:Factor XII [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "(2227"

Phrase: ")."
Processing 00000000.tx.276: Significantly, fibrin deposits were increased at wound sites in normal or plasminogen-deleted mice that were treated with a broad-spectrum MMP inhibitor (18). 

Phrase: "Significantly,"

Phrase: "fibrin deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "were"

Phrase: "increased at wound sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0043250:Wound [Injury or Poisoning]
   770   C0205145:Sites [Spatial Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "in normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "or"

Phrase: "plasminogen-deleted mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "were"

Phrase: "treated with a broad-spectrum MMP inhibitor"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   800   C1513016:Matrix Metalloproteinase Inhibitor [Pharmacologic Substance]
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1152589:metalloproteinase inhibitor [Molecular Function]
   744   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0332464:Broad [Spatial Concept]
   744   C1522326:Treated [Functional Concept]
   744   C1704640:Matrix [Spatial Concept]
   744   C1706515:Matrix [Body Substance]
   744   C1883073:Spectrum [Quantitative Concept]
   744   C1999216:Inhibitor [Qualitative Concept]
   744   C2827424:Spectrum [Conceptual Entity]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.277: Coincident with these effects, the delayed wound healing response of plasminogen-null mice was further affected by the metalloproteinase inhibitor, but this latter result should be interpreted cautiously as effects on adamalysin-dependent shedding of surface-associated growth factors (e.g., HB-EGF) must be considered (68). 

Phrase: "Coincident with these effects,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205420:Coincident [Temporal Concept]

Phrase: "the delayed wound healing response of plasminogen-null mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   745   C3258117:Response delay [Finding]
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "affected by the metalloproteinase inhibitor,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1999216:Inhibitor [Qualitative Concept]
   726 E C0001721:Affect [Mental Process]

Phrase: "but"

Phrase: "this latter result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "should"

Phrase: "be"

Phrase: "interpreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285553:interpreted [Functional Concept]

Phrase: "cautiously as effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on adamalysin-dependent shedding"

Phrase: "of surface-associated growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "HB-EGF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019046:Hb [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "must"

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.278: This caveat aside, fibrin-degradation products consistent with MMP-dependent proteolysis have been detected in rheumatoid synovial fluid and MMP-9 has recently been implicated in fibrinolytic events in an in vivo nephritis model (22, 23, 27). 

Phrase: "This caveat aside,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871599:Caveat [Governmental or Regulatory Activity]

Phrase: "fibrin-degradation products"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0163275:Fibrin Degradation Products [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]
   755 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "consistent with MMP-dependent proteolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "have"

Phrase: "been"

Phrase: "detected in rheumatoid synovial fluid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0039097:Synovial Fluid [Body Substance]
   760   C0005889:FLUID [Body Substance]
   760   C0302908:fluid [Substance]
   760   C0442726:Detected [Finding]
   760   C0444611:Fluid [Qualitative Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1550315:Synovial [Body Part, Organ, or Organ Component]
   760   C1704353:Fluid [Substance]

Phrase: "and"

Phrase: "MMP-9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0165519:Matrix Metalloproteinase 9 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:MATRIX METALLOPROTEINASE 9 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "implicated in fibrinolytic events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
   770   C0441471:Events [Event]
   770   C3541888:Events [Classification]

Phrase: "in an in vivo nephritis model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1515657:In Vivo Model [Research Activity]
   812   C3161035:Model [Intellectual Product]

Phrase: "(22,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.279: In the latter studies, renal damage was exacerbated in MMP-9 null mice and linked to increased fibrin deposition (27). 

Phrase: "In the latter studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "renal damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "was"

Phrase: "exacerbated in MMP-9 null mice"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0165519:Matrix Metalloproteinase 9 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1334523:MATRIX METALLOPROTEINASE 9 [Gene or Genome]
   778   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0206745:Null Mouse [Mammal]
   748   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0436331:Exacerbated [Finding]
   748   C0456148:Null [Quantitative Concept]
   748   C1444749:Exacerbated [Qualitative Concept]
   748   C1704640:Matrix [Spatial Concept]
   748   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "linked to increased fibrin deposition"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0333565:Fibrin deposition [Pathologic Function]
   797   C0151644:FIBRIN INCREASED [Finding]
   760   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0333562:Deposition [Functional Concept]
   760   C0442805:Increased [Functional Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.280: Further, while MMP-9 has been reported to degrade fibrin rather inefficiently relative to other secreted MMPs (e.g., MMP-3 or MMP-7; references 22 and 23), Lelongt et al. demonstrated that the proteinase could efficiently degrade fibrin under their in vitro conditions (27). 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "while"

Phrase: "MMP-9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0165519:Matrix Metalloproteinase 9 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:MATRIX METALLOPROTEINASE 9 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "degrade"

Phrase: "fibrin rather inefficiently relative to other secreted MMPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C1547039:*Relative [Quantitative Concept]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "MMP-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0164371:Matrix Metalloproteinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366358:MATRIX METALLOPROTEINASE 3 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MMP-7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0166059:Matrix Metalloproteinase 7 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417212:MATRIX METALLOPROTEINASE 7 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: ";"

Phrase: "references"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "22"

Phrase: "and"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Lelongt et al."

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the proteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1622131:proteinase [Molecular Function]
  1000   C1947941:Proteinase [Enzyme]

Phrase: "could"

Phrase: "efficiently"

Phrase: "degrade"

Phrase: "fibrin under their in vitro conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.281: In vivo, however, the situation is more complex as ECM components such as type I collagen are deposited into fibrin networks by fibroblasts (1). 

Phrase: "In vivo, however,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the situation"

Phrase: "is"

Phrase: "more complex as ECM components"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "such as type I collagen"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0041455:Type 1 Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "are"

Phrase: "deposited into fibrin networks"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0333562:deposited [Functional Concept]
   770   C1882071:networks [Conceptual Entity]
   737 E C1513822:Network [Professional or Occupational Group]
   737 E C1705739:Network [Manufactured Object]

Phrase: "by fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.282: As these ECM-fibrin composites display a heightened resistance to plasmin-dependent fibrinolysis (69), secreted MMPs may play an important role in fibrin clearance by either attacking fibrin(ogen) directly or by collaborating with plasmin to dissolve the stabilized fibrin deposits. 

Phrase: "As these ECM-fibrin composites"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0205199:composites [Qualitative Concept]
   793 E C1547335:Composite [Idea or Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "a heightened resistance to plasmin-dependent fibrinolysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]
   743   C0332325:Resistant to [Functional Concept]

Phrase: "(69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "secreted MMPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1721004:Matrix Metalloproteinases, Secreted [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in fibrin clearance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "by either attacking fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   755 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "or by collaborating"

Phrase: "with plasmin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "dissolve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549535:Dissolve [Functional Concept]

Phrase: "the stabilized fibrin deposits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]
Processing 00000000.tx.283: Given evidence that MT-MMPs maybe shed from the cell surface or expressed directly as soluble enzymes (44, 70), this class of enzymes may either promote invasion or function as bulk fibrinolysins dependent on their presentation at the cell surface. 

Phrase: "Given evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that MT-MMPs maybe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "shed from the cell surface"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "expressed"

Phrase: "directly as soluble enzymes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0014442:Enzymes [Enzyme,Organic Chemical]
   770   C0014445:enzymes [Functional Concept]
   770   C1749467:soluble [Cell Component]
   770   C1947931:Directly [Qualitative Concept]
   770   C1948047:Soluble [Qualitative Concept]

Phrase: "(44,"

Phrase: "70"

Phrase: ")"

Phrase: ","

Phrase: "this class of enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456387:Class [Intellectual Product]
   770   C1705943:Class [Classification]

Phrase: "may"

Phrase: "either"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]

Phrase: "or"

Phrase: "function as bulk fibrinolysins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "dependent on their presentation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "at the cell surface."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]
Processing 00000000.tx.284: In summary, we have identified a subset of MT-MMPs as the lead candidates responsible for allowing mammalian cells to traverse fibrin-rich tissues in a plasminogen-independent fashion. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a subset of MT-MMPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515021:Subset [Classification]

Phrase: "as the lead candidates"

Phrase: "responsible for allowing mammalian cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "to traverse fibrin-rich tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0040300:Tissues [Tissue]
   779 E C1547928:Tissue [Intellectual Product]

Phrase: "in a plasminogen-independent fashion."
Processing 00000000.tx.285: We note, however, that the comparable activities of MT1-MMP, MT2-MMP, and MT3-MMP with regard to fibrin-invasive activity do not similarly extend to other matrix barriers such as type I collagen. 

Phrase: "We"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "however,"

Phrase: "that"

Phrase: "the comparable activities of MT1-MMP,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C1150224:metalloproteinase activity [Molecular Function]
   748   C0441655:Activities [Activity]
   714 E C0205177:Activity [Functional Concept]
   714 E C0439167:% activity [Quantitative Concept]
   714 E C1561536:*Activity [Idea or Concept]

Phrase: "MT2-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT3-MMP with regard to fibrin-invasive activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C1150224:metalloproteinase activity [Molecular Function]
   742   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1704640:Matrix [Spatial Concept]
   742   C1706515:Matrix [Body Substance]

Phrase: "do"

Phrase: "not similarly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "extend to other matrix barriers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0231448:Extend [Functional Concept]
   760   C0439792:extend [Spatial Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   726   C1706912:BARRIER [Medical Device]

Phrase: "such as type I collagen."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0041455:Type 1 Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]
Processing 00000000.tx.286: Nonetheless, despite only 50% homology between MT1-MMP and MT2-MMP or MT3-MMP at the amino acid level (19), each of the membrane-anchored metalloproteinases allows expressing cells to display comparable fibrin-invasive and fibrinolytic activity. 

Phrase: "Nonetheless,"

Phrase: "despite only 50% homology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1334043:Homology [Gene or Genome]
   827   C2697616:Homology [Qualitative Concept]

Phrase: "between MT1-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "MT2-MMP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "MT3-MMP at the amino acid level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   767   C1295499:Acid metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1704640:Matrix [Spatial Concept]
   744   C1706515:Matrix [Body Substance]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "each of the membrane-anchored metalloproteinases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0025255:Membrane [Tissue]
   753   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0596901:Membrane [Cell Component]
   753   C1293132:anchored [Therapeutic or Preventive Procedure]
   753   C1457900:Each [Quantitative Concept]
   753   C1706182:Membrane [Manufactured Object]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "expressing cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "comparable fibrin-invasive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205281:Invasive [Qualitative Concept]

Phrase: "and"

Phrase: "fibrinolytic activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.287: The ability of MT2-MMP and MT3-MMP, but not other fibrinolytic MMPs, to confer fibrin-invasive activity in the absence or presence of MT1-MMP, identifies a new pro-invasive system for traversing the provisional matrix under pathophysiologic conditions.  

Phrase: "The ability of MT2-MMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "MT3-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0668750:MT3-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "other fibrinolytic MMPs,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confer"

Phrase: "fibrin-invasive activity in the absence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "or"

Phrase: "presence of MT1-MMP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "identifies"

Phrase: "a new pro-invasive system for traversing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "the provisional matrix under pathophysiologic conditions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]
Processing 00000000.tx.288: Acknowledgments  This work was supported by National Institutes of Health grants CA71699 and CA88308. 

Phrase: "Acknowledgments"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institutes of Health grants CA71699"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   744   C0018173:Grants [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C1521721:Supported [Conceptual Entity]
   744   C3245503:national [Intellectual Product]
   711 E C0183683:Support [Medical Device]
   711 E C1272753:Institute [Idea or Concept]
   711 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "CA88308."
Processing 00000000.tx.289: Submitted: May 14, 2001 Revised: October 18, 2001 Accepted: December 11, 2001  Footnotes  K.B. 

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: ":"

Phrase: "May 14,"

Phrase: "2001"

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: ":"

Phrase: "October 18,"

Phrase: "2001"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: ":"

Phrase: "December 11,"

Phrase: "2001  Footnotes  K.B."
Processing 00000000.tx.290: Hotary, I. 

Phrase: "Hotary,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.291: Yana, and F. 

Phrase: "Yana,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555081:Yana [Population Group]

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.292: Sabeh contributed equally to this work. 

Phrase: "Sabeh"

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.293: * Abbreviations used in this paper: H and E, hematoxylin and eosin; 

Phrase: "* Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used in this paper"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0030351:Paper [Manufactured Object]
   770   C1273517:used [Finding]
   770   C1547566:Paper [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "H and E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "hematoxylin and eosin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.294: MMP, matrix metalloproteinase; 

Phrase: "MMP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "matrix metalloproteinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: ";"
Processing 00000000.tx.295: PDGF, platelet-derived growth factor; 

Phrase: "PDGF,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: "platelet-derived growth factor"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: ";"
Processing 00000000.tx.296: RT, reverse transcription; 

Phrase: "RT,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]

Phrase: "reverse transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.297: SF/HFG, scatter factor/hepatocyte growth factor; 

Phrase: "SF/HFG,"

Phrase: "scatter factor/hepatocyte growth factor"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0062534:Hepatocyte Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1442521:HEPATOCYTE GROWTH FACTOR [Gene or Genome]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0227525:Hepatocyte [Cell]
   804   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]

Phrase: ";"
Processing 00000000.tx.298: TIMP, tissue inhibitor of metalloproteases.  

Phrase: "TIMP,"

Phrase: "tissue inhibitor of metalloproteases."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1152589:metalloprotease inhibitor [Molecular Function]
   770   C0040300:Tissue [Tissue]
   770   C1547928:Tissue [Intellectual Product]
   770   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.299: References Top Abstract Introduction Materials and Methods Results Discussion References  Singer, A.J., and R.A.F. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Singer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335076:Singer [Professional or Occupational Group]

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "and"

Phrase: "R.A.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.300: Clark. 

Phrase: "Clark."
Processing 00000000.tx.301: 1999. 

Phrase: "1999."
Processing 00000000.tx.302: Cutaneous wound healing. 

Phrase: "Cutaneous wound healing."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0043240:Wound Healing [Organism Function]
           Healing
   873   C0564444:skin wound [Injury or Poisoning]
   827   C0043250:Wound [Injury or Poisoning]
   827   C0205249:Healing [Functional Concept]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.303: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.304: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.305: J. 

Phrase: "J."
Processing 00000000.tx.306: Med. 

Phrase: "Med."
Processing 00000000.tx.307: 341:738746.[Free FullText] Dvorak, H.F., L.F. 

Phrase: "341"

Phrase: ":"

Phrase: "738746."

Phrase: "[Free FullText"

Phrase: "] Dvorak,"

Phrase: "H.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "L.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.308: Brown, M. 

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.309: Detmar, and A.M. 

Phrase: "Detmar,"

Phrase: "and"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.310: Dvorak. 

Phrase: "Dvorak."
Processing 00000000.tx.311: 1995. 

Phrase: "1995."
Processing 00000000.tx.312: Vascular permeability factor, vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. 

Phrase: "Vascular permeability factor,"
Meta Candidates (Total=19; Excluded=8; Pruned=0; Remaining=11)
  1000   C0078058:Vascular Permeability Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1171892:vascular permeability factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522575:Vascular Permeability Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   913   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   901   C0162337:Vascular Permeability [Organ or Tissue Function]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0031164:Permeability [Natural Phenomenon or Process]
   827   C1521761:Factor [Functional Concept]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   827   C2827422:Factor [Conceptual Entity]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   755 E C0205326:Permeable [Functional Concept]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   711 E C0333275:Bloody [Qualitative Concept]

Phrase: "vascular endothelial growth factor,"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "microvascular hyperpermeability,"

Phrase: "and"

Phrase: "angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.313: Am. 

Phrase: "Am."
Processing 00000000.tx.314: J. 

Phrase: "J."
Processing 00000000.tx.315: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.316: 146:10291039.[Abstract] Hiraoka, N., E. 

Phrase: "146"

Phrase: ":"

Phrase: "10291039."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hiraoka,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "E."
Processing 00000000.tx.317: Allen, I.J. 

Phrase: "Allen,"

Phrase: "I.J."
Processing 00000000.tx.318: Apel, M.R. 

Phrase: "Apel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539824:APEL [Gene or Genome]

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.319: Gyetko, and S.J. 

Phrase: "Gyetko,"

Phrase: "and S.J."
Processing 00000000.tx.320: Weiss. 

Phrase: "Weiss."
Processing 00000000.tx.321: 1998. 

Phrase: "1998."
Processing 00000000.tx.322: Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. 

Phrase: "Matrix metalloproteinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "regulate"

Phrase: "neovascularization by acting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0027686:Neovascularisation [Pathologic Function]

Phrase: "as"

Phrase: "pericellular fibrinolysins."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016016:fibrinolysins [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   789 E C0733564:Thrombolysin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.323: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.324: 95:365377.[Medline] Brown, L.F., N. 

Phrase: "95"

Phrase: ":"

Phrase: "365377."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "L.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.325: Lanir, J. 

Phrase: "Lanir,"

Phrase: "J."
Processing 00000000.tx.326: McDonagh, K. 

Phrase: "McDonagh,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.327: Tognazzi, A.M. 

Phrase: "Tognazzi,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.328: Dvorak, and H.F. 

Phrase: "Dvorak,"

Phrase: "and"

Phrase: "H.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.329: Dvorak. 

Phrase: "Dvorak."
Processing 00000000.tx.330: 1993. 

Phrase: "1993."
Processing 00000000.tx.331: Fibroblast migration in fibrin gel matrices. 

Phrase: "Fibroblast migration in fibrin gel matrices."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2612061:fibroblast migration [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.332: Am. 

Phrase: "Am."
Processing 00000000.tx.333: J. 

Phrase: "J."
Processing 00000000.tx.334: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.335: 142:273283.[Abstract] Greiling, D., and R.A.F. 

Phrase: "142"

Phrase: ":"

Phrase: "273283."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Greiling,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "R.A.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.336: Clark. 

Phrase: "Clark."
Processing 00000000.tx.337: 1997. 

Phrase: "1997."
Processing 00000000.tx.338: Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. 

Phrase: "Fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a conduit for fibroblast transmigration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0441247:Conduit [Medical Device]

Phrase: "from collagenous stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "into fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "clot"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009074:CLOT [Organic Chemical,Pharmacologic Substance]
  1000   C0302148:Clot [Acquired Abnormality]

Phrase: "provisional matrix."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]
Processing 00000000.tx.339: J. 

Phrase: "J."
Processing 00000000.tx.340: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.341: 110:861870.[Abstract/Free FullText] Ronfard, V., and Y. 

Phrase: "110"

Phrase: ":"

Phrase: "861870."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ronfard,"

Phrase: "V.,"

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.342: Barrandon. 

Phrase: "Barrandon."
Processing 00000000.tx.343: 2001. 

Phrase: "2001."
Processing 00000000.tx.344: Migration of keratinocytes through tunnels of digested fibrin. 

Phrase: "Migration of keratinocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   841   C1656945:keratinocyte migration [Cell Function]
   790   C0600210:Migration [Social Behavior]
   790   C1533574:Migration [Physiologic Function]
   790   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "through tunnels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337138:tunnels [Manufactured Object]

Phrase: "of digested fibrin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   789 E C0443215:Fibrinous [Qualitative Concept]
Processing 00000000.tx.345: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.346: Natl. 

Phrase: "Natl."
Processing 00000000.tx.347: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.348: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.349: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.350: 98:45044509.[Abstract/Free FullText] Mach, F., U. 

Phrase: "98"

Phrase: ":"

Phrase: "45044509."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mach,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0667830:MACH [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332667:MACH [Gene or Genome]
  1000   C1705065:MACH [Gene or Genome]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "U."
Processing 00000000.tx.351: Schonbeck, R.P. 

Phrase: "Schonbeck,"

Phrase: "R.P."
Processing 00000000.tx.352: Fabunmi, C. 

Phrase: "Fabunmi,"

Phrase: "C."
Processing 00000000.tx.353: Murphy. 

Phrase: "Murphy."
Processing 00000000.tx.354: E. 

Phrase: "E."
Processing 00000000.tx.355: Atkinson, J.-Y. 

Phrase: "Atkinson,"

Phrase: "J.-Y."
Processing 00000000.tx.356: Bonnefoy, P. 

Phrase: "Bonnefoy,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.357: Graber, and P. 

Phrase: "Graber,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.358: Libby. 

Phrase: "Libby."
Processing 00000000.tx.359: 1999. 

Phrase: "1999."
Processing 00000000.tx.360: T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism. 

Phrase: "T lymphocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039194:T-Lymphocytes [Cell]
   861   C0024264:Lymphocytes [Cell]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.361: Am. 

Phrase: "Am."
Processing 00000000.tx.362: J. 

Phrase: "J."
Processing 00000000.tx.363: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.364: 154:229238.[Abstract/Free FullText] Lanir, N., P.S. 

Phrase: "154"

Phrase: ":"

Phrase: "229238."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lanir,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "P.S."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234833:P s [Organ or Tissue Function]
  1000   C0722388:P & S [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.365: Ciano, L. 

Phrase: "Ciano,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.366: Van De Water, J. 

Phrase: "Van De Water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   827   C0599638:WATER [Substance]
   827   C1550678:Water [Inorganic Chemical]
   755 E C0443350:Watery [Qualitative Concept]

Phrase: "J."
Processing 00000000.tx.367: McDonagh, A.M. 

Phrase: "McDonagh,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.368: Dvorak, and H.F. 

Phrase: "Dvorak,"

Phrase: "and"

Phrase: "H.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.369: Dvorak. 

Phrase: "Dvorak."
Processing 00000000.tx.370: 1988. 

Phrase: "1988."
Processing 00000000.tx.371: Macrophage migration in fibrin gel matrices. 

Phrase: "Macrophage migration in fibrin gel matrices."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.372: J. 

Phrase: "J."
Processing 00000000.tx.373: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.374: 140:23402349.[Abstract/Free FullText] Bugge, T.H., K.W. 

Phrase: "140"

Phrase: ":"

Phrase: "23402349."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bugge,"

Phrase: "T.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: "K.W."
Processing 00000000.tx.375: Kombrinck, Q. 

Phrase: "Kombrinck,"

Phrase: "Q."
Processing 00000000.tx.376: Xiao, K. 

Phrase: "Xiao,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.377: Holmback, C.C. 

Phrase: "Holmback,"

Phrase: "C.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.378: Daugherty, D.P. 

Phrase: "Daugherty,"

Phrase: "D.P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.379: Witte, and J.L. 

Phrase: "Witte,"

Phrase: "and"

Phrase: "J.L."
Processing 00000000.tx.380: Degen. 

Phrase: "Degen."
Processing 00000000.tx.381: 1997. 

Phrase: "1997."
Processing 00000000.tx.382: Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. 

Phrase: "Growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "dissemination of Lewis lung carcinoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205221:Dissemination [Spatial Concept]

Phrase: "in plasminogen-deficient mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.383: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.384: 90:45224531.[Abstract/Free FullText] Montesano, R., M.S. 

Phrase: "90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "45224531."

Phrase: "[Abstract/Free FullText"

Phrase: "] Montesano,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.385: Pepper, J.-D. 

Phrase: "Pepper,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453397:Pepper [Plant]
  1000   C1123063:Pepper [Food]

Phrase: "J.-D."
Processing 00000000.tx.386: Vassalli, and L. 

Phrase: "Vassalli,"

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.387: Orci. 

Phrase: "Orci."
Processing 00000000.tx.388: 1987. 

Phrase: "1987."
Processing 00000000.tx.389: Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors. 

Phrase: "Phorbol ester"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031586:Phorbol Ester [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0014898:Ester [Organic Chemical]
   861   C0031588:phorbol [Organic Chemical]
   861   C0070750:Phorbol [Organic Chemical]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cultured endothelial cells to"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   875   C0007600:cultured cells [Cell]
   875   C0007635:Cultured Cells [Cell]
   875   C3282338:Cells, Cultured [Cell]
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "invade"

Phrase: "a fibrin matrix in the presence of fibrinolytic inhibitors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1704640:Matrix [Spatial Concept]
   742   C1706515:Matrix [Body Substance]
Processing 00000000.tx.390: J. 

Phrase: "J."
Processing 00000000.tx.391: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.392: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.393: 132:509516.[Medline] Kookwijk. 

Phrase: "132"

Phrase: ":"

Phrase: "509516."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kookwijk."
Processing 00000000.tx.394: P., M.G.M. van Erck, W.J.A. de Vree, M.A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "M."

Phrase: "G.M. van Erck,"

Phrase: "W.J."

Phrase: "A. de Vree,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.395: Vermeer, H.A. 

Phrase: "Vermeer,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.396: Weich, R. 

Phrase: "Weich,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.397: Hanemaaijer, and V.W.M. van Hinsbergh. 

Phrase: "Hanemaaijer,"

Phrase: "and"

Phrase: "V.W.M. van Hinsbergh."
Processing 00000000.tx.398: 1996. 

Phrase: "1996."
Processing 00000000.tx.399: Cooperative effect of TNF, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. 

Phrase: "Cooperative effect of TNF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "bFGF,"

Phrase: "and"

Phrase: "VEGF on the formation of tubular structures of human microvascular endothelial cells"

Phrase: "in a fibrin matrix."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]
Processing 00000000.tx.400: Role of urokinase activity. 

Phrase: "Role of urokinase activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.401: J. 

Phrase: "J."
Processing 00000000.tx.402: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.403: 132:11771188.[Abstract] Knox, P., S. 

Phrase: "132"

Phrase: ":"

Phrase: "11771188."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Knox,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.404: Crooks, M.C. 

Phrase: "Crooks,"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.405: Scaife, and S. 

Phrase: "Scaife,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.406: Patel. 

Phrase: "Patel."
Processing 00000000.tx.407: 1987. 

Phrase: "1987."
Processing 00000000.tx.408: Role of plasminogen, plasmin, and plasminogen activators in the migration of fibroblasts into plasma clots. 

Phrase: "Role of plasminogen,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "plasmin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "plasminogen activators in the migration of fibroblasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0032144:Plasminogen Activators [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   778   C2756980:Plasminogen Activators [Molecular Function]
   748   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: "into plasma clots."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0302148:clots [Acquired Abnormality]
   827 E C0009074:CLOT [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.409: J. 

Phrase: "J."
Processing 00000000.tx.410: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.411: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.412: 132:501508.[Medline] Dvorak, H.F., V.S. 

Phrase: "132"

Phrase: ":"

Phrase: "501508."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dvorak,"

Phrase: "H.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "V.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642225:V/s [Quantitative Concept]
Processing 00000000.tx.413: Harvey, P. 

Phrase: "Harvey,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.414: Estrella, L.F. 

Phrase: "Estrella,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2623314:Estrella [Bacterium]

Phrase: "L.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.415: Brown, J. 

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J."
Processing 00000000.tx.416: McDonagh, and A.M. 

Phrase: "McDonagh,"

Phrase: "and"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.417: Dvorak. 

Phrase: "Dvorak."
Processing 00000000.tx.418: 1987. 

Phrase: "1987."
Processing 00000000.tx.419: Fibrin containing gels induce angiogenesis. 

Phrase: "Fibrin containing gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.420: Implications for tumor stroma generation and wound healing. 

Phrase: "Implications for tumor stroma generation"

Phrase: "and"

Phrase: "wound healing."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.421: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.422: Invest. 

Phrase: "Invest."
Processing 00000000.tx.423: 57:673686.[Medline] Murphy, G., and J. 

Phrase: "57"

Phrase: ":"

Phrase: "673686."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Murphy,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.424: Gavrilovic. 

Phrase: "Gavrilovic."
Processing 00000000.tx.425: 1999. 

Phrase: "1999."
Processing 00000000.tx.426: Proteolysis and cell migration: creating a path? 

Phrase: "Proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "and"

Phrase: "cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: ":"

Phrase: "creating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706214:Create [Activity]
   966   C3244320:create [Functional Concept]

Phrase: "a path?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919386:PATH [Laboratory Procedure]
  1000   C1705483:Path [Intellectual Product]
Processing 00000000.tx.427: Curr. 

Phrase: "Curr."
Processing 00000000.tx.428: Opin. 

Phrase: "Opin."
Processing 00000000.tx.429: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.430: 11:614621.[CrossRef][Medline] Quaranta, V. 

Phrase: "11"

Phrase: ":"

Phrase: "614621."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Quaranta,"

Phrase: "V."
Processing 00000000.tx.431: 2000. 

Phrase: "2000."
Processing 00000000.tx.432: Cell migration through extracellular matrix: membrane-type metalloproteinases make the way. 

Phrase: "Cell migration through extracellular matrix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1622501:Migration, Cell [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: ":"

Phrase: "membrane-type metalloproteinases"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0025255:Membrane [Tissue]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0332307:Type [Qualitative Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the way."
Processing 00000000.tx.433: J. 

Phrase: "J."
Processing 00000000.tx.434: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.435: 149:11671169.[Abstract/Free FullText] Romer, J., T.H. 

Phrase: "149"

Phrase: ":"

Phrase: "11671169."

Phrase: "[Abstract/Free FullText"

Phrase: "] Romer,"

Phrase: "J.,"

Phrase: "T.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.436: Bugge, C. 

Phrase: "Bugge,"

Phrase: "C."
Processing 00000000.tx.437: Pyke, L.R. 

Phrase: "Pyke,"

Phrase: "L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.438: Lund, M.J. 

Phrase: "Lund,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.439: Flick, J.L. 

Phrase: "Flick,"

Phrase: "J.L."
Processing 00000000.tx.440: Degen, and K. 

Phrase: "Degen,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.441: Dano. 

Phrase: "Dano."
Processing 00000000.tx.442: 1996. 

Phrase: "1996."
Processing 00000000.tx.443: Impaired wound healing in mice with a disrupted plasminogen gene. 

Phrase: "Impaired wound healing in mice"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   862   C0151692:Impaired wound healing [Pathologic Function]
           HEALING IMPAIRED
   806   C0043240:Wound Healing [Organism Function]
           Healing
   797 E C0574776:healing wound [Finding]
   797 E C1265679:healing wound [Anatomical Abnormality]
   760   C0043250:Wound [Injury or Poisoning]
   760   C0205249:Healing [Functional Concept]
   726 E C0016204:Wind NOS [Sign or Symptom]
   726 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "with a disrupted plasminogen gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1367553:Plasminogen Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.444: Nat. 

Phrase: "Nat."
Processing 00000000.tx.445: Med. 

Phrase: "Med."
Processing 00000000.tx.446: 2:287292.[Medline] Bugge, T.H., M.J. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "287292."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bugge,"

Phrase: "T.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.447: Flick, M.J.S. 

Phrase: "Flick,"

Phrase: "M."

Phrase: "J.S."
Processing 00000000.tx.448: Danton, C.C. 

Phrase: "Danton,"

Phrase: "C.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.449: Daugherty, J. 

Phrase: "Daugherty,"

Phrase: "J."
Processing 00000000.tx.450: Romer, K. 

Phrase: "Romer,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.451: Dano, P. 

Phrase: "Dano,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.452: Carmeliet, D. 

Phrase: "Carmeliet,"

Phrase: "D."
Processing 00000000.tx.453: Collen, and J.L. 

Phrase: "Collen,"

Phrase: "and"

Phrase: "J.L."
Processing 00000000.tx.454: Degen. 

Phrase: "Degen."
Processing 00000000.tx.455: 1996. 

Phrase: "1996."
Processing 00000000.tx.456: Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. 

Phrase: "Urokinase-type plasminogen activator"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0042071:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Plasminogen Activator, Urokinase
           Urokinase
  1000   C1522670:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Urokinase Plasminogen Activator
           Urokinase
   923   C1335224:plasminogen activator, urokinase [Gene or Genome]
           UROKINASE
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "effective in fibrin clearance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:effective [Qualitative Concept]
   770   C1704419:Effective [Qualitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of its receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "tissue-type plasminogen activator."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0032143:Tissue-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Tissue Plasminogen Activator
   923   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   861   C0019633:tissue type [Laboratory Procedure]
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C2713035:Tissue type [Tissue]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0040300:Tissue [Tissue]
   812   C0332307:Type [Qualitative Concept]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1547052:*Type [Quantitative Concept]
   812   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.457: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.458: Natl. 

Phrase: "Natl."
Processing 00000000.tx.459: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.460: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.461: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.462: 93:58995904.[Abstract/Free FullText] Lund, L.R., J. 

Phrase: "93"

Phrase: ":"

Phrase: "58995904."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lund,"

Phrase: "L.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "J."
Processing 00000000.tx.463: Romer, T.H. 

Phrase: "Romer,"

Phrase: "T.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.464: Bugge, R.S. 

Phrase: "Bugge,"

Phrase: "R.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.465: Nielsen, T.L. 

Phrase: "Nielsen,"

Phrase: "T.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.466: Frandsen, J.L. 

Phrase: "Frandsen,"

Phrase: "J.L."
Processing 00000000.tx.467: Degen, R.W. 

Phrase: "Degen,"

Phrase: "R.W."
Processing 00000000.tx.468: Stephens, and K. 

Phrase: "Stephens,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.469: Dano. 

Phrase: "Dano."
Processing 00000000.tx.470: 1999. 

Phrase: "1999."
Processing 00000000.tx.471: Functional overlap between two classes of matrix-degrading proteases in wound healing. 

Phrase: "Functional overlap between two classes of matrix-degrading proteases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0185027:overlap [Therapeutic or Preventive Procedure]
   742   C1948020:Overlap [Conceptual Entity]

Phrase: "in wound healing."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0043240:Wound Healing [Organism Function]
           Healing
   861   C0043250:Wound [Injury or Poisoning]
   861   C0205249:Healing [Functional Concept]
   827 E C0016204:Wind NOS [Sign or Symptom]
   827 E C0043187:Wind [Natural Phenomenon or Process]
   777 E C0021501:wounds [Qualitative Concept]
   777 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.472: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.473: 18:46454656.[Abstract/Free FullText] Nagase, H., and J.F. 

Phrase: "18"

Phrase: ":"

Phrase: "46454656."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nagase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001057:NAGase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3538752:NAGASE [Laboratory Procedure]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.474: Woessner, Jr. 

Phrase: "Woessner,"

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.475: 1999. 

Phrase: "1999."
Processing 00000000.tx.476: Matrix metalloproteinases. 

Phrase: "Matrix metalloproteinases."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]
Processing 00000000.tx.477: J. 

Phrase: "J."
Processing 00000000.tx.478: Biol. 

Phrase: "Biol."
Processing 00000000.tx.479: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.480: 274:2149121494.[Free FullText] Marchenko, G.N., and A.Y. 

Phrase: "274"

Phrase: ":"

Phrase: "2149121494."

Phrase: "[Free FullText"

Phrase: "] Marchenko,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "A.Y."
Processing 00000000.tx.481: Strongin. 

Phrase: "Strongin."
Processing 00000000.tx.482: 2001. 

Phrase: "2001."
Processing 00000000.tx.483: MMP-28 a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors. 

Phrase: "MMP-28"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1422595:MATRIX METALLOPROTEINASE 28 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "a new human matrix metalloproteinase with an unusual cysteine-switch sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1704640:Matrix [Spatial Concept]
   738   C1706515:Matrix [Body Substance]

Phrase: "is"

Phrase: "widely"

Phrase: "expressed in tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0027651:Tumors [Neoplastic Process]
   756 E C1578706:Tumor [Intellectual Product]
   756 E C3273930:Tumor [Finding]
Processing 00000000.tx.484: Gene. 

Phrase: "Gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.485: 265:8793.[CrossRef][Medline] Lohi, J., C.L. 

Phrase: "265"

Phrase: ":"

Phrase: "8793."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lohi,"

Phrase: "J.,"

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.486: Wilson, J.D. 

Phrase: "Wilson,"

Phrase: "J.D."
Processing 00000000.tx.487: Roby, and W.C. 

Phrase: "Roby,"

Phrase: "and"

Phrase: "W.C."
Processing 00000000.tx.488: Parks. 

Phrase: "Parks."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562547:parks [Manufactured Object]
   966 E C3160718:PARK [Disease or Syndrome]
Processing 00000000.tx.489: 2001. 

Phrase: "2001."
Processing 00000000.tx.490: Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. 

Phrase: "Epilysin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422595:EPILYSIN [Gene or Genome]

Phrase: "a novel human matrix metalloproteinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "(MMP-28"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1422595:MATRIX METALLOPROTEINASE 28 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: ")"

Phrase: "expressed in testis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0039597:Testis [Body Part, Organ, or Organ Component]
   790   C1278981:Testis [Body Part, Organ, or Organ Component]
   706 E C0021358:Testes [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "keratinocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022567:Keratinocytes [Cell]

Phrase: "and in response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0871261:Response [Organism Attribute]
   790   C1515981:And [Idea or Concept]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.491: J. 

Phrase: "J."
Processing 00000000.tx.492: Biol. 

Phrase: "Biol."
Processing 00000000.tx.493: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.494: 276:1013410144.[Abstract/Free FullText] Bini, A., Y. 

Phrase: "276"

Phrase: ":"

Phrase: "1013410144."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bini,"

Phrase: "A.,"

Phrase: "Y."
Processing 00000000.tx.495: Itoh, B.J. 

Phrase: "Itoh,"

Phrase: "B.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.496: Kudryk, and H. 

Phrase: "Kudryk,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.497: Nagase. 

Phrase: "Nagase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001057:NAGase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3538752:NAGASE [Laboratory Procedure]
Processing 00000000.tx.498: 1996. 

Phrase: "1996."
Processing 00000000.tx.499: Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): Hydrolysis of the Gly 404-Ala 405 peptide bond. 

Phrase: "Degradation of cross-linked fibrin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "by matrix metalloproteinase 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0164371:Matrix Metalloproteinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366358:MATRIX METALLOPROTEINASE 3 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(stromelysin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0164371:Stromelysin 1 [Amino Acid, Peptide, or Protein,Enzyme]
           Stromelysin
  1000   C1619831:Stromelysin 1 [Laboratory Procedure]

Phrase: ")"

Phrase: ":"

Phrase: "Hydrolysis of the Gly 404-Ala 405 peptide bond."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0020291:Hydrolysis [Natural Phenomenon or Process]
Processing 00000000.tx.500: Biochemistry. 

Phrase: "Biochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]
Processing 00000000.tx.501: 35:1305613063.[CrossRef][Medline] Bini, A., D. 

Phrase: "35"

Phrase: ":"

Phrase: "1305613063."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bini,"

Phrase: "A.,"

Phrase: "D."
Processing 00000000.tx.502: Wu, J. 

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "J."
Processing 00000000.tx.503: Schnuer, and B.J. 

Phrase: "Schnuer,"

Phrase: "and"

Phrase: "B.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.504: Kudryk. 

Phrase: "Kudryk."
Processing 00000000.tx.505: 1999. 

Phrase: "1999."
Processing 00000000.tx.506: Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments. 

Phrase: "Characterization of stromelysin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "(MMP-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0164371:Matrix Metalloproteinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366358:MATRIX METALLOPROTEINASE 3 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: ")"

Phrase: ","

Phrase: "matrilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0166059:Matrilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2698026:Matrilysin [Laboratory Procedure]

Phrase: "(MMP-7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0166059:Matrix Metalloproteinase 7 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417212:MATRIX METALLOPROTEINASE 7 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "membrane type 1 matrix metalloproteinase (MT1-MMP)"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0671550:Membrane-Type-1 Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1618608:membrane-type 1 matrix metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   924   C0256102:Membrane-Type Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0441729:Type 1 [Classification]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025255:Membrane [Tissue]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0332307:Type [Qualitative Concept]
   804   C0596901:Membrane [Cell Component]
   804   C1547052:*Type [Quantitative Concept]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706182:Membrane [Manufactured Object]
   804   C1706515:Matrix [Body Substance]
   733 E C0205287:Membranous [Qualitative Concept]

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332255:fragment [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "D-"

Phrase: "dimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimer [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "D-like monomer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: ":"

Phrase: "NH2-terminal sequences of late-stage"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "digest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digest [Physiologic Function]

Phrase: "fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.507: Biochemistry. 

Phrase: "Biochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]
Processing 00000000.tx.508: 38:1392813936.[CrossRef][Medline] Lijnen, H.R., F. 

Phrase: "38"

Phrase: ":"

Phrase: "1392813936."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lijnen,"

Phrase: "H.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.509: Ugwu, M.-C. 

Phrase: "Ugwu,"

Phrase: "M.-C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.510: Rio, and D. 

Phrase: "Rio,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445581:Rio [Intellectual Product]

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.511: Collen. 

Phrase: "Collen."
Processing 00000000.tx.512: 1998. 

Phrase: "1998."
Processing 00000000.tx.513: Plasminogen/plasmin and matrix metalloproteinase system function in mice with targeted inactivation of stromelysin-3 (MMP-11). 

Phrase: "Plasminogen/plasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "matrix metalloproteinase system function in mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
   748   C1180473:Functional system [Body System]

Phrase: "with targeted inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "of stromelysin-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0174383:Stromelysin 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0164371:Stromelysin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(MMP-11"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0174383:Matrix Metalloproteinase 11 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366519:MATRIX METALLOPROTEINASE 11 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: ")."
Processing 00000000.tx.514: Fibrinolysis Proteol. 

Phrase: "Fibrinolysis Proteol."
Processing 00000000.tx.515: 12:155164. 

Phrase: "12"

Phrase: ":"

Phrase: "155164."
Processing 00000000.tx.516: English, W.R., X.S. 

Phrase: "English,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376245:English [Language]
  1000   C1556083:English [Population Group]
  1000   C3540738:English [Intellectual Product]

Phrase: "W.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "X.S."
Processing 00000000.tx.517: Puente, J.M.P. 

Phrase: "Puente,"

Phrase: "J."

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.518: Freije, V. 

Phrase: "Freije,"

Phrase: "V."
Processing 00000000.tx.519: Knauper, A. 

Phrase: "Knauper,"

Phrase: "A."
Processing 00000000.tx.520: Amour, A. 

Phrase: "Amour,"

Phrase: "A."
Processing 00000000.tx.521: Merryweather, C Lopez-Otin, and G. 

Phrase: "Merryweather,"

Phrase: "C Lopez-Otin,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.522: Murphy. 

Phrase: "Murphy."
Processing 00000000.tx.523: 2000. 

Phrase: "2000."
Processing 00000000.tx.524: Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor- convertase activity but does not activate pro-MMP2. 

Phrase: "Membrane type 4 matrix metalloproteinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1569872:Membrane-Type 4 Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   924   C0256102:Membrane-Type Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]

Phrase: "(MMP17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417206:MMP17 [Gene or Genome]

Phrase: ")"

Phrase: "has"

Phrase: "tumor necrosis factor- convertase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   717   C1323304:tumor necrosis factor [Molecular Function]
   717   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "pro-MMP2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0172537:MMP-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1334522:MMP2 [Gene or Genome]
   861   C2698024:MMP2 [Laboratory Procedure]
Processing 00000000.tx.525: J. 

Phrase: "J."
Processing 00000000.tx.526: Biol. 

Phrase: "Biol."
Processing 00000000.tx.527: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.528: 275:1404614055.[Abstract/Free FullText] Hiller, O., A. 

Phrase: "275"

Phrase: ":"

Phrase: "1404614055."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hiller,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.529: Lichte, A. 

Phrase: "Lichte,"

Phrase: "A."
Processing 00000000.tx.530: Oberpichler, A. 

Phrase: "Oberpichler,"

Phrase: "A."
Processing 00000000.tx.531: Kocourek, and H. 

Phrase: "Kocourek,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.532: Tschesche. 

Phrase: "Tschesche."
Processing 00000000.tx.533: 2000. 

Phrase: "2000."
Processing 00000000.tx.534: Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3 and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. 

Phrase: "Matrix metalloproteinases collagenase-2,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   906   C0172537:Matrix Metalloproteinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   906   C1334522:MATRIX METALLOPROTEINASE 2 [Gene or Genome]
   861   C0172956:Collagenase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]

Phrase: "macrophage elastase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0968475:Macrophage elastase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030306:Elastase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0699918:Elastase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "collagenase-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0255672:Collagenase 3 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417202:COLLAGENASE 3 [Gene or Genome]
   861   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "membrane type 1-matrix metalloproteinase"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0671550:Membrane-Type-1 Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1618608:membrane-type 1 matrix metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   924   C0256102:Membrane-Type Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0441729:Type 1 [Classification]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025255:Membrane [Tissue]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0332307:Type [Qualitative Concept]
   804   C0596901:Membrane [Cell Component]
   804   C1547052:*Type [Quantitative Concept]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706182:Membrane [Manufactured Object]
   804   C1706515:Matrix [Body Substance]
   733 E C0205287:Membranous [Qualitative Concept]

Phrase: "impair"

Phrase: "clotting by degradation of fibrinogen"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0005778:Clotting [Organ or Tissue Function]
   760   C1328723:clotting [Physiologic Function]
   726 E C0009074:CLOT [Organic Chemical,Pharmacologic Substance]
   726 E C0302148:Clot [Acquired Abnormality]

Phrase: "and"

Phrase: "factor XII."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015525:Factor XII [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.535: J. 

Phrase: "J."
Processing 00000000.tx.536: Biol. 

Phrase: "Biol."
Processing 00000000.tx.537: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.538: 275:3300833013.[Abstract/Free FullText] Lelongt, B., S. 

Phrase: "275"

Phrase: ":"

Phrase: "3300833013."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lelongt,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.539: Bengatta, M. 

Phrase: "Bengatta,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.540: Delauche, L.R. 

Phrase: "Delauche,"

Phrase: "L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.541: Lund, Z. 

Phrase: "Lund,"

Phrase: "Z."
Processing 00000000.tx.542: Werb, and P.M. 

Phrase: "Werb,"

Phrase: "and"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.543: Ronco. 

Phrase: "Ronco."
Processing 00000000.tx.544: 2001. 

Phrase: "2001."
Processing 00000000.tx.545: Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity. 

Phrase: "Matrix metalloproteinase 9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0165519:Matrix Metalloproteinase 9 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:MATRIX METALLOPROTEINASE 9 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "protects"

Phrase: "mice from anti-glomerular basement membrane nephritis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   730   C1522271:Mouse Renal Glomerulus [Tissue]
           Mouse Glomerulus
   711   C1517673:Mouse Kidney [Tissue]

Phrase: "through its fibrinolytic activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.546: J. 

Phrase: "J."
Processing 00000000.tx.547: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.548: Med. 

Phrase: "Med."
Processing 00000000.tx.549: 193:793802.[Abstract/Free FullText] Holmbeck, K., P. 

Phrase: "193"

Phrase: ":"

Phrase: "793802."

Phrase: "[Abstract/Free FullText"

Phrase: "] Holmbeck,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.550: Bianco, J. 

Phrase: "Bianco,"

Phrase: "J."
Processing 00000000.tx.551: Caterina, S. 

Phrase: "Caterina,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.552: Yamada, M. 

Phrase: "Yamada,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.553: Kromer, S.A. 

Phrase: "Kromer,"

Phrase: "S.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.554: Kuznetsov, M. 

Phrase: "Kuznetsov,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.555: Mankani, P.G. 

Phrase: "Mankani,"

Phrase: "P.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.556: Robey, A.R. 

Phrase: "Robey,"

Phrase: "A.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.557: Poole, I. 

Phrase: "Poole,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.558: Pidoux, et al. 

Phrase: "Pidoux,"

Phrase: "et al."
Processing 00000000.tx.559: 1999. 

Phrase: "1999."
Processing 00000000.tx.560: MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. 

Phrase: "MT1-MMP-deficient mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C1618608:MT1-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "develop"

Phrase: "dwarfism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013336:Dwarfism [Congenital Abnormality,Disease or Syndrome]

Phrase: "osteopenia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029453:Osteopenia [Pathologic Function]

Phrase: "arthritis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003864:Arthritis [Disease or Syndrome]
   907 E C0018099:Gout [Disease or Syndrome]

Phrase: "and"

Phrase: "connective tissue disease due to inadequate collagen turnover."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0009782:Connective tissue disease [Disease or Syndrome]
   770   C0009780:Connective Tissue [Tissue]
   767   C0009326:Collagen disease [Disease or Syndrome]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0040300:Tissue [Tissue]
   744   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.561: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.562: 99:8192.[Medline] Zhou, Z., S.S. 

Phrase: "99"

Phrase: ":"

Phrase: "8192."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhou,"

Phrase: "Z.,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.563: Apte, R. 

Phrase: "Apte,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.564: Soininen, R. 

Phrase: "Soininen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.565: Cao, G.Y. 

Phrase: "Cao,"

Phrase: "G.Y."
Processing 00000000.tx.566: Baaklini, R.W. 

Phrase: "Baaklini,"

Phrase: "R.W."
Processing 00000000.tx.567: Rauser, J. 

Phrase: "Rauser,"

Phrase: "J."
Processing 00000000.tx.568: Wang, Y Cao, and K. 

Phrase: "Wang,"

Phrase: "Y Cao,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.569: Tryggvason. 

Phrase: "Tryggvason."
Processing 00000000.tx.570: 2000. 

Phrase: "2000."
Processing 00000000.tx.571: Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase 1. 

Phrase: "Impaired endochondral ossification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1622923:endochondral ossification [Organ or Tissue Function]
   827   C0029433:Ossification [Organ or Tissue Function]

Phrase: "and"

Phrase: "angiogenesis in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0302600:Angiogenesis [Organ or Tissue Function]
   790   C1519670:angiogenesis [Neoplastic Process]

Phrase: "deficient in membrane-type matrix metalloproteinase 1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0011155:Deficient [Functional Concept]
   748   C1636779:% deficient [Quantitative Concept]
   731   C0671550:Membrane-Type Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   731   C1417203:MEMBRANE-TYPE MATRIX METALLOPROTEINASE 1 [Gene or Genome]
   731   C1618608:Membrane-Type Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.572: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.573: Natl. 

Phrase: "Natl."
Processing 00000000.tx.574: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.575: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.576: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.577: 97:40524057.[Abstract/Free FullText] Hotary, K., E. 

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "40524057."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hotary,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "E."
Processing 00000000.tx.578: Allen, A. 

Phrase: "Allen,"

Phrase: "A."
Processing 00000000.tx.579: Punturieri, I. 

Phrase: "Punturieri,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.580: Yana, and S.J. 

Phrase: "Yana,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555081:Yana [Population Group]

Phrase: "and S.J."
Processing 00000000.tx.581: Weiss. 

Phrase: "Weiss."
Processing 00000000.tx.582: 2000. 

Phrase: "2000."
Processing 00000000.tx.583: Regulation of cell invasion and morphogenesis in a 3-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2 and 3. 

Phrase: "Regulation of cell invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "morphogenesis in a 3-dimensional type I collagen matrix"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0026559:Morphogenesis [Organism Function]

Phrase: "by membrane-type matrix metalloproteinases 1,"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   991   C0671550:Membrane-Type Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   991   C1417203:MEMBRANE-TYPE MATRIX METALLOPROTEINASE 1 [Gene or Genome]
   991   C1618608:Membrane-Type Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0256102:Membrane-Type Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0441729:Type 1 [Classification]
   867   C0127082:Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   867   C1417199:MATRIX METALLOPROTEINASE 1 [Gene or Genome]
   840   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025255:Membrane [Tissue]
   804   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0332307:Type [Qualitative Concept]
   804   C0596901:Membrane [Cell Component]
   804   C1547052:*Type [Quantitative Concept]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706182:Membrane [Manufactured Object]
   804   C1706515:Matrix [Body Substance]
   733 E C0205287:Membranous [Qualitative Concept]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.584: J. 

Phrase: "J."
Processing 00000000.tx.585: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.586: 149:13091323.[Abstract/Free FullText] Havemose-Poulsen, A., P. 

Phrase: "149"

Phrase: ":"

Phrase: "13091323."

Phrase: "[Abstract/Free FullText"

Phrase: "] Havemose-Poulsen,"

Phrase: "A.,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.587: Holmstrup, K. 

Phrase: "Holmstrup,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.588: Stoltze, and H. 

Phrase: "Stoltze,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.589: Birkedal-Hansen. 

Phrase: "Birkedal-Hansen."
Processing 00000000.tx.590: 1998. 

Phrase: "1998."
Processing 00000000.tx.591: Dissolution of type I collagen fibrils by gingival fibroblasts isolated from patients of various periodontitis categories. 

Phrase: "Dissolution of type I collagen fibrils"

Phrase: "by gingival fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "isolated from patients of various periodontitis categories."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0031099:Periodontitis [Disease or Syndrome]
   748   C0205409:Isolated [Functional Concept]
   748   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   748   C0683312:Categories [Intellectual Product]
   748   C1548221:Isolated [Idea or Concept]
   714 E C0370215:Isolate [Substance]
   714 E C1555713:category [Idea or Concept]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.592: J. 

Phrase: "J."
Processing 00000000.tx.593: Periodontal Res. 

Phrase: "Periodontal Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.594: 33:280291.[Medline] Yana, I., and S.J. 

Phrase: "33"

Phrase: ":"

Phrase: "280291."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yana,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555081:Yana [Population Group]

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and S.J."
Processing 00000000.tx.595: Weiss. 

Phrase: "Weiss."
Processing 00000000.tx.596: 2000. 

Phrase: "2000."
Processing 00000000.tx.597: Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. 

Phrase: "Regulation of membrane type-1 matrix metalloproteinase activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   703   C0671550:Membrane-Type-1 Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   703   C1618608:membrane-type 1 matrix metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "by proprotein convertases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1100660:Proprotein Convertases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0379214:pro protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1709708:Proprotein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.598: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.599: Biol. 

Phrase: "Biol."
Processing 00000000.tx.600: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.601: 11:23872401.[Abstract/Free FullText] D'Ortho, M.-P., H. 

Phrase: "11"

Phrase: ":"

Phrase: "23872401."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "D'"

Phrase: "Ortho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0812371:Ortho- [Idea or Concept]

Phrase: "M.-"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.602: Will, S. 

Phrase: "Will"

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.603: Atkinson, G. 

Phrase: "Atkinson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.604: Butler, A. 

Phrase: "Butler,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402644:Butler [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.605: Messent, J. 

Phrase: "Messent,"

Phrase: "J."
Processing 00000000.tx.606: Gavrilovic, B. 

Phrase: "Gavrilovic,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.607: Smith, R. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.608: Timpl, L. 

Phrase: "Timpl,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.609: Zardi, and G. 

Phrase: "Zardi,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.610: Murphy. 

Phrase: "Murphy."
Processing 00000000.tx.611: 1997. 

Phrase: "1997."
Processing 00000000.tx.612: Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. 

Phrase: "Membrane-type matrix metalloproteinases 1"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   991   C0671550:Membrane-Type Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   991   C1417203:MEMBRANE-TYPE MATRIX METALLOPROTEINASE 1 [Gene or Genome]
   991   C1618608:Membrane-Type Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0256102:Membrane-Type Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0441729:Type 1 [Classification]
   867   C0127082:Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   867   C1417199:MATRIX METALLOPROTEINASE 1 [Gene or Genome]
   840   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025255:Membrane [Tissue]
   804   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0332307:Type [Qualitative Concept]
   804   C0596901:Membrane [Cell Component]
   804   C1547052:*Type [Quantitative Concept]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706182:Membrane [Manufactured Object]
   804   C1706515:Matrix [Body Substance]
   733 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "broad-spectrum proteolytic capacities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1516240:Capacity [Quantitative Concept]

Phrase: "comparable to many matrix metalloproteinases."
Processing 00000000.tx.613: Eur. 

Phrase: "Eur."
Processing 00000000.tx.614: J. 

Phrase: "J."
Processing 00000000.tx.615: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.616: 250:751757.[Abstract] Corbett, S.A., C.L. 

Phrase: "250"

Phrase: ":"

Phrase: "751757."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Corbett,"

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.617: Wilson, and J.E. 

Phrase: "Wilson,"

Phrase: "and"

Phrase: "J.E."
Processing 00000000.tx.618: Schwarzbauer. 

Phrase: "Schwarzbauer."
Processing 00000000.tx.619: 1996. 

Phrase: "1996."
Processing 00000000.tx.620: Changes in cell spreading and cytoskeletal organization are induced by adhesion to a fibronectin-fibrin matrix. 

Phrase: "Changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "spreading"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332261:Spreading [Qualitative Concept]
   966 E C1947932:Spread [Activity]

Phrase: "and"

Phrase: "cytoskeletal organization"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1511632:Cytoskeletal Organization [Cell Function]
   861   C0029237:Organisation [Physiologic Function]
   861   C0029246:Organization [Organization]
   861   C0220885:organization [Qualitative Concept]
   861   C1300196:Organization [Functional Concept]
   861   C1522486:Organization [Professional or Occupational Group]

Phrase: "are"

Phrase: "induced by adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001511:Adhesion [Pathologic Function]
   790   C0175633:Adhesion [Natural Phenomenon or Process]
   790   C0205263:Induced [Functional Concept]

Phrase: "to a fibronectin-fibrin matrix."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]
Processing 00000000.tx.621: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.622: 88:158166.[Abstract/Free FullText] Nehls, V., and R. 

Phrase: "88"

Phrase: ":"

Phrase: "158166."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nehls,"

Phrase: "V.,"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.623: Herrmann. 

Phrase: "Herrmann."
Processing 00000000.tx.624: 1996. 

Phrase: "1996."
Processing 00000000.tx.625: The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. 

Phrase: "The configuration of fibrin clots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449830:Configuration [Spatial Concept]
   760   C2827597:Configuration [Conceptual Entity]

Phrase: "determines"

Phrase: "capillary morphogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026559:Morphogenesis [Organism Function]

Phrase: "and"

Phrase: "endothelial cell migration."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1624612:endothelial cell migration [Cell Function]
   901   C1622501:Migration, Cell [Cell Function]
   827   C0600210:Migration [Social Behavior]
   827   C1533574:Migration [Physiologic Function]
   827   C1881827:MIGRATION [Phenomenon or Process]
   734   C0225336:Endothelial cell [Cell]
Processing 00000000.tx.626: Microvasc. 

Phrase: "Microvasc."
Processing 00000000.tx.627: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.628: 51:347364.[CrossRef][Medline] Okada, A., C. 

Phrase: "51"

Phrase: ":"

Phrase: "347364."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Okada,"

Phrase: "A.,"

Phrase: "C."
Processing 00000000.tx.629: Tomasetto, Y. 

Phrase: "Tomasetto,"

Phrase: "Y."
Processing 00000000.tx.630: Lutz, J.-P. 

Phrase: "Lutz,"

Phrase: "J.-P."
Processing 00000000.tx.631: Belocq, M.-C. 

Phrase: "Belocq,"

Phrase: "M.-C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.632: Rio, and P. 

Phrase: "Rio,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445581:Rio [Intellectual Product]

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.633: Basset. 

Phrase: "Basset."
Processing 00000000.tx.634: 1997. 

Phrase: "1997."
Processing 00000000.tx.635: Expression of matrix metalloproteinases during rat skin wound healing: Evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. 

Phrase: "Expression of matrix metalloproteinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "during rat skin wound healing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0043240:Wound Healing [Organism Function]
           Healing
   812   C0205249:Healing [Functional Concept]

Phrase: ":"

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that membrane type-1 matrix metalloproteinase"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0671550:Membrane-Type-1 Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1618608:membrane-type 1 matrix metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   924   C0256102:Membrane-Type Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0441729:Type 1 [Classification]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025255:Membrane [Tissue]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0332307:Type [Qualitative Concept]
   804   C0596901:Membrane [Cell Component]
   804   C1547052:*Type [Quantitative Concept]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706182:Membrane [Manufactured Object]
   804   C1706515:Matrix [Body Substance]
   733 E C0205287:Membranous [Qualitative Concept]

Phrase: "is"

Phrase: "a stromal activator of pro-gelatinase A."
Processing 00000000.tx.636: J. 

Phrase: "J."
Processing 00000000.tx.637: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.638: 137:6777.[Abstract/Free FullText] Pilcher, B.K., J.A. 

Phrase: "137"

Phrase: ":"

Phrase: "6777."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pilcher,"

Phrase: "B.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "J."

Phrase: "A."
Processing 00000000.tx.639: Dumin, B.D. 

Phrase: "Dumin,"

Phrase: "B.D."
Processing 00000000.tx.640: Sudbeck, S.M. 

Phrase: "Sudbeck,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.641: Krane, H.G. 

Phrase: "Krane,"

Phrase: "H.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560020:h g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.642: Welgus, and W.C. 

Phrase: "Welgus,"

Phrase: "and"

Phrase: "W.C."
Processing 00000000.tx.643: Parks. 

Phrase: "Parks."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562547:parks [Manufactured Object]
   966 E C3160718:PARK [Disease or Syndrome]
Processing 00000000.tx.644: 1997. 

Phrase: "1997."
Processing 00000000.tx.645: The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. 

Phrase: "The activity of collagenase-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1150174:collagenase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "required for keratinocyte migration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1656945:keratinocyte migration [Cell Function]
   770   C0022567:keratinocyte [Cell]
   770   C0600210:Migration [Social Behavior]
   770   C1514873:Required [Functional Concept]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "on a type I collagen matrix."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1704640:Matrix [Spatial Concept]
   812   C1706515:Matrix [Body Substance]
   756   C0041455:Type 1 Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.646: J. 

Phrase: "J."
Processing 00000000.tx.647: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.648: 137:14451457.[Abstract/Free FullText] Koshikawa, N., G. 

Phrase: "137"

Phrase: ":"

Phrase: "14451457."

Phrase: "[Abstract/Free FullText"

Phrase: "] Koshikawa,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.649: Giannelli, V. 

Phrase: "Giannelli,"

Phrase: "V."
Processing 00000000.tx.650: Cirulli, K. 

Phrase: "Cirulli,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.651: Miyazaki, and V. 

Phrase: "Miyazaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0315755:Miyazaki [Bacterium]

Phrase: "and"

Phrase: "V."
Processing 00000000.tx.652: Quaranta. 

Phrase: "Quaranta."
Processing 00000000.tx.653: 2000. 

Phrase: "2000."
Processing 00000000.tx.654: Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. 

Phrase: "Role of cell surface metalloprotease MT1-MMP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in epithelial cell migration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2611926:epithelial cell migration [Cell Function]
   901   C1622501:Migration, Cell [Cell Function]
   827   C0600210:Migration [Social Behavior]
   827   C1533574:Migration [Physiologic Function]
   827   C1881827:MIGRATION [Phenomenon or Process]
   734   C0014597:Epithelial cell [Cell]

Phrase: "over laminin-5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0171955:laminin-5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.655: J. 

Phrase: "J."
Processing 00000000.tx.656: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.657: 148:615624.[Abstract/Free FullText] Belkin, A.M., S.S. 

Phrase: "148"

Phrase: ":"

Phrase: "615624."

Phrase: "[Abstract/Free FullText"

Phrase: "] Belkin,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.658: Akimov, L.S. 

Phrase: "Akimov,"

Phrase: "L.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.659: Zaritskaya, B.I. 

Phrase: "Zaritskaya,"

Phrase: "B.I."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.660: Ratnikov, E.I. 

Phrase: "Ratnikov,"

Phrase: "E.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.661: Deryugina, and A.Y. 

Phrase: "Deryugina,"

Phrase: "and"

Phrase: "A.Y."
Processing 00000000.tx.662: Strongin. 

Phrase: "Strongin."
Processing 00000000.tx.663: 2001. 

Phrase: "2001."
Processing 00000000.tx.664: Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. 

Phrase: "Matrix-dependent proteolysis of surface transglutaminase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597304:Proteolysis [Molecular Function]

Phrase: "by membrane-type metalloproteinase"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0025255:Membrane [Tissue]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0332307:Type [Qualitative Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "regulates"

Phrase: "cancer cell adhesion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   734   C0334227:Cancer Cell [Cell]

Phrase: "and"

Phrase: "locomotion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023946:Locomotion [Organism Function]
Processing 00000000.tx.665: J. 

Phrase: "J."
Processing 00000000.tx.666: Biol. 

Phrase: "Biol."
Processing 00000000.tx.667: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.668: 276:1841518422.[Abstract/Free FullText] Behrendtsen, O., and Z Werb. 

Phrase: "276"

Phrase: ":"

Phrase: "1841518422."

Phrase: "[Abstract/Free FullText"

Phrase: "] Behrendtsen,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Z Werb."
Processing 00000000.tx.669: 1997. 

Phrase: "1997."
Processing 00000000.tx.670: Metalloproteinases regulate parietal endoderm differentiating and migrating in cultured mouse embryos. 

Phrase: "Metalloproteinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "regulate"

Phrase: "parietal endoderm"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014144:Endoderm [Embryonic Structure]
   861   C0442030:Parietal [Spatial Concept]
   789 E C0521461:Endodermal [Body Location or Region]

Phrase: "differentiating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205615:differentiating [Qualitative Concept]

Phrase: "and"

Phrase: "migrating in cultured mouse embryos."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0013935:Embryos [Embryonic Structure]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0232902:migrating [Functional Concept]
   726 E C1305370:Embryo [Embryonic Structure]
Processing 00000000.tx.671: Dev. 

Phrase: "Dev."
Processing 00000000.tx.672: Dyn. 

Phrase: "Dyn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600130:dyn [Quantitative Concept]
Processing 00000000.tx.673: 208:255-265.[CrossRef][Medline] Makela, M., H. 

Phrase: "208"

Phrase: ":"

Phrase: "255-265."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Makela,"

Phrase: "M."

Phrase: ","

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.674: Larjava, E. 

Phrase: "Larjava,"

Phrase: "E."
Processing 00000000.tx.675: Pirila, P. 

Phrase: "Pirila,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.676: Maisi, T. 

Phrase: "Maisi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.677: Salo, T. 

Phrase: "Salo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.678: Sorsa, and V.-J. 

Phrase: "Sorsa,"

Phrase: "and"

Phrase: "V.-J."
Processing 00000000.tx.679: Uitto. 

Phrase: "Uitto."
Processing 00000000.tx.680: 1999. 

Phrase: "1999."
Processing 00000000.tx.681: Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. 

Phrase: "Matrix metalloproteinase 2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0172537:Matrix Metalloproteinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334522:MATRIX METALLOPROTEINASE 2 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(gelatinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206528:Gelatinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "A)"

Phrase: "is"

Phrase: "related to migration of keratinocytes."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   781   C1656945:keratinocyte migration [Cell Function]
   760   C0022567:Keratinocytes [Cell]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]
   726 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.682: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.683: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.684: 251:6778.[CrossRef][Medline] Kim, M.H., R.P. 

Phrase: "251"

Phrase: ":"

Phrase: "6778."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kim,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "R.P."
Processing 00000000.tx.685: Kitson, P. 

Phrase: "Kitson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.686: Albertsson, U. 

Phrase: "Albertsson,"

Phrase: "U."
Processing 00000000.tx.687: Nannmark, P.H. 

Phrase: "Nannmark,"

Phrase: "P.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.688: Basse, P.J.K. 

Phrase: "Basse,"

Phrase: "P.J.K."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2346601:J/K [Quantitative Concept]
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.689: Kuppen, M.E. 

Phrase: "Kuppen,"

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.690: Hodland, and R.H. 

Phrase: "Hodland,"

Phrase: "and"

Phrase: "R.H."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.691: Goldfarb. 

Phrase: "Goldfarb."
Processing 00000000.tx.692: 2000. 

Phrase: "2000."
Processing 00000000.tx.693: Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors. 

Phrase: "Secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "and"

Phrase: "membrane-associated matrix metalloproteinases of IL-2-activated NK cells"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0256102:Matrix Metalloproteinases, Membrane-Associated [Amino Acid, Peptide, or Protein,Enzyme]
   766   C0598414:cell associated matrix [Tissue]
   761   C0172537:Matrix Metalloproteinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   761   C1334522:MATRIX METALLOPROTEINASE 2 [Gene or Genome]
   760   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   741   C1383501:Cell Matrix [Cell Component]
   739   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1704640:Matrix [Spatial Concept]
   739   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "their inhibitors."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.694: J. 

Phrase: "J."
Processing 00000000.tx.695: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.696: 164:58835889.[Abstract/Free FullText] Yamanaka, H., K. 

Phrase: "164"

Phrase: ":"

Phrase: "58835889."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yamanaka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.697: Makino, M. 

Phrase: "Makino,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.698: Takizawa, H. 

Phrase: "Takizawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.699: Nakamura, N. 

Phrase: "Nakamura,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.700: Fujimoto, H. 

Phrase: "Fujimoto,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.701: Moriya, R. 

Phrase: "Moriya,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.702: Nemori, H. 

Phrase: "Nemori,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.703: Sato, M. 

Phrase: "Sato,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.704: Seiki, and Y. 

Phrase: "Seiki,"

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.705: Okada. 

Phrase: "Okada."
Processing 00000000.tx.706: 2000. 

Phrase: "2000."
Processing 00000000.tx.707: Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in rheumatoid synovium. 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "tissue localization of membrane-types 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3 matrix metalloproteinases in rheumatoid synovium."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0164371:Matrix Metalloproteinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1366358:MATRIX METALLOPROTEINASE 3 [Gene or Genome]
   790   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]
Processing 00000000.tx.708: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.709: Invest. 

Phrase: "Invest."
Processing 00000000.tx.710: 80:677687.[Medline] Shofuda, K.-I., H. 

Phrase: "80"

Phrase: ":"

Phrase: "677687."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shofuda,"

Phrase: "K.-I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.711: Yasumitsu, A. 

Phrase: "Yasumitsu,"

Phrase: "A."
Processing 00000000.tx.712: Nishihashi, K. 

Phrase: "Nishihashi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.713: Miki, and K. 

Phrase: "Miki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2681565:MIKI [Gene or Genome]

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.714: Miyazaki. 

Phrase: "Miyazaki."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0315755:Miyazaki [Bacterium]
Processing 00000000.tx.715: 1997. 

Phrase: "1997."
Processing 00000000.tx.716: Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain. 

Phrase: "Expression of three membrane-type matrix metalloproteinases (MT-MMPs)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in rat vascular smooth muscle cells"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "and"

Phrase: "characterization of MT3-MMPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "with"

Phrase: "and without transmembrane domain."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1519623:Transmembrane Domain [Amino Acid Sequence]
   770   C1167322:transmembrane [Cell Component]
   770   C1515981:And [Idea or Concept]
   770   C1880389:Domain [Functional Concept]
   770   C1883221:Domain [Conceptual Entity]
   770   C2752508:transmembrane [Cell Component]
   770   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.717: J. 

Phrase: "J."
Processing 00000000.tx.718: Biol. 

Phrase: "Biol."
Processing 00000000.tx.719: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.720: 272:97499754.[Abstract/Free FullText] Fjorn, S.F., N. 

Phrase: "272"

Phrase: ":"

Phrase: "97499754."

Phrase: "[Abstract/Free FullText"

Phrase: "] Fjorn,"

Phrase: "S.F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.721: Hastrup, J.F. 

Phrase: "Hastrup,"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.722: Larsen, L.R. 

Phrase: "Larsen,"

Phrase: "L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.723: Lund, and C. 

Phrase: "Lund,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.724: Pyke. 

Phrase: "Pyke."
Processing 00000000.tx.725: 2000. 

Phrase: "2000."
Processing 00000000.tx.726: Messenger RNA for membrane-type 2 matrix metalloproteinase, MT2-MMP, is expressed in human placenta of first trimester. 

Phrase: "Messenger RNA for membrane-type 2 matrix metalloproteinase,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0335218:Messenger [Professional or Occupational Group]
   703   C0528100:Membrane-Type-2 Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "MT2-MMP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0528100:MT2-Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "is"

Phrase: "expressed in human placenta of first trimester."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C3641799:First in Human [Event]
   778   C0032979:Trimester, First [Temporal Concept]
   748   C0032043:Placenta [Embryonic Structure]
   748   C0032982:Trimester [Temporal Concept]
   748   C0086418:Human [Human]
   748   C0205435:First [Quantitative Concept]
   748   C1278988:Placenta [Embryonic Structure]
   748   C1279901:First [Qualitative Concept]
   748   C1550656:Placenta [Body Substance]
Processing 00000000.tx.727: Placenta. 

Phrase: "Placenta."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0032043:Placenta [Embryonic Structure]
  1000   C1278988:Placenta [Embryonic Structure]
  1000   C1550656:Placenta [Body Substance]
   928 E C0230956:Placental [Mammal]
Processing 00000000.tx.728: 21:170176.[CrossRef][Medline] Nakada, M., H. 

Phrase: "21"

Phrase: ":"

Phrase: "170176."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nakada,"

Phrase: "M."

Phrase: ","

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.729: Nakamura, E. 

Phrase: "Nakamura,"

Phrase: "E."
Processing 00000000.tx.730: Ikeda, N. 

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.731: Fujimoto, J. 

Phrase: "Fujimoto,"

Phrase: "J."
Processing 00000000.tx.732: Yamashita, H. 

Phrase: "Yamashita,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.733: Sato, M. 

Phrase: "Sato,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.734: Seiki, and Y. 

Phrase: "Seiki,"

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.735: Okada. 

Phrase: "Okada."
Processing 00000000.tx.736: 1999. 

Phrase: "1999."
Processing 00000000.tx.737: Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "tissue localization of membrane-type 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3 matrix metalloproteinases in human astrocytic tumors."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   788   C0164371:Matrix Metalloproteinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   788   C1366358:MATRIX METALLOPROTEINASE 3 [Gene or Genome]
   778   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1704640:Matrix [Spatial Concept]
   748   C1706515:Matrix [Body Substance]
Processing 00000000.tx.738: Am. 

Phrase: "Am."
Processing 00000000.tx.739: J. 

Phrase: "J."
Processing 00000000.tx.740: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.741: 154:417428.[Abstract/Free FullText] Shofuda, K.-I., Y. 

Phrase: "154"

Phrase: ":"

Phrase: "417428."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shofuda,"

Phrase: "K.-I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Y."
Processing 00000000.tx.742: Nagashima, K. 

Phrase: "Nagashima,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.743: Kawahara, H. 

Phrase: "Kawahara,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.744: Yasumitsu, K. 

Phrase: "Yasumitsu,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.745: Miki, and K. 

Phrase: "Miki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2681565:MIKI [Gene or Genome]

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.746: Miyazaki. 

Phrase: "Miyazaki."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0315755:Miyazaki [Bacterium]
Processing 00000000.tx.747: 1998. 

Phrase: "1998."
Processing 00000000.tx.748: Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury. 

Phrase: "Elevated expression of membrane-type 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "3 matrix metalloproteinases in rat vascular smooth muscle cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0164371:Matrix Metalloproteinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C1366358:MATRIX METALLOPROTEINASE 3 [Gene or Genome]
   764   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   745   C1383501:Cell Matrix [Cell Component]
   742   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1704640:Matrix [Spatial Concept]
   742   C1706515:Matrix [Body Substance]

Phrase: "activated by arterial injury."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0340652:Arterial injury [Injury or Poisoning]
   770   C0003842:Arterial [Body Part, Organ, or Organ Component]
   770   C0221464:Arterial [Spatial Concept]
   770   C1879547:Activated [Activity]
   770   C3263722:Injury [Injury or Poisoning]
   770   C3263723:Injury [Injury or Poisoning]
   737 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.749: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.750: Invest. 

Phrase: "Invest."
Processing 00000000.tx.751: 78:915923.[Medline] Pei, D., and S.J. 

Phrase: "78"

Phrase: ":"

Phrase: "915923."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pei,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0814202:PEI [Intellectual Product]
  1000   C1880568:PEI [Therapeutic or Preventive Procedure]

Phrase: "D."

Phrase: ","

Phrase: "and S.J."
Processing 00000000.tx.752: Weiss. 

Phrase: "Weiss."
Processing 00000000.tx.753: 1995. 

Phrase: "1995."
Processing 00000000.tx.754: Furin-dependent intracellular activation of the human stromelysin-3 zymogen. 

Phrase: "Furin-dependent intracellular activation of the human stromelysin-3 zymogen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1622116:zymogen activation [Molecular Function]
   739   C1879547:Activation [Activity]
Processing 00000000.tx.755: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.756: 375:244247.[CrossRef][Medline] Carr, M.E., Jr., and B.M. 

Phrase: "375"

Phrase: ":"

Phrase: "244247."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Carr,"

Phrase: "M."

Phrase: "E.,"

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "B.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.757: Alving. 

Phrase: "Alving."
Processing 00000000.tx.758: 1995. 

Phrase: "1995."
Processing 00000000.tx.759: Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. 

Phrase: "Effect of fibrin structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on plasmin-mediated dissolution"

Phrase: "of plasma clots."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0302148:clots [Acquired Abnormality]
   827 E C0009074:CLOT [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.760: Blood Coagul. 

Phrase: "Blood Coagul."
Processing 00000000.tx.761: Fibrinolysis. 

Phrase: "Fibrinolysis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0016017:Fibrinolysis [Physiologic Function]
  1000   C1305868:Fibrinolysis [Laboratory Procedure]
   928 E C0040044:Fibrinolytic [Therapeutic or Preventive Procedure]
Processing 00000000.tx.762: 6:567573.[Medline] Carr, M.E., Jr., D.A. 

Phrase: "6"

Phrase: ":"

Phrase: "567573."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Carr,"

Phrase: "M."

Phrase: "E.,"

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.763: Gabriel, and J. 

Phrase: "Gabriel,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.764: McDonagh. 

Phrase: "McDonagh."
Processing 00000000.tx.765: 1987. 

Phrase: "1987."
Processing 00000000.tx.766: Influence of factor XIII and fibronectin on fiber size and density in thrombin-induced fibrin gels. 

Phrase: "Influence of factor XIII"

Phrase: "and"

Phrase: "fibronectin on fiber size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "density in thrombin-induced fibrin gels."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178587:density [Quantitative Concept]
Processing 00000000.tx.767: J. 

Phrase: "J."
Processing 00000000.tx.768: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.769: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.770: Med. 

Phrase: "Med."
Processing 00000000.tx.771: 110:747752.[Medline] Collet, J.P., D. 

Phrase: "110"

Phrase: ":"

Phrase: "747752."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Collet,"

Phrase: "J.P.,"

Phrase: "D."
Processing 00000000.tx.772: Park, C. 

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.773: Lesty, J. 

Phrase: "Lesty,"

Phrase: "J."
Processing 00000000.tx.774: Soria, C. 

Phrase: "Soria,"

Phrase: "C."
Processing 00000000.tx.775: Soria, G. 

Phrase: "Soria,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.776: Montalescot, and J.W. 

Phrase: "Montalescot,"

Phrase: "and"

Phrase: "J.W."
Processing 00000000.tx.777: Weisel. 

Phrase: "Weisel."
Processing 00000000.tx.778: 2000. 

Phrase: "2000."
Processing 00000000.tx.779: Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed. 

Phrase: "Influence of fibrin network conformation"

Phrase: "and"

Phrase: "fibrin fiber diameter on fibrinolysis speed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1301886:Diameter [Quantitative Concept]
Processing 00000000.tx.780: Arterioscler. 

Phrase: "Arterioscler."
Processing 00000000.tx.781: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.782: Vasc. 

Phrase: "Vasc."
Processing 00000000.tx.783: Biol. 

Phrase: "Biol."
Processing 00000000.tx.784: 20:13541361.[Abstract/Free FullText] Pei, D., and S.J. 

Phrase: "20"

Phrase: ":"

Phrase: "13541361."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pei,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0814202:PEI [Intellectual Product]
  1000   C1880568:PEI [Therapeutic or Preventive Procedure]

Phrase: "D."

Phrase: ","

Phrase: "and S.J."
Processing 00000000.tx.785: Weiss. 

Phrase: "Weiss."
Processing 00000000.tx.786: 1996. 

Phrase: "1996."
Processing 00000000.tx.787: Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 activate progelatinase A and express intrinsic matrix-degrading activity. 

Phrase: "Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "progelatinase A"

Phrase: "and"

Phrase: "express"

Phrase: "intrinsic matrix-degrading activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.788: J. 

Phrase: "J."
Processing 00000000.tx.789: Biol. 

Phrase: "Biol."
Processing 00000000.tx.790: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.791: 271:91359140.[Abstract/Free FullText] Ohuchi, E., K. 

Phrase: "271"

Phrase: ":"

Phrase: "91359140."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ohuchi,"

Phrase: "E.,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.792: Imai, Y. 

Phrase: "Imai,"

Phrase: "Y."
Processing 00000000.tx.793: Fujii, H. 

Phrase: "Fujii,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.794: Sato, M. 

Phrase: "Sato,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.795: Seiki, and Y. 

Phrase: "Seiki,"

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.796: Okada. 

Phrase: "Okada."
Processing 00000000.tx.797: 1997. 

Phrase: "1997."
Processing 00000000.tx.798: Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. 

Phrase: "Membrane type 1 matrix metalloproteinase"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0671550:Membrane-Type-1 Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1618608:membrane-type 1 matrix metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   924   C0256102:Membrane-Type Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0441729:Type 1 [Classification]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025255:Membrane [Tissue]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0332307:Type [Qualitative Concept]
   804   C0596901:Membrane [Cell Component]
   804   C1547052:*Type [Quantitative Concept]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706182:Membrane [Manufactured Object]
   804   C1706515:Matrix [Body Substance]
   733 E C0205287:Membranous [Qualitative Concept]

Phrase: "digests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:Digests [Physiologic Function]

Phrase: "interstitial collagens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0009325:Collagens [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827 E C1167364:collagen [Cell Component]
   777 E C0439689:Collagenous [Qualitative Concept]

Phrase: "and"

Phrase: "other extracellular matrix macromolecules."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178735:macromolecules [Chemical Viewed Structurally]
   734   C0015350:Extracellular Matrix [Tissue]
Processing 00000000.tx.799: J. 

Phrase: "J."
Processing 00000000.tx.800: Biol. 

Phrase: "Biol."
Processing 00000000.tx.801: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.802: 272:24462451.[Abstract/Free FullText] Shimada, T., H. 

Phrase: "272"

Phrase: ":"

Phrase: "24462451."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.803: Nakamura, E. 

Phrase: "Nakamura,"

Phrase: "E."
Processing 00000000.tx.804: Ohuchi, Y. 

Phrase: "Ohuchi,"

Phrase: "Y."
Processing 00000000.tx.805: Fujii, Y. 

Phrase: "Fujii,"

Phrase: "Y."
Processing 00000000.tx.806: Murakami, H. 

Phrase: "Murakami,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.807: Sato, M. 

Phrase: "Sato,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.808: Seiki, and Y. 

Phrase: "Seiki,"

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.809: Okada. 

Phrase: "Okada."
Processing 00000000.tx.810: 1999. 

Phrase: "1999."
Processing 00000000.tx.811: Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase. 

Phrase: "Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C1880022:Characterization [Activity]
Processing 00000000.tx.812: Eur. 

Phrase: "Eur."
Processing 00000000.tx.813: J. 

Phrase: "J."
Processing 00000000.tx.814: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.815: 262:907914.[Abstract/Free FullText] Creemers, E., J. 

Phrase: "262"

Phrase: ":"

Phrase: "907914."

Phrase: "[Abstract/Free FullText"

Phrase: "] Creemers,"

Phrase: "E.,"

Phrase: "J."
Processing 00000000.tx.816: Cleutjens, J. 

Phrase: "Cleutjens,"

Phrase: "J."
Processing 00000000.tx.817: Smits, S. 

Phrase: "Smits,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.818: Heymans, L. 

Phrase: "Heymans,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.819: Moons, D. 

Phrase: "Moons,"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
  1000   C0079853:Moons [Geographic Area]
   907 E C0037125:Silver [Element, Ion, or Isotope]
   907 E C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   907 E C1305285:Silver [Qualitative Concept]
   907 E C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   880 E C0003782:Argyria [Injury or Poisoning]
   880 E C3463959:Argyria [Eukaryote]

Phrase: "D."
Processing 00000000.tx.820: Collen, M. 

Phrase: "Collen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.821: Daemen, and P. 

Phrase: "Daemen,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.822: Carmeliet. 

Phrase: "Carmeliet."
Processing 00000000.tx.823: 2000. 

Phrase: "2000."
Processing 00000000.tx.824: Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. 

Phrase: "Disruption of the plasminogen gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "abolishes"

Phrase: "wound healing after myocardial infarction."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0043240:Wound Healing [Organism Function]
           Healing
   797 E C0574776:healing wound [Finding]
   797 E C1265679:healing wound [Anatomical Abnormality]
   760   C0043250:Wound [Injury or Poisoning]
   760   C0205249:Healing [Functional Concept]
   726 E C0016204:Wind NOS [Sign or Symptom]
   726 E C0043187:Wind [Natural Phenomenon or Process]
Processing 00000000.tx.825: Am. 

Phrase: "Am."
Processing 00000000.tx.826: J. 

Phrase: "J."
Processing 00000000.tx.827: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.828: 156:18651873.[Abstract/Free FullText] Shi, C., A. 

Phrase: "156"

Phrase: ":"

Phrase: "18651873."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shi,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.829: Patel, D. 

Phrase: "Patel,"

Phrase: "D."
Processing 00000000.tx.830: Zhang, H. 

Phrase: "Zhang,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.831: Wang, P. 

Phrase: "Wang,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.832: Carmeliet, G.L. 

Phrase: "Carmeliet,"

Phrase: "G.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439294:g l [Quantitative Concept]
Processing 00000000.tx.833: Reed, M.-E. 

Phrase: "Reed,"

Phrase: "M.-"

Phrase: "E."
Processing 00000000.tx.834: Lee, E. 

Phrase: "Lee,"

Phrase: "E."
Processing 00000000.tx.835: Haber, and N.E.S. 

Phrase: "Haber,"

Phrase: "and"

Phrase: "N.E.S."
Processing 00000000.tx.836: Sibinga. 

Phrase: "Sibinga."
Processing 00000000.tx.837: 1999. 

Phrase: "1999."
Processing 00000000.tx.838: Plasminogen is not required for neointima formation in a mouse model of vein graft stenosis. 

Phrase: "Plasminogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required for neointima formation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2936381:Neointima Formation [Pathologic Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1514873:Required [Functional Concept]
   770   C1522492:Formation [Functional Concept]
   770   C2936380:Neointima [Acquired Abnormality]

Phrase: "in a mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "of vein graft stenosis."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0009814:Stenosis [Pathologic Function]
   827   C0678234:stenosis [Qualitative Concept]
   827   C0947637:Stenosis [Pathologic Function]
   827   C1261287:Stenosis [Anatomical Abnormality]
   827   C2632116:Stenosis [Eukaryote]
   755 E C0333181:Stenotic [Functional Concept]
Processing 00000000.tx.839: Circ. 

Phrase: "Circ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332520:Circ [Quantitative Concept]
  1000   C2347774:circ [Quantitative Concept]
Processing 00000000.tx.840: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.841: 84:883890.[Abstract/Free FullText] Bajou, K., V. 

Phrase: "84"

Phrase: ":"

Phrase: "883890."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bajou,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "V."
Processing 00000000.tx.842: Masson, R.D. 

Phrase: "Masson,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.843: Gerald, P.M. 

Phrase: "Gerald,"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.844: Schmitt, V. 

Phrase: "Schmitt,"

Phrase: "V."
Processing 00000000.tx.845: Albert, M. 

Phrase: "Albert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.846: Praus, L.R. 

Phrase: "Praus,"

Phrase: "L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.847: Lund, T.L. 

Phrase: "Lund,"

Phrase: "T.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.848: Frandsen, N. 

Phrase: "Frandsen,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.849: Brunner, K. 

Phrase: "Brunner,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.850: Dano, et al. 

Phrase: "Dano,"

Phrase: "et al."
Processing 00000000.tx.851: 2001. 

Phrase: "2001."
Processing 00000000.tx.852: The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: Implications for antiangiogenic strategies. 

Phrase: "The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0027686:Vascularisation [Pathologic Function]
   735   C0042382:Vascularisation [Functional Concept]

Phrase: "with proteases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "not vitronectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1336937:VITRONECTIN [Gene or Genome]

Phrase: ":"

Phrase: "Implications for antiangiogenic strategies."
Processing 00000000.tx.853: J. 

Phrase: "J."
Processing 00000000.tx.854: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.855: 152:77784.[CrossRef] Deryugina, E.I., M.A. 

Phrase: "152"

Phrase: ":"

Phrase: "77784."

Phrase: "[CrossRef"

Phrase: "] Deryugina,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.856: Bourdon, K. 

Phrase: "Bourdon,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.857: Jungwirth, J.W. 

Phrase: "Jungwirth,"

Phrase: "J.W."
Processing 00000000.tx.858: Smith, and A.Y. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "and"

Phrase: "A.Y."
Processing 00000000.tx.859: Strongin. 

Phrase: "Strongin."
Processing 00000000.tx.860: 2000. 

Phrase: "2000."
Processing 00000000.tx.861: Functional activation of integrin V3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. 

Phrase: "Functional activation of integrin V3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C2247060:integrin activation [Cell Function]
   760   C1879547:Activation [Activity]

Phrase: "in tumor cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0431085:Tumor cells [Cell]
   966 E C0597032:Tumor Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "membrane-type 1 matrix metalloproteinase."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0671550:Membrane-Type-1 Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1618608:membrane-type 1 matrix metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   924   C0256102:Membrane-Type Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0441729:Type 1 [Classification]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025255:Membrane [Tissue]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0332307:Type [Qualitative Concept]
   804   C0596901:Membrane [Cell Component]
   804   C1547052:*Type [Quantitative Concept]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706182:Membrane [Manufactured Object]
   804   C1706515:Matrix [Body Substance]
   733 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.862: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.863: J. 

Phrase: "J."
Processing 00000000.tx.864: Cancer. 

Phrase: "Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]
Processing 00000000.tx.865: 86:1523.[Medline] Dong, J., L.K. 

Phrase: "86"

Phrase: ":"

Phrase: "1523."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dong,"

Phrase: "J.,"

Phrase: "L.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.866: Opresko, P.J. 

Phrase: "Opresko,"

Phrase: "P.J."
Processing 00000000.tx.867: Dempsey, D.A. 

Phrase: "Dempsey,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.868: Lauffenburger, R.J. 

Phrase: "Lauffenburger,"

Phrase: "R.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.869: Coffey, and H.S. 

Phrase: "Coffey,"

Phrase: "and"

Phrase: "H.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.870: Wiley. 

Phrase: "Wiley."
Processing 00000000.tx.871: 1999. 

Phrase: "1999."
Processing 00000000.tx.872: Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. 

Phrase: "Metalloprotease-mediated ligand release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "regulates"

Phrase: "autocrine signaling through the epidermal growth factor receptor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0525010:Autocrine Signaling [Cell Function]
   767   C1514762:Receptor Signaling [Molecular Function]
   744   C0037083:Signaling [Cell Function]
   744   C3537152:signaling [Biologic Function]
Processing 00000000.tx.873: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.874: Natl. 

Phrase: "Natl."
Processing 00000000.tx.875: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.876: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.877: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.878: 96:62356240.[Abstract/Free FullText] Eguchi, S., P.J. 

Phrase: "96"

Phrase: ":"

Phrase: "62356240."

Phrase: "[Abstract/Free FullText"

Phrase: "] Eguchi,"

Phrase: "S."

Phrase: ","

Phrase: "P.J."
Processing 00000000.tx.879: Dempsey, G.D. 

Phrase: "Dempsey,"

Phrase: "G.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439417:g d [Quantitative Concept]
Processing 00000000.tx.880: Frank, E.D. 

Phrase: "Frank,"

Phrase: "E.D."
Processing 00000000.tx.881: Motley, and T. 

Phrase: "Motley,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.882: Inagami. 

Phrase: "Inagami."
Processing 00000000.tx.883: 2001. 

Phrase: "2001."
Processing 00000000.tx.884: Activation of MAPKs by angiotensin II in vascular smooth muscle cells. 

Phrase: "Activation of MAPKs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C1155551:MAPK activation [Molecular Function]
   790   C1879547:Activation [Activity]

Phrase: "by angiotensin II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003009:Angiotensin 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in vascular smooth muscle cells."
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]
Processing 00000000.tx.885: Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. 

Phrase: "Metalloprotease-dependent EGF receptor activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1514758:Receptor Activation [Cell Function]
   804   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "required for activation of ERK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514873:Required [Functional Concept]
   760   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "p38 MAPK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120843:MAPK, p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "not for JNK."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1150587:JNK [Molecular Function]
   790   C1367731:JNK [Gene or Genome]
   790   C1518422:Not [Functional Concept]
   790   C1705632:JNK [Gene or Genome]
Processing 00000000.tx.886: J. 

Phrase: "J."
Processing 00000000.tx.887: Biol. 

Phrase: "Biol."
Processing 00000000.tx.888: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.889: 276:79577962.[Abstract/Free FullText] Nath, D., N.J. 

Phrase: "276"

Phrase: ":"

Phrase: "79577962."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nath,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538040:NATH [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "N.J."
Processing 00000000.tx.890: Williamson, R. 

Phrase: "Williamson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.891: Jarvis, and G. 

Phrase: "Jarvis,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.892: Murphy. 

Phrase: "Murphy."
Processing 00000000.tx.893: 2001. 

Phrase: "2001."
Processing 00000000.tx.894: Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase. 

Phrase: "Shedding of c-"

Phrase: "Met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "is"

Phrase: "regulated by crosstalk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010357:Crosstalk [Molecular Function]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C2986468:Cross-talk [Cell Function]

Phrase: "between a G-protein coupled receptor"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0682972:G Protein-Coupled Receptor [Amino Acid, Peptide, or Protein,Receptor]
   875   C0597357:protein receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   861   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439267:g% [Quantitative Concept]
   812   C1948027:Coupled [Functional Concept]
   779 E C0010222:couple [Family Group]

Phrase: "and"

Phrase: "the EGF receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034802:Receptor, EGF [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "is"

Phrase: "mediated by a TIMP-3 sensitive metalloproteinase."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0210492:TIMP-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C1527365:TIMP-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0332324:Sensitive [Functional Concept]
   748   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.895: J. 

Phrase: "J."
Processing 00000000.tx.896: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.897: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.898: 114:13131220. 

Phrase: "114"

Phrase: ":"

Phrase: "13131220."
Processing 00000000.tx.899: Hoegy, S.E., H.-R. 

Phrase: "Hoegy,"

Phrase: "S."

Phrase: "E.,"

Phrase: "H.-R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.900: Oh, M.L. 

Phrase: "Oh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "M.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.901: Corcoran, and W.G. 

Phrase: "Corcoran,"

Phrase: "and"

Phrase: "W.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.902: Stetler-Stevenson. 

Phrase: "Stetler-Stevenson."
Processing 00000000.tx.903: 2001. 

Phrase: "2001."
Processing 00000000.tx.904: Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition. 

Phrase: "Tissue inhibitor of metalloproteinases-2 (TIMP-2)"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C3178655:Tissue Inhibitor of Metalloproteinases 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase Inhibitor 2
   991 E C0145946:Tissue Inhibitor of Metalloproteinase-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-2 Tissue Inhibitor
   991 E C1336629:TISSUE INHIBITOR OF METALLOPROTEINASE 2 [Gene or Genome]
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "TKR-growth factor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "signaling independent of metalloproteinase inhibition."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0332291:Independent of [Functional Concept]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0037083:Signaling [Cell Function]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.905: J. 

Phrase: "J."
Processing 00000000.tx.906: Biol. 

Phrase: "Biol."
Processing 00000000.tx.907: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.908: 276:32033214.[Abstract/Free FullText] Stracke, J.O., M. 

Phrase: "276"

Phrase: ":"

Phrase: "32033214."

Phrase: "[Abstract/Free FullText"

Phrase: "] Stracke,"

Phrase: "J.O.,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.909: Hutton, M. 

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.910: Stewart, A.M. 

Phrase: "Stewart,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551641:Stewart [Population Group]

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.911: Pendas, B. 

Phrase: "Pendas,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.912: Smith, C. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.913: Lopez-Otin, G. 

Phrase: "Lopez-Otin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.914: Murphy, and V. 

Phrase: "Murphy,"

Phrase: "and"

Phrase: "V."
Processing 00000000.tx.915: Knauper. 

Phrase: "Knauper."
Processing 00000000.tx.916: 2000. 

Phrase: "2000."
Processing 00000000.tx.917: Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. 

Phrase: "Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1880022:Characterization [Activity]
Processing 00000000.tx.918: J. 

Phrase: "J."
Processing 00000000.tx.919: Biol. 

Phrase: "Biol."
Processing 00000000.tx.920: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.921: 275:1480914816.[Abstract/Free FullText] Miyamori, H., T. 

Phrase: "275"

Phrase: ":"

Phrase: "1480914816."

Phrase: "[Abstract/Free FullText"

Phrase: "] Miyamori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.922: Takino, M. 

Phrase: "Takino,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.923: Seiki, and H. 

Phrase: "Seiki,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.924: Sato. 

Phrase: "Sato."
Processing 00000000.tx.925: 2000. 

Phrase: "2000."
Processing 00000000.tx.926: Human membrane type-2 matrix metalloproteinase is defective in cell-associated activation of progelatinase A. 

Phrase: "Human membrane type-2 matrix metalloproteinase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1568286:membrane-type 2 matrix metalloproteinase, human [Amino Acid, Peptide, or Protein,Enzyme]
   947   C0528100:Membrane-Type-2 Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   895   C0256102:Membrane-Type Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1704640:Matrix [Spatial Concept]
   799   C1706515:Matrix [Body Substance]

Phrase: "is"

Phrase: "defective in cell-associated activation of progelatinase A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1326120:cell activation [Cell Function]
   744   C1879547:Activation [Activity]
Processing 00000000.tx.927: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.928: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.929: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.930: Commun. 

Phrase: "Commun."
Processing 00000000.tx.931: 267:796800.[CrossRef][Medline] Itoh, Y., M. 

Phrase: "267"

Phrase: ":"

Phrase: "796800."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Itoh,"

Phrase: "Y.,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.932: Kajita, H. 

Phrase: "Kajita,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.933: Kinoh, H. 

Phrase: "Kinoh,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.934: Mori, A. 

Phrase: "Mori,"

Phrase: "A."
Processing 00000000.tx.935: Okada, and M. 

Phrase: "Okada,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.936: Seiki. 

Phrase: "Seiki."
Processing 00000000.tx.937: 1999. 

Phrase: "1999."
Processing 00000000.tx.938: Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. 

Phrase: "Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1569872:Membrane-Type 4 Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   924   C0256102:Membrane-Type Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]

Phrase: "is"

Phrase: "a glycosylphosphatidylinositol-anchored proteinase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1622131:proteinase [Molecular Function]
   827   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.939: J. 

Phrase: "J."
Processing 00000000.tx.940: Biol. 

Phrase: "Biol."
Processing 00000000.tx.941: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.942: 274:3426034266.[Abstract/Free FullText] Nakahara, H., L. 

Phrase: "274"

Phrase: ":"

Phrase: "3426034266."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nakahara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.943: Howard, E.W. 

Phrase: "Howard,"

Phrase: "E.W."
Processing 00000000.tx.944: Thompson, H. 

Phrase: "Thompson,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.945: Sato, M. 

Phrase: "Sato,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.946: Seiki, Y. 

Phrase: "Seiki,"

Phrase: "Y."
Processing 00000000.tx.947: Yeh, and W.-T. 

Phrase: "Yeh,"

Phrase: "and"

Phrase: "W.-T."
Processing 00000000.tx.948: Chen. 

Phrase: "Chen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]
Processing 00000000.tx.949: 1997. 

Phrase: "1997."
Processing 00000000.tx.950: Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. 

Phrase: "Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   846   C1818621:membrane docking [Cell Function]
   790   C0442632:docking [Manufactured Object]
   790   C1522290:Docking [Molecular Function]
   756 E C0330386:Dock [Plant]

Phrase: "to invadopodia"

Phrase: "is"

Phrase: "required for cell invasion."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C2699153:Cell Invasion [Pathologic Function]
           Invasion
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1269955:Invasion [Finding]
   770   C1514873:Required [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.951: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.952: Natl. 

Phrase: "Natl."
Processing 00000000.tx.953: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.954: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.955: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.956: 94:79597964.[Abstract/Free FullText] Lehti, K., H. 

Phrase: "94"

Phrase: ":"

Phrase: "79597964."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lehti,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.957: Valtanen, S. 

Phrase: "Valtanen,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.958: Wickstrom, J. 

Phrase: "Wickstrom,"

Phrase: "J."
Processing 00000000.tx.959: Lohi, and J. 

Phrase: "Lohi,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.960: Keski-Oja. 

Phrase: "Keski-Oja."
Processing 00000000.tx.961: 2000. 

Phrase: "2000."
Processing 00000000.tx.962: Regulation of membrane-type 1 matrix metalloproteinase activity by its cytoplasmic domain. 

Phrase: "Regulation of membrane-type 1 matrix metalloproteinase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   703   C0671550:Membrane-Type-1 Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   703   C1618608:membrane-type 1 matrix metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "by its cytoplasmic domain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1511625:Cytoplasmic Domain [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.963: J. 

Phrase: "J."
Processing 00000000.tx.964: Biol. 

Phrase: "Biol."
Processing 00000000.tx.965: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.966: 275:1500615013.[Abstract/Free FullText] Tokumaru, S., S. 

Phrase: "275"

Phrase: ":"

Phrase: "1500615013."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tokumaru,"

Phrase: "S."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.967: Higashiyama, T. 

Phrase: "Higashiyama,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.968: Endo, T. 

Phrase: "Endo, T."
Processing 00000000.tx.969: Nakagawa, J.-I., Miyagawa, K. 

Phrase: "Nakagawa,"

Phrase: "J.-I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Miyagawa,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.970: Yamamori, Y. 

Phrase: "Yamamori,"

Phrase: "Y."
Processing 00000000.tx.971: Hanakawa, H. 

Phrase: "Hanakawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.972: Ohmoto, K. 

Phrase: "Ohmoto,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.973: Yoshino, Y. 

Phrase: "Yoshino,"

Phrase: "Y."
Processing 00000000.tx.974: Shirakata, et al. 

Phrase: "Shirakata,"

Phrase: "et al."
Processing 00000000.tx.975: 2000. 

Phrase: "2000."
Processing 00000000.tx.976: Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. 

Phrase: "Ectodomain shedding of epidermal growth factor receptor ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C1621321:receptor shedding [Molecular Function]

Phrase: "is"

Phrase: "required for keratinocyte migration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1656945:keratinocyte migration [Cell Function]
   770   C0022567:keratinocyte [Cell]
   770   C0600210:Migration [Social Behavior]
   770   C1514873:Required [Functional Concept]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "in cutaneous wound healing."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0043240:Wound Healing [Organism Function]
           Healing
   873   C0564444:skin wound [Injury or Poisoning]
   827   C0043250:Wound [Injury or Poisoning]
   827   C0205249:Healing [Functional Concept]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.977: J. 

Phrase: "J."
Processing 00000000.tx.978: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.979: 151:209219.[Abstract/Free FullText] Siebenlist, K.R., and M.W. 

Phrase: "151"

Phrase: ":"

Phrase: "209219."

Phrase: "[Abstract/Free FullText"

Phrase: "] Siebenlist,"

Phrase: "K.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "M."

Phrase: "W."
Processing 00000000.tx.980: Mosessons. 

Phrase: "Mosessons."
Processing 00000000.tx.981: 1994. 

Phrase: "1994."
Processing 00000000.tx.982: Progressive cross-linking of fibrin chains increases resistance to fibrinolysis. 

Phrase: "Progressive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205329:Progressive [Functional Concept]

Phrase: "cross-linking of fibrin chains"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332220:Cross-linking [Functional Concept]
   790 E C0178576:Cross link [Natural Phenomenon or Process]
   760   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0337112:chains [Manufactured Object]
   760   C1524075:Chains [Idea or Concept]
   760   C2828360:Cross [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "resistance to fibrinolysis."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   847   C0332325:Resistant to [Functional Concept]
       E   Resistant
   790   C0237834:Resistance [Mental Process]
   790   C1514892:Resistance [Physiologic Function]
   718 E C1550464:resistent [Idea or Concept]
   718 E C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.983: J. 

Phrase: "J."
Processing 00000000.tx.984: Biol. 

Phrase: "Biol."
Processing 00000000.tx.985: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.986: 269:2841428419.[Abstract/Free FullText] Imai, K., E. 

Phrase: "269"

Phrase: ":"

Phrase: "2841428419."

Phrase: "[Abstract/Free FullText"

Phrase: "] Imai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "E."
Processing 00000000.tx.987: Ohuchi, T. 

Phrase: "Ohuchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.988: Aoki, H. 

Phrase: "Aoki,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.989: Nomura, Y. 

Phrase: "Nomura,"

Phrase: "Y."
Processing 00000000.tx.990: Fujii, H. 

Phrase: "Fujii,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.991: Sato, M. 

Phrase: "Sato,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.992: Seiki, and Y. 

Phrase: "Seiki,"

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.993: Okada. 

Phrase: "Okada."
Processing 00000000.tx.994: 1996. 

Phrase: "1996."
Processing 00000000.tx.995: Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. 

Phrase: "Membrane-type matrix metalloproteinase 1"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
  1000   C0671550:Membrane-Type Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417203:MEMBRANE-TYPE MATRIX METALLOPROTEINASE 1 [Gene or Genome]
  1000   C1618608:Membrane-Type Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0256102:Membrane-Type Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0127082:Matrix Metalloproteinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1417199:MATRIX METALLOPROTEINASE 1 [Gene or Genome]
   875   C0441729:Type 1 [Classification]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0025255:Membrane [Tissue]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0332307:Type [Qualitative Concept]
   804   C0596901:Membrane [Cell Component]
   804   C1547052:*Type [Quantitative Concept]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706182:Membrane [Manufactured Object]
   804   C1706515:Matrix [Body Substance]
   733 E C0205287:Membranous [Qualitative Concept]

Phrase: "is"

Phrase: "a gelatinolytic enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "secreted in a complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439855:Complex [Qualitative Concept]
   770   C1327616:Secreted [Cell Function]
   770   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "with tissue inhibitor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "of metalloproteinases 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.996: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.997: 56:27072710.[Abstract]

Phrase: "56"

Phrase: ":"

Phrase: "27072710."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

